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ABSTRACT 
 
PART I: THE STUDY OF 2-ARYL-1,3-DITHIANE DERIVATIVES AS 
PRONUCLEOPHILES IN PALLADIUM-CATALYZED ALLYLIC ALKYLATION AND 
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Chapter 1 and 2 detail studies of 2-aryl-1,3-dithianes as pronucleophiles in 
palladium-catalyzed allylic alkylation and propellylation to access skeletally diverse aryl 
alkyl ketone cores. Allylic carbonate and [1.1.1]propellane electrophiles successfully 
couple with in situ generated 2-sodio-1,3-dithiane nucleophiles to afford the corresponding 
products in good to excellent yields. Deprotection of these products leads to valuable aryl 
alkyl ketones. The palladium-catalyzed allylic alkylation of 2-aryl-1,3-dithianes is 
examined in chapter 1. A direct synthesis of b,g-unsaturated ketones via a one-pot 
allylation-oxidation protocol is also presented. Additionally, the utility of this method is 
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demonstrated through a sequential one-pot allylation-Heck cyclization to produce 
asterogynin derivatives which are important bioactive compounds in medicinal chemistry. 
Chapter 2 discloses a general method for the synthesis of bicyclo[1.1.1]pentane 
(BCP)-containing dithianes which, upon deprotection, provide access to BCP analogues 
of medicinally abundant diarylketones. Transformation of the dithiane part into a variety of 
functional groups such as BCP aryl difluoromethanes and BCP esteare demonstrated. A 
computational study indicates that the reaction of 2-aryl-1,3-dithianes and 
[1.1.1]propellane proceeds via a two-electron pathway.  
Chapter 3 focuses on a protocol for ligand-free palladium catalyzed allylic 
amination of in situ generated hydrazone nucleophiles at room temperature. This method 
is effective and applicable for a variety of hydrazones in excellent yields and also 
economical due to low palladium loading and ligand-free conditions. In addition, we 
demonstrated an example of tandem allylation-Fischer indole cyclization to afford the core 
structure of antifungal drug. 
In chapter 4, we introduce detailed on novel synthesis of (Z/E)-1,3-diiodobut-2-ene 
and (E)-1,3-diiodo-2-methylprop-1-ene which are considered as precursors of Criegee 
intermediates methyl vinyl ketone oxide (MVK-oxide) and methacrolein oxide (MARC-
oxide) respectively.  
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CHAPTER 1 
Palladium-Catalyzed Allylic Alkylation of 2-Aryl-1,3-dithianes, An Umpolung 
Synthesis of β,γ-Unsaturated Ketones 
1.1 Introduction 
β,γ-Unsaturated ketones are important building blocks for the synthesis of 
bioactive compounds used in the pharmaceutical industry.[1] Some examples include 
griseofulvin, isopinnatal, nidemone, and trichostatin A (Figure 1-1). The synthesis of β,γ-
unsaturated ketones is challenging, however, due to their facile isomerization to the 
thermodynamically favored α,β-unsaturated ketones.[2] 
 
 
Figure 1-1 Examples of β,γ-unsaturated ketone motifs in pharmaceuticals.  
 
Although several methods have been reported for the synthesis of β,γ-unsaturated 
ketones, only a few procedures are practical. The acylation of olefins, for example, is a 
potentially useful and common procedure to access β,γ-unsaturated ketones, but α,β-
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unsaturated ketone byproducts are nearly always observed and usually very difficult to 
separate from the desired products.[3] A variety of allylic organometallics[4] have been used 
with acyl halides to generate β,γ-unsaturated ketones in moderate to good yields (Scheme 
1-1, a). Unfortunately, these multi-step procedures are time-consuming and complicated 
by the need to synthesize and purify the intermediates, which limits their application.[4d, 5] 
In 2012, Nagalakshmi and coworkers demonstrated that copper nano particle could be 
employed as a heterogeneous catalyst for the allylation of acid chlorides; however, the 
scope of this reaction is limited to linear allyl halides (Scheme 1-1, b).[6] Thus, it is clear 
that new methods to prepare a wide range of β,γ-unsaturated ketones in high yields are 
very desirable. 
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Scheme 1-1. β,γ-Unsaturated ketone synthesis. 
 
Retrosynthetic analysis of β,γ-unsaturated ketones leads to two possible disconnections, 
the more traditional acid chloride and allyl anion approach and the less common allyl 
cation and the acyl anion equivalent (Figure 1-2). Acyl anion equivalents can be generated 
by a variety of methods, the most well-known of which is the use of 1,3-dithiane 
nucleophiles. 
Ar
SS
Ar Ar'
SS
H
Pd/NIXANTPHOS
base
R Cl
O
Br R
OCu (nano particle)
THF, 24 oC
R Cl
O
Br R
OIn
DMF/H2O 
24 oC
R'
R"
a. Bindi
Ar
SS Ar
SS
H
Pd/SPhos 
NaN(SiMe3)2 (2 equiv)
DME, 24 oC, 3 h
OBoc
Ar'Br
Ar Ar'
O
Ar
O
After deprotection:
After deprotection:
Ar
OBoc
ArAr
SS
H
Pd/L*
Ar Ar
Ar
S
S
After deprotection:
Ar Ar Ar Ar
or
Ar O Ar
b. Nagalakshmi
c. Walsh and Schmink
d. Zhang
e. This work
up to 96% ee
4 
 
 
Figure 1-2. Retrosynthesis of β,γ-unsaturated ketones. 
 
The concept of umpolung synthesis, or dipole inversion, was demonstrated by Corey and 
Seebach in 1965 with the introduction of metallated dithianes.[7] It was shown that 1,3-
dithianes could be deprotonated with strong bases, such as n-butyllithium, and employed 
as acyl anion equivalents with a variety of electrophiles. Following this breakthrough, 
metallated 1,3-dithianes became well-established reagents in organic synthesis and are 
widely used in C–C bond formation. [8] Although the reactivity of metallated 1,3-dithianes 
has been well-developed over the years, it is surprising that only a handful of publications 
have reported the use of 1,3-dithianes in transition metal catalyzed reactions. In our effort 
to develop deprotonative cross-coupling processes (DCCP),[9] we became interested in 
the coupling of 2-aryl-1,3-dithianes to aryl halides under conditions where the dithianes 
are reversibly deprotonated in the presence of base.  Based on this approach, we 
developed an arylation of dithianes and demonstrated its application to the synthesis of 
medicinally relevant benzophenone derivatives (Scheme 1-1, c).[10] Schmink and 
coworkers simultaneously reported very similar conditions for this coupling reaction.[11] 
Since several of the nucleophiles we employed in arylation reactions also found utility in 
palladium and nickel catalyzed allylic substitution reactions, we decided to investigate 
metallated 1,3-dithianes in allylic alkylation reactions. During our investigations, Liu, 
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Zhang and coworkers published an enantioselective allylic substitution (up to 96% ee) with 
Boc activated (E)-1,3-diarylprop-2-en-1-ols (Scheme 1-1, d).[12]  There is little overlap 
between their choices of electrophiles and the ones presented herein. 
Herein we report a room-temperature palladium-catalyzed allylic alkylation of 1,3-
dithianes to form β,γ-unsaturated ketone equivalents in good to excellent yields (Scheme 
1-1, e) and a one-pot allylic alkylation-deprotection to generate β,γ-unsaturated ketones 
directly with yields up to 90%. To further demonstrate the utility of this method, a sequential 
dithiane initiated allylic substitution-Heck cyclization to afford the core structure of 
asterogynin is presented. Experiments to probe the stereochemistry of the reaction point 
to a mechanism that involves exo-attack of the metallated 1,3-dithiane on the π-allyl 
palladium intermediate, indicating that the metallated dithiane behaves as a “soft” 
nucleophile (double inversion mechanism). 
 
1.2 Results and discussion 
We carried out optimization studies using 2-phenyl-1,3-dithiane 1-1a as a pronucleophile 
and tert-butyl cyclohex-2-enyl carbonate 1-2a as an electrophilic partner. Initially, we 
conducted the allylic alkylation reaction using conditions similar to those employed in our 
arylation of 2-aryl-1,3-dithianes and allylic alkylation of diarylmethanes,[13] which are 
Pd(OAc)2 (10 mol %), van Leeuwen’s NIXANTPHOS[14] (20 mol %), NaN(SiMe3)2 (2 
equiv), and DME solvent at room temperature (Scheme 2). After 3 h the allylic substitution 
product was afforded in 70% assay yield (AY), as determined by 1H NMR of the crude 
reaction mixture. We next examined palladium precursors Pd(dba)2, Cl2Pd(NCPh)2 and 
[PdCl(C3H5)]2. Catalyst prepared from Cl2Pd(NCPh)2 showed the highest activity, affording 
product 1-3aa in 84% AY. 
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Scheme 1-12. Initial lab scale (0.1 mmol) optimization using NIXANTPHOS as ligand with 
different Pd sources. 
 
In search of a more efficient catalyst, we then screened 42 diverse mono- and bidentate 
phosphine ligands (10–20 mol %) and 2 bases, Li/NaN(SiMe)2, using microscale (10 μmol) 
high-throughput experiments (HTE) (see Supporting Information for details). The results 
revealed that the most promising hits were CataCXium PCy[15] and SPhos.[16] Employing 
the two top hits on laboratory scale (0.1 mmol) led to product 1-3aa in 94% (CataCXium 
PCy) and 92% (SPhos) AY, respectively. We chose to continue with SPhos, because it is 
more economical. 
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Scheme 1-3. Ligand identification in the allylic substitution. 
 
With the optimized Pd/ligand combination, we next studied the Pd-phosphine ratio. 
Decreasing the palladium-ligand ratio from 10 and 20 mol % to 10 and 15 mol % did not 
impact the yield (Table 1-1, entry 1). However, 10 mol % of each resulted in a drop in the 
AY of 1-3aa to 83% yield (entry 2). We next examined the impact of reducing the palladium 
and ligand loading. Decreasing the palladium loading from 10 to 2.5 mol % with 3.75 mol 
% SPhos provided the allylation product in 95% AY (entry 3). Further decreasing catalyst 
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loading to 1.0 mol % Pd and 1.5 mol% SPhos resulted in 60% AY (entry 4). Reaction 
concentrations also impact the reaction outcome. Reducing the concentration of 1-1a from 
0.2 to 0.1 M provided AY of 97%, whereas further reduction to 0.05 caused the assay yield 
to fall to 84% (entries 5–6). Reducing the equivalents of the electrophile from 2 to 1.5 gave 
96% AY, but further reduction to 1.2 equiv caused a decrease in AY to 84% (entries 7–8). 
Heating the reaction mixture to 60 °C caused increased decomposition of the electrophile 
1-2a and decreased the AY of 1-3aa to 87% (entry 9). The optimized conditions in entry 7 
were then used to examine the scope of nucleophiles. 
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Table 1-1. Optimization of allylic alkylation of 1a.a,b 
 
 
aReactions conducted on 0.1 mmol scale. bAssay yields (AY) determined by 1H NMR spectroscopy 
of the crude reaction mixture. 
 
1.2.1. Scope of Nucleophiles in the Palladium-Catalyzed Allylic Alkylation Reaction.  
Having identified the optimal conditions, we explored allylic alkylation with tert-butyl 
cyclohex-2-en-1-yl carbonate 1-2a and a variety of 1,3-dithiane pronucleophiles. The 
parent 2-phenyl-1,3-dithiane furnished the product 1-3aa in 95% isolated yield.  
Ph
SS
Ph
SS
H
OBoc Cl2Pd(NCPh)2 X mol %
 SPhos Y mol %
 NaN(SiMe3)2 (2 equiv)
DME, Conc, temp, 3 h
 1-1a              1-2a                                                         1-3aa
1 equiv         1.5 equiv
Entry X/Y 
(mol %) 
1a:2a T 
oC 
Conc. 
(M) 
AY 
(%) 
1 10/15 1:2 rt 0.2 95 
2 10/10 1:2 rt 0.2 84 
3 2.5/3.75 1:2 rt 0.2 95 
4 1/1.5 1:2 rt 0.2 60 
5 2.5/3.75 1:2 rt 0.1 97  
6 2.5/3.75 1:2 rt 0.05 84 
7 2.5/3.75 1:1.5 rt 0.1 96 
8 2.5/3.75 1:1.2 rt 0.1 84 
9 2.5/3.75 1:1.5 60 0.1 87 
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Pronucleophiles with electron donating groups are less acidic and more challenging to 
deprotonate.   Nonetheless, both 2-(4-tolyl)-1,3-dithiane and 2-(4-methoxyphenyl)-1,3-
dithiane gave the corresponding products, 1-3ba and 1-3ca in 74 and 77% yields, 
respectively. Pronucleophiles with electron withdrawing groups underwent substitution to 
give excellent yields. Thus, 2-(3-methoxyphenyl)-, 2-(4-fluorophenyl)-, 2-(3-fluorophenyl)-
, and 2-(3-trifluoromethylphenyl)-1,3-dithianes underwent Pd catalyzed allylation with 1-
2a to afford 1-3da, 1-3ea, 1-3fa and 1-3ga in 83, 99, 90 and 89% yields, respectively. A 
sterically hindered substrate 2-(1-napthalyl)-1,3-dithiane reacted to afford 1-3ha29 in 70% 
yield; however, 2-(2-tolyl)-1,3-dithiane did not perform well under the established reaction 
conditions, giving only 8% yield. The heterocyclic substrate 2-(3-thiophenyl)-1,3-dithiane 
reacted to provide 1-3ia in 71% yield, but 2-(3-furyl)-1,3-dithiane was not an effective 
pronucleophile in this reaction.                                                                                                                       
In order to be useful, reactions must be scalable. To examine the scalability of our 
substitution, the allylation of 2-thiophen-1,3-dithiane with 1-2a was examined on 4.9 mmol 
scale (1.0 g), providing the corresponding product 1-3ia in 69% yield (0.96 g). 
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Table 1-2. Scope of nucleophiles in allylic alkylation with 1-2a.a,b  
 
 
aReactions conducted on 0.1 mmol scale. bIsolated yields after chromatographic purification. c4.9 
mmol 1-2a. 
 
1.2.2. Scope of Electrophiles in the Palladium-Catalyzed Allylic Alkylation reaction.  
Ar
SS
Ar
SS
H
OBoc Cl2Pd(NCPh)2 2.5 mol %
SPhos 3.75 mol %
NaN(SiMe3)2 (2 equiv)
DME, rt, 3 h
SS
1-3aa, 95%                  1-3ba, 74%                  1-3ca, 77%
SS SS
MeO
SS
OMe
SS
F
SS
F
  1-3da, 83%                  1-3ea, 99%                  1-3fa, 90%
SS
CF3
SS SS
S
1-3ga, 89%              1-3ha, 70%                  1-3ia, 71%
(0.96 g, 69%)[c]
 1-1a–i         1-2a –2ah                                          1-3aa–ia
1 equiv         1.5 equiv
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Under optimal conditions, the scope of allylic carbonate derived electrophiles reacting with 
2-phenyl-1,3-dithiane 1-1a was examined (Table 1-3). Cyclopentenyl and cycloheptenyl 
electrophiles reacted to provide the desired products 1-3ab and 1-3ac in 97 and 87% 
yields, respectively. The reaction of the 7-membered ring substrate was slower and 
required a longer reaction time (16 h). In the case of linear allylic carbonate derivatives, 
CataCXium PCy performed better than SPhos under the optimized conditions. The parent 
allyl OBoc and 2-Me allyl OBoc delivered 1-3ad and 1-3ae in 87 and 88% yields after 3 h, 
respectively. Longer reaction times (16 h) were needed for unsymmetrical η3-allyl groups. 
It is known that π-allyl palladium complexes often react with carbon nucleophiles at the 
less substituted end of the π-allyl.[17] For Boc-protected prenyl alcohol 1-2f, however, the 
branched isomer 1-3af’ was slightly favored (linear:branched 1:1.7, 86% yield). The 
allylation with Boc-protected cinnamyl alcohol 2h slightly favored the linear product 1-3ah 
(80%) with linear:branched ratio of 2.2:1. Surprisingly the allylation with geranyl alcohol 1-
2g gave only linear product 1-3ag in moderate yield. 
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Table 1-3. Scope of electrophiles in allylic alkylation with 1-1a.a,b  
 
 
 
aReactions conducted on 0.1 mmol scale. bIsolated yield after chromatographic purification. c16 h. 
d3.75 mol% of CataCXium PCy. e3.75 mol% of CataCXium PCy, 16 h, ratio of linear:branched (L:B) 
determined by 1H NMR of purified reaction products. 
 
 
 
SS SS SS
SS
SS
 1-3ab, 97%             1-3ac, 87%[c]            1-3ad, 87%[d]
1-3ae, 88%[d]                      1-3ag, 69%[e]
SS
SS
Ph
SS SS
Ph
1-3af and 1-3af’, 
90%[e]                    
(L:B=1:1.7)
SS
Ph
SS
H
Cl2Pd(NCPh)2 2.5 mol %
SPhos 3.75 mol %
NaN(SiMe3)2 (2 equiv)
DME, 24 oC, 3 h
  1-1a           1-2a–2h                                           3aa–3ah
1 equiv        1.5 equiv
OBoc
R n
R
n
1-3ah and 1-3ah’, 82%[e]
(L:B=2.2:1)
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1.2.3. Probing the Stereochemistry of the Allylic Substitution.  
In Tsuji-Trost allylic alkylation reactions, the nucleophiles are divided into two classes 
based on the pKa of the pronucleophile: (1) “hard” or unstabilized nucleophiles from 
pronucleophiles with pKa values > 25 and (2) “soft” or stabilized nucleophiles from 
pronucleophiles with pKa’s < 25.[18] The difference between these two species is the nature 
of attack by the nucleophile on the π-allyl intermediate. The “hard” nucleophiles undergo 
attack on the metal center of the π-allyl palladium complex followed by reductive 
elimination. This reaction pathway proceeds by a single inversion in the allylic substitution. 
In contrast, “soft” nucleophiles directly attack the π-allyl, providing net retention of 
stereochemistry (via double inversion).  
To determine which of these two pathways was operative in our allylic substitution, 2-
phenyl-1,3-dithiane (pKa = 31[19]) was coupled with cis-disubstituted stereoprobe 1-2j to 
generate the substitution product in 92% yield as a single diastereomer (Scheme 4). 
Analysis of the 1H NMR spectrum of 1-3aj indicated that the structure was consistent with 
the cis-isomer. This result reveals that 2-phenyl-1,3-dithiane behaves as a “soft” 
nucleophile. This result is consistent with our prior work using diphenylmethane 
pronucleophiles,[17e, 20] and supports our hypothesis that soft nucleophiles should be 
classified as those with pronucleophile pKa's up to at least 32. 
 
Ph
SS
Ph
SS
H Cl2Pd(NCPh)2 2.5 mol %
SPhos 3.75 mol %
NaN(SiMe3)2 (2 equiv)
DME, 0.1 M, rt, 10 h
1-3aj,  92%          
single disatereomer
OBoc
OTBDMS
OTBDMS
1-1a
1-2j
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Scheme 1-4. Stereoprobe study indicating that the allylic substitution reaction proceeds 
via the double inversion or soft nucleophile pathway. 
1.2.4. Development of a Sequential One-Pot Umpolung Synthesis of β, γ-
Unsaturated Ketones.  
Conversion of the dithiane product to the corresponding ketone can be challenging.[21] 
With our allylic substitution products, great care must be exercised to avoid the facile 
isomerization of the alkene into conjugation with the carbonyl group. An attractive 
oxidative approach employs iodine in the conversion of 1,3-dithianes to the corresponding 
carbonyl compounds.[22] A key advantage of using iodine to remove the dithiane is that it 
avoids heavy metal reagents, such as mercury,[23] silver,[24] thallium,[25] and cerium,[26] 
some of which are toxic. In 2008, Barik and coworkers disclosed an effective protocol for 
1,3-dithiane deprotection using a combination of iodine and hydrogen peroxide in the 
presence of SDS (sodium dodecyl sulfate, proposed to stabilize reactive intermediates).[27] 
Based on these conditions, we developed a one-pot allylation-deprotection that could be 
conducted without isolation or purification of the intermediate dithiane. We found that 
hydrogen peroxide was not necessary when the deprotection was carried out over a longer 
reaction time (12 h). Thus, after the allylic alkylation step was completed, as judged by 
TLC, the crude reaction mixture was dried and I2 was added in a catalytic amount (2 mol 
%) in THF. A solution of SDS in water was then added to the flask, and the resulting 
reaction mixture was stirred at rt for 12–16 h. Using the 2-(4-tolyl)-1,3-dithiane 1-1b, 2-(2-
fluorophenyl)-1,3-dithiane 1-1f, and 2-(3-thiophenyl)-1,3-dithiane 1-1i, the corresponding 
β,γ-unsaturated ketones were isolated directly from a single reaction flask in 90 (1-4ba), 
83 (1-4fa),  and 55% yields (1-4ia), over the two steps (Table 1-4). The yield of the β,γ-
unsaturated ketone 1-4ia could be improved to 72% by isolating and purifying dithiane 1-
3ia prior to submission to the oxidative deprotection conditions. Under the two-step 
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method, allylated products with five, six and seven membered ring OBoc 1-3ab, 1-3aa 
and 1-3ac underwent deprotection to afford the corresponding β,γ-unsaturated ketones 1-
4ab, 1-4aa and- 1-4ac in 71%, 80% and 52% yields respectively.      
 
Table 1-4. Sequential one-pot synthesis of β,γ-unsaturated ketones.a,b,c 
 
 
aReactions conducted on 0.1 mmol scale. bIsolated yield after chromatographic purification. cThe 
oxidation conditions were developed based on Barik’s conditions. dAllylation product isolated and 
purified before oxidation (16 h reaction time). 
 
1.2.5. Development of a Sequential Allylation-Heck Cyclization.  
Asterogynin derivatives are important bioactive compounds in medicinal chemistry. To 
further demonstrate the synthetic value of our method, we were interested in pursuing the 
Ar H
SS
1.) Pd(NCPh)2Cl2 2.5 mol %
    SPhos 3.75 mol %
    NaN(SiMe3)2 (2 equiv)     
    DME, 24 oC, 3 h
2.) SDS (2 equiv)
     I2 (0.05 equiv) 
     H2O:THF (1:3), 24 oC, 16 h
OBoc
Ar
O
O O
F
O
S
1-4ba, 90%                     1-4fa, 83%                    1-4ia, 72%[d]
O
1-4aa, 80%[d]                      1-4ab, 71%[d]                 1-4ac, 52%[d]
O O
n
n = 0-2
n
n = 0-2
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synthesis of asterogynin derivatives via a tandem allylation-Heck cyclization. Considering 
the differences between allylic alkylation and Heck cyclization, we explored the reaction 
conditions separately. Based on the Heck reaction literature,[28] we started investigating 
the cyclization of the allylated product 1-3jb  with the combination of Cl2Pd(NCPh)2, PPh3,  
and carbonate bases in DME for 16 h at 60 °C, but under these conditions the cyclization 
product was not detected. We next studied different Pd sources, bases, solvents, and 
temperatures and found that 5 mol% Pd(OAc)2, 15 mol % PPh3, and 5 equiv of NEt3 in 
acetonitrile at 80 oC were the most promising conditions, which afforded 1-4jb in 75% yield 
(Table 5, entry 7). Based on this success, we began examining a sequential allylation-
Heck cyclization of 1-1j with different electrophiles (Scheme 1-5). After completion of the 
allylation (determined by TLC), the catalyst was removed from the crude reaction mixture 
by filtration through a pad of silica. The reaction mixture was dried under vacuum, 
dissolved in MeCN and transferred to a separate vial containing a premixed solution of 
Pd(OAc)2 and PPh3 in MeCN and NEt3. The reaction mixture was then stirred for 16 h at 
80 oC. The cyclopentenyl electrophile 1-2b reacted to afford the allylation-Heck cyclization 
product 1-4jb in 67% yield over the two steps, and the acyclic allylic carbonate 1-2d 
yielded the isolated product 1-4jd in 75% yield. In the case of the cyclohexenyl electrophile 
1-2a, the cyclization was more challenging. With this substrate, the reaction was 
conducted in DMF, and the temperature had to be increased to 120 °C. Under these 
conditions, the product 1-4ja was isolated in 71% yield (Scheme 1-5) with cis isomer 
confirmed by the crystal structure of 1-4jb (Figure 3) which was obtained by slow 
evaporation with dry THF to get colorless crystal and its ccdc number is 1854101. The 
structure crystalized in the orthorhombic space group Pca21 which showed that two 
hydrogen atoms on C8 and C12 are cis to each other.   
 
18 
 
Table 1-5. Optimization of Heck cyclization of 1-3jb.a 
 
 
Entry Pd Base Sol. T 
(oC) 
AY 
(%) 
1 Cl2Pd(NCPh)2 Ag2CO3 DME 60 0 
2 Cl2Pd(NCPh)2 Na2CO3 DME 60 0 
3 Pd(OAc)2 Ag2CO3 DME 60 0 
4 Pd(OAc)2 Na2CO3 DME 60 trace 
5 Pd(OAc)2 Na2CO3 MeCN 80 12 
6 Pd(OAc)2 NEt3 DME 60 30 
7 Pd(OAc)2 NEt3 MeCN 80 75 
aAssay yields (AY) determined by 1H NMR spectroscopy of the crude reaction mixtures. 
 
 
Figure 1-3. The structure of 1-4jb with 50% thermal ellipsoids. 
SS
Br
SS
Pd source 5 mol %
PPh3 15 mol %
base (5 equiv)
solvent, temp, 16 h
1-3jb                                                              1-4jb
H
H
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Scheme 1-5. A sequential Allylation-Heck cyclization.a,b 
aReactions conducted on 0.1 mmol scale. bIsolated yield after chromatographic purification. cHeck 
cyclization conducted in DMF at 120 oC. Allylation: Cl2Pd(NCPh)2 5 mol %, dppe 7.5 mol %, 
NaN(SiMe3)2 (2 equiv) in DME at 24 oC for 36 h. Heck cyclization: Pd(OAc)2 5 mol %, PPh3 15 mol 
%, NEt3 (5 equiv) in MeCN at 120 °C for 16 h. 
 
Finally, we conducted a one-pot allylation-Heck cyclization-deprotection process using 
dithiane 1-1j and the cyclopentenyl-OBoc 1-2b (Scheme 1-6, see Supporting Information 
for experimental details). The ketone derivative 1-5jb was isolated in 52% overall yield 
over three steps. 
 
 
Scheme 1-6. A one-pot synthesis of 1-5jb.a,b 
 
H
SS
Br
OBoc
OBoc
OBoc
SS
SS
1-1j1-4jb, 67%
1-4ja, 71%[c]
1-4jd, 75%
1-2b
1-2a
1-2d
SS
H
H H
H
H
SS
Br
  1-1j               1-2b                                                  1-5jb
1 equiv          1.5 equiv                                         52% yield
OBoc
O1) Allylic substitution
2) Heck reaction
3) Deprotection
H
H
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aReactions conducted on 0.1 mmol scale. bIsolated yield after chromatographic purification. 
Allylation: Cl2Pd(NCPh)2 5 mol %, dppe 7.5 mol %, NaN(SiMe3)2 (2 equiv) in DME at 24 oC for 36 
h. Heck cyclization: Pd(OAc)2 5 mol %, PPh3 15 mol %, NEt3 (5 equiv) in MeCN at 120 °C for 16 h. 
Deprotection: SDS (0.2 equiv), I2 (0.05 equiv) in THF:H2O (3:1) at 24 °C for 16 h. 
 
1.3 Conclusion 
In summary, we have developed the palladium-catalyzed allylic alkylation of 2-aryl-1,3-
dithiane derivatives for umpolung synthesis of variously substituted β,γ-unsaturated 
ketone derivatives. This protocol is easily applicable to various substitution patterns of the 
2-aryl-1,3-dithianes and allylic electrophiles (including cyclic derivatives). In addition, 
allylated dithianes can be effectively transformed in the same reaction flask to the 
corresponding β,γ-unsaturated ketone derivatives in good yields. Importantly, our 
conditions successfully avoid isomerization of the β,γ-unsaturated ketone products. We 
also have employed this method in a sequential synthesis of asterogynin derivatives. 
Allylated o-bromo phenyl substituted dithiane derivatives can undergo Heck-type 
cyclization by a simple synthetic operation to give oligo cyclic ketones in good overall 
yields. Moreover, we have presented the first stereochemical investigation of Pd-catalyzed 
allylic substitution of 2-aryl-1,3-dithianes. The result of this study showed that 
deprotonated 2-phenyl-1,3-dithiane behaves as a “soft” nucleophile, which undergoes 
external attack on the π-allyl palladium complex under our reaction conditions.    
1.4 Experimental 
General Methods: All reactions were performed under nitrogen using oven-dried 
glassware and standard Schlenk or vacuum line techniques. Air- and moisture-sensitive 
solutions were handled under nitrogen and transferred via syringe. Anhydrous DME and 
Acetonitrile were purchased from Sigma-Aldrich and used as solvents without further 
purification. Unless otherwise stated, reagents were commercially available and used as 
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purchased without further purification. Chemicals were obtained from Sigma-Aldrich, 
Acros, TCI America or Matrix Scientific. TLC was performed with Merck TLC Silicagel60 
F254 plates and detection was under UV light at 220 nm. Silica gel (230–400 mesh, 
Silicycle) was used for flash chromatography. The 1H NMR and 13C{1H} NMR spectra were 
obtained using a Bruker AM-500 Fourier-transform NMR spectrometer at 500 and 125 
MHz, respectively. Chemical shifts are reported in units of parts per million (ppm) 
downfield from tetramethylsilane (TMS), and all coupling constants are reported in hertz. 
The infrared spectra were obtained with KBr plates using a Perkin-Elmer Spectrum 100 
Series FTIR spectrometer. High resolution mass spectrometry (HRMS) data were 
obtained on a Waters LC-TOF mass spectrometer (model LCT-XE Premier) using 
chemical ionization (CI) or electrospray ionization (ESI) in positive or negative mode, 
depending on the analyte. Melting points were determined on a Unimelt Thomas-Hoover 
melting point apparatus. 
 
Preparation of 2-aryl-1,3-dithianes and allylic electrophiles 
2-Aryl-1,3-dithianes and allylic electrophiles were prepared according to literature reports. 
The spectroscopic data matched the previous reported data[10. 13c]. 
 
Preparations and characterizations for Pd-catalyzed allylic alkylation of 2-aryl-1,3-
dithianes 
General Procedure A: An 8 mL reaction vial equipped with a stir bar was charged with 2-
aryl-1,3-dithiane (0.10 mmol, 1.0 equiv). Under a nitrogen atmosphere in a glovebox, a 
solution (from a stock solution) of Cl2Pd(NCPh)2 (1.0 mg, 0.0025 mmol) and SPhos (1.5 
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mg, 0.00375 mmol) in 0.5 mL of dry DME was taken up by micropipette (Fisher Scientific, 
1 mL tip) and added to the reaction vial. After that, the allylic partner (0.15 mmol, 1.5 equiv) 
was added to the reaction mixture using micropipette (Fisher Scientific, 200 μL tip). A 
solution of NaN(SiMe3)2 (36.8 mg, 0.20 mmol, 2.0 equiv) in 0.5 mL of dry DME was added 
to the reaction vial by micropipette (Fisher Scientific, 1 mL tip). After the addition of 
NaN(SiMe3)2 solution, the mixture turned color from pale orange to dark brown. The 
reaction vial was sealed with a closed cap, removed from the glovebox and was stirred at 
rt for 3 h. Next, the reaction mixture was quenched with 3 drops of H2O, diluted with 3 mL 
of ethyl acetate, and filtered over a pad of silica. The pad was rinsed with 6 mL ethyl 
acetate (2×3), and the solution was concentrated. The crude material was loaded onto a 
silica gel column and purified by flash chromatography with 2% ethyl acetate in hexanes. 
 
2-(Cyclohex-2-en-1-yl)-2-phenyl-1,3-dithiane (1-3aa): The reaction 
was performed following General Procedure A with 2-phenyl-1,3-
dithiane 1-1a (19.6 mg, 0.1 mmol), cyclohexenyl OBoc 1-2a (30 μL, 0.15 
mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(26.2 mg, 95% yield) as a white solid. Rf = 0.8 (Et2O/hexanes 1:5). M.p. = 72-74 °C. 1H 
NMR (500 MHz, CDCl3) δ 8.07–7.81 (m, 2H), 7.48 – 7.32 (m, 2H), 7.27–7.23 (m, 1H), 5.93 
(m, 1H), 5.86 – 5.71 (m, 1H), 2.81–2.49 (m, 5H), 1.88 (m, 4H), 1.65 (m, 1H), 1.60 – 1.42 
(m, 2H), 1.35 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 140.7, 129.9, 129.7, 128.2, 126.9, 
126.7, 64.4, 48.7, 27.5, 27.3, 25.4, 25.0, 24.6, 22.3. IR (thin film): 3026, 2927, 2359, 1487, 
1441, 908, 702 cm–1. HRMS calculated for C16H21S2: 277.1085, observed 277.1082 
[M+H]+.  
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2-(Cyclohex-2-en-1-yl)-2-(p-tolyl)-1,3-dithiane (1-3ba): The reaction 
was performed following General Procedure A with 2-(p-toly)-1,3-
dithiane 1-1b (21.0 mg, 0.1 mmol), cyclohexenyl OBoc 1-2a (30 μL, 0.15 
mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(21.4 mg, 74% yield) as colorless oil. Rf = 0.8 (Et2O/hexanes 1:5). 1H NMR (500 MHz, 
CDCl3) δ 7.80 (dd, J = 8.6, 2.1 Hz, 2H), 7.17 (d, J = 8.5 Hz, 2H), 5.95 (d, J = 11.8 Hz, 1H), 
5.78 (d, J = 9.5 Hz, 1H), 2.79 – 2.52 (m, 5H), 2.36 (s, 3H), 2.08–1.80 (m, 4H), 1.78 – 1.62 
(m, 1H), 1.62 – 1.45 (m, 2H), 1.38 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 137.5, 136.2, 
129.7, 129.5, 128.9, 126.9, 64.2, 48.7, 27.4, 27.2, 25.3, 24.9, 24.5, 22.2, 20.8. IR (thin 
film): 2984, 2941, 2908, 2256, 1739, 1447, 1373, 1239, 1047, 918, 734 cm–1. HRMS 
calculated for C17H22S2: 290.1163, observed 290.1168 [M]+.  
 
2-(Cyclohex-2-en-1-yl)-2-(4-methoxyphenyl)-1,3-dithiane (1-
3ca): The reaction was performed following General Procedure A 
with 2-(4-methoxyphenyl)-1,3-dithiane 1-1c (22.6 mg, 0.1 mmol), 
cyclohexenyl OBoc 1-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (23.6 mg, 77% yield) as colorless oil. Rf = 
0.7 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 2.2 Hz, 1H), 7.83 (d, J 
= 2.2 Hz, 1H), 6.91 (d, J = 2.2 Hz, 1H), 6.89 (d, J = 2.2 Hz, 1H), 5.95 (d, J = 10.3 Hz, 1H), 
5.80 – 5.74 (m, 1H), 3.83 (s, 3H), 2.77 – 2.66 (m, 2H), 2.61 (m, 3H), 2.01 – 1.81 (m, 4H), 
1.75 – 1.62 (m, 1H), 1.56 (m, 1H), 1.54 – 1.44 (m, 1H), 1.38 (m, 1H). 13C{1H} NMR (125 
MHz, CDCl3) δ 158.1, 132.4, 131.1, 129.5, 126.9, 113.3, 63.9, 55.2, 48.7, 27.4, 27.1, 25.4, 
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24.9, 24.5, 22.2. IR (thin film): 2984, 2908, 2256, 1740, 1446, 1373, 1240, 1046, 918, 734 
cm–1. HRMS calculated for C17H23OS2: 307.1190, observed 307.1190 [M+H]+. 
 
2-(Cyclohex-2-en-1-yl)-2-(3-methoxyphenyl)-1,3-dithiane (1-3da): 
The reaction was performed following General Procedure A with 2-(3-
methoxyphenyl)-1,3-dithiane 1-1d (22.6 mg, 0.1 mmol), cyclohexenyl 
OBoc 1-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). 
The crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (25.4 mg, 83% yield) as colorless oil. Rf = 
0.7 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.53 (t, J = 4.9 Hz, 2H), 7.28 (dd, J 
= 14.2, 6.4 Hz, 1H), 6.85-6.76 (m, 1H), 5.95 (d, J = 10.3 Hz, 1H), 5.86 – 5.71 (m, 1H), 3.82 
(s, 3H), 2.71 (m, 2H), 2.65 – 2.57 (m, 3H), 2.01 – 1.82 (m, 4H), 1.74 – 1.62 (m, 1H), 1.58 
– 1.44 (m, 2H), 1.36 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 159.6, 142.4, 129.4, 128.9, 
126.8, 122.2, 115.8, 111.6, 64.1, 55.1, 48.5, 27.4, 27.2, 25.1, 24.8, 24.5, 22.1. IR (thin 
film): 2984, 2908, 1740, 1447, 1373, 1239, 1046, 938, 847, 607 cm–1. HRMS calculated 
for C17H23OS2: 307.1190, observed 307.1193 [M+H]+. 
 
2-(Cyclohex-2-en-1-yl)-2-(4-fluoroyphenyl)-1,3-dithiane (1-3ea): 
The reaction was performed following General Procedure A with 2-
(4-fluorophenyl)-1,3-dithiane 1-1e (21.4 mg, 0.1 mmol), 
cyclohexenyl OBoc 1-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (29.1 mg, 99% yield) as colorless oil. Rf = 
0.8 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.99 – 7.85 (m, 2H), 7.15 – 6.95 (m, 
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2H), 5.93 (m, 1H), 5.79 (m, 1H), 2.79 – 2.47 (m, 5H), 2.03 – 1.82 (m, 4H), 1.67 (m, 1H), 
1.64 – 1.54 (m, 1H), 1.54 – 1.30 (m, 2H). 13C{1H} NMR (125 MHz, CDCl3) δ 162.5 (d, 1JC-
F = 245.3 Hz), 136.2, 136.2, 131.7, 131.6, 129.7, 126.5, 114.9 (d, 2JC-F = 21.1 Hz), 63.6, 
48.6, 27.4, 27.1, 25.2, 24.9, 24.5, 22.1. IR (thin film): 2983, 1740, 1373, 1240, 1046, 774 
cm–1. HRMS calculated for C16H19FS2: 294.0912, observed 294.0923 [M]+.  
2-(Cyclohex-2-en-1-yl)-2-(3-fluoroyphenyl)-1,3-dithiane (1-3fa): The 
reaction was performed following General Procedure A with 2-(3-
fluorophenyl)-1,3-dithiane 1-1f (21.4 mg, 0.1 mmol), cyclohexenyl OBoc 
1-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (26.5 mg, 90% yield) as colorless oil. Rf = 
0.8 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.81 – 7.57 (m, 2H), 7.42 – 7.27 (m, 
1H), 7.02 – 6.87 (m, 1H), 5.91 (m, 1H), 5.78 (m, 1H), 2.75 – 2.54 (m, 5H), 2.00 – 1.80 (m, 
4H), 1.66 (m, 1H), 1.60 – 1.41 (m, 2H), 1.36 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 
164.0 (d, 1JC-F = 243.3 Hz), 143.9 (d, 3JC-F = 6.3 Hz), 129.8, 129.4 (d, 3JC-F = 8.1 Hz), 126.5, 
125.5 (d, 4JC-F = 2.6 Hz), 117.0 (d, 2JC-F = 23.5 Hz), 113.7 (d, 2JC-F = 21.1 Hz), 63.6, 48.5, 
27.4, 27.2, 25.1, 24.8, 24.5, 22.1. IR (thin film): 3027, 2928, 2941, 1739, 1447, 1582, 1476, 
1422, 1225, 774, 707 cm–1. HRMS calculated for C16H19FS2: 294.0912, observed 
294.0925 [M]+. 
 
2-(Cyclohex-2-en-1-yl)-2-(3-(trifluoromethyl)phenyl)-1,3-dithiane 
(1-3ga): The reaction was performed following General Procedure A 
with 2-(3-(trifluoromethyl)phenyl)-1,3-dithiane 1-1g (26.4 mg, 0.1 
mmol), cyclohexenyl OBoc 1-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 
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(36.7 mg, 0.20 mmol). The crude product was purified by flash chromatography on silica 
gel (eluted with hexanes:ethyl acetate 98:2) to give the product (30.6 mg, 89% yield) as 
colorless oil. Rf = 0.8 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.23 (s, 1H), 8.15 
(d, J = 7.2 Hz, 1H), 7.61 – 7.44 (d, J = 7.6 Hz, 2H), 5.92 (d, J = 10.3 Hz, 1H), 5.81 (m, 1H), 
2.75 – 2.48 (m, 5H), 2.05 – 1.80 (m, 4H), 1.78 – 1.62 (m, 1H), 1.59 – 1.32 (m, 3H). 13C{1H} 
NMR (125 MHz, CDCl3) δ 142.1, 133.3, 130.7 (q, 2JC-F = 32.1 Hz), 130.2, 128.8, 127.5 (q, 
1JC-F = 271.2 Hz), 126.7 (q, 3JC-F = 3.7 Hz), 126.2, 123.6 (q, 3JC-F = 3.7 Hz), 63.6, 48.4, 
27.3, 27.1, 25.0, 24.8, 24.4, 22.1. IR (thin film): 2984, 2941, 2908, 2256, 1739, 1447, 1373, 
1239, 1046, 918, 734, 607 cm–1. HRMS calculated for C17H20F3S2: 345.0959, observed 
345.0947 [M+H]+.  
 
2-(Cyclohex-2-en-1-yl)-2-(naphthalene-1-yl)-1,3-dithiane (1-3ha): 
The reaction was performed following General Procedure A with 2-
(naphthalene-1-yl)-1,3-dithiane 1-1h (24.6 mg, 0.1 mmol), 
cyclohexenyl OBoc 1-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). 
The crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (22.8 mg, 70% yield) as a pale pink 
solid. Crystal structure was obtained by slow evaporation with THF at room tempurature. 
(see X-ray determination structure for more detail). Rf = 0.8 (Et2O/hexanes 1:5). M.p. = 
140-142 °C. 1H NMR (500 MHz, CDCl3 at 320K) δ 9.17 – 9.01 (m, 1H), 8.36 (d, J = 7.5 
Hz, 1H), 7.98 – 7.77 (m, 2H), 7.60 – 7.39 (m, 3H), 5.85 (s (br), 2H), 3.73 – 3.56 (m, 1H), 
2.74 (m, 4H), 2.13 – 1.86 (m, 4H), 1.74 (m, 2H), 1.51 – 1.19 (m, 2H). 13C{1H} NMR (125 
MHz, CDCl3 at 320K) δ 136.0, 135.5, 131.8, 131.3, 129.5, 129.4, 127.6, 125.3, 124.6, 
124.3, 65.5, 45.6, 28.0, 25.2, 25.2, 22.8. IR (thin film): 3026, 2928, 2239, 1596, 1508, 
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1422, 1391, 1276, 908, 788, 731 cm–1. HRMS calculated for C20H22S2: 326.1163, 
observed 326.1169 [M]+.  
 
2-(Cyclohex-2-en-1-yl)-2-(thiophen-3-yl)-1,3-dithiane (1-3ga): The 
reaction was performed following General Procedure A with 2-(thiophen-
2-yl)-1,3-dithiane 1-1g (20.2 mg, 0.1 mmol), cyclohexenyl OBoc 1-2a (30 
μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified 
by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the 
product (20 mg, 70% yield) as colorless oil. Rf = 0.7 (Et2O/hexanes 1:5). 1H NMR (500 
MHz, CDCl3) δ 7.48 (t, J = 2.2 Hz, 1H), 7.27 (d, J = 6.2 Hz, 2H), 5.94 (m, 1H), 5.80 (m, 
1H), 2.79 (m, 2H), 2.73 – 2.55 (m, 3H), 2.00 – 1.87 (m, 4H), 1.73 – 1.64 (m, 2H), 1.57 – 
1.50 (m, 1H), 1.41 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 143.4, 129.6, 129.2, 126.7, 
125.5, 125.2, 60.3, 47.9, 27.6, 27.3, 25.4, 24.9, 24.6, 22.1. IR (thin film): 2984, 2941, 2908, 
1741, 1447, 1373, 1240, 1046, 734, 607 cm–1. HRMS calculated for C14H19S3: 283.0649, 
observed 283.0646 [M+H]+.  
 
Gram-scale Synthesis: A 100 ml schlenk flask equipped with a stir bar was charged with 
2-(thiophen-2-yl)-1,3-dithiane 1-1g (1.0 g, 4.95 mmol). Under a nitrogen atmosphere in a 
glovebox, a solution (from a stock solution) of Cl2Pd(NCPh)2 (47.5 mg, 0.12 mmol) and 
SPhos (78.0 mg, 0.19 mmol) in 20 mL of dry DME was taken up by syringe and added to 
the reaction vial. After that, the allylic partner 1-2a (1.49 mL, 7.43 mmol) was added to the 
reaction mixture using syringe. A solution of NaN(SiMe3)2 (1.82 g, 9.90 mmol) in 20 mL of 
dry DME was added to the reaction vial by syringe. After the addition of NaN(SiMe3)2 
solution, the mixture turned color from pale orange to dark brown. The reaction vial was 
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sealed with a closed cap, removed from the glovebox and was stirred at rt for 3 h. Next, 
the reaction mixture was quenched with 10 mL of H2O and extracted with EtOAc (3 x 20 
mL), washing with brine. The organic phase was dried over anhydrous Na2SO4 and 
concentrated under vacuum. The crude material was loaded onto a silica gel column and 
purified by flash chromatography with 2% ethyl acetate in hexanes to give the product 
(0.96 g, 69%) as colorless oil. 
 
2-(Cyclopent-2-en-1-yl)-2-phenyl-1,3-dithiane (1-3ab): The reaction 
was performed following General Procedure A with 2-phenyl-1,3-
dithiane 1-1a (19.6 mg, 0.1 mmol), cyclopetenyl OBoc 1-2b (30 μL, 0.15 
mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(25.4 mg, 97% yield) as colorless oil. Rf = 0.8 (Et2O/hexanes 1:5) 1H NMR (500 MHz, 
CDCl3) δ 7.98 – 7.96 (m, 1H), 7.95 (d, J = 1.0 Hz, 1H), 7.46 – 7.31 (m, 2H), 7.32 – 7.16 
(m, 1H), 5.80 (m, 1H), 5.69 (ddd, J = 5.8, 4.1, 2.0 Hz, 1H), 3.23 (m, 1H), 2.78 – 2.52 (m, 
4H), 2.14 (m, 2H), 2.09 – 1.99 (m, 1H), 1.99 – 1.84 (m, 2H), 1.78 (m, 1H). 13C{1H} NMR 
(125 MHz, CDCl3) δ 140.7, 133.8, 129.8, 129.7, 128.2, 126.7, 64.0, 59.2, 32.2, 27.3, 27.2, 
25.4, 25.3. IR (thin film): 2902, 1447, 1373, 1239, 1047, 918, 734, 701 cm–1. HRMS 
calculated for C15H18S2: 262.0859, observed 262.0853 [M]+.  
 
2-(Cyclohent-2-en-1-yl)-2-phenyl-1,3-dithiane (1-3ac): The reaction 
was performed following General Procedure A with 2-phenyl-1,3-
dithiane 1-1a (19.6 mg, 0.1 mmol), cycloheptenyl OBoc 1-2c (30 μL, 
0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by 
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flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the 
product (25.2 mg, 87% yield) as a white solid. Rf = 0.8 (Et2O/hexanes 1:5). M.p. = 104-
106 °C. 1H NMR (500 MHz, CDCl3) δ 8.03 – 7.90 (m, 2H), 7.45 – 7.32 (m, 2H), 7.32 – 7.19 
(m, 1H), 6.10 (m, 1H), 5.81 (m, 1H), 2.88 – 2.50 (m, 5H), 2.19 – 1.99 (m, 2H), 1.99 – 1.80 
(m, 4H), 1.59 (m, 1H), 1.44 – 1.30 (m, 1H), 1.23 – 1.06 (m, 2H). 13C{1H} NMR (125 MHz, 
CDCl3) δ 140.4, 132.8, 131.3, 129.9, 128.0, 126.6, 64.2, 52.0, 31.1, 27.9 (d, J = 19.2 Hz), 
27.2 (d, J = 8.5 Hz), 25.8, 25.0. IR (thin film): 2921, 2848, 1735, 1442, 1277, 909, 733, 
705, 680 cm–1. HRMS calculated for C17H23S2: 291.1241, observed 291.1241 [M+H]+.  
 
2-Allyl-2-phenyl-1,3-dithiane (1-3ad): The reaction was performed 
following General Procedure A with 2-phenyl-1,3-dithiane 1-1a (19.6 
mg, 0.1 mmol), allyl OBoc 1-2d (26 μL, 0.15 mmol) and NaN(SiMe3)2 
(36.7 mg, 0.20 mmol). The crude product was purified by flash chromatography on silica 
gel (eluted with hexanes:ethyl acetate 98:2) to give the product (20.5 mg, 87% yield) as 
colorless oil. Rf = 0.8 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.97 – 7.87 (m, 
2H), 7.39 (m, 2H), 7.29 – 7.26 (m, 1H), 5.61 (m, 1H), 5.17 – 4.92 (m, 2H), 2.79 – 2.73 (m, 
2H), 2.73 – 2.61 (m, 4H), 1.94 (m, 2H). 13C{1H} NMR (125 MHz, CDCl3) δ 141.5, 131.8, 
130.4, 128.8, 128.4, 128.2, 127.0, 118.8, 58.2, 49.5, 27.9, 27.5, 25.09. IR (thin film): 2931, 
2908, 1639, 1482, 1270, 1107, 1030, 895 cm–1. HRMS calculated for C13H16S2: 236.0693, 
observed 236.0701 [M]+.  
 
2-(2-Methylallyl)-2-phenyl-1,3-dithiane (1-3ae): The reaction was 
performed following General Procedure A with 2-phenyl-1,3-dithiane 1-
1a (19.6 mg, 0.1 mmol), 2-methylallyl OBoc 1-2e (26 μL, 0.15 mmol) 
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and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(22.1 mg, 88% yield) as colorless oil. Rf = 0.8 (Et2O/hexanes 1:5) 1H NMR (500 MHz, 
CDCl3) δ 7.93 (d, J = 7.9 Hz, 2H), 7.37 (d, J = 7.8 Hz, 2H), 7.30 – 7.18 (m, 1H), 4.80 (d, J 
= 9.5 Hz, 1H), 4.61 (d, J = 12.3 Hz, 1H), 2.86 – 2.57 (m, 6H), 1.93 (m, 2H), 1.37 (s, 3H). 
13C{1H} NMR (125 MHz, CDCl3) δ 141.4, 139.6, 129.2, 128.3, 126.9, 116.8, 58.3, 53.3, 
27.7, 25.0, 24.3. IR (thin film): 3075, 2930, 2904, 1643, 1482, 1442, 1277, 1118, 1033, 
898, 699 cm–1. HRMS calculated for C14H18S2: 250.0850, observed 250.0853 [M]+.  
 
2-(2-Methylbut-3-en-2-yl)-2-phenyl-1,3-dithiane (1-3af): The reaction 
was performed following General Procedure A with 2-phenyl-1,3-dithiane 
1-1a (19.6 mg, 0.1 mmol), 3-methylbut-2-en-1-yl OBoc 1-2f (31 μL, 0.15 
mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(23.8 mg, 90% yield, linear: branched= 1:1.7) as colorless oil. Rf = 0.8 (Et2O/hexanes 1:5). 
1H NMR (500 MHz, CDCl3) δ 7.97 (d, J = 8.0 Hz, 2H), 7.37 (dd, J = 13.0, 6.3 Hz, 3H), 6.18 
(dd, J = 17.3, 10.8 Hz, 1H), 5.00 (d, J = 6.6 Hz, 1H), 4.96 (m, 1H), 2.79 – 2.44 (m, 4H), 
1.85 – 1.77 (m, 2H), 1.41 (s, 6H), 1.14 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) as a mixture 
δ 170.7, 141.3, 139.6, 136.0, 128.4 (dd, J = 17.8, 10.7 Hz), 128.0, 127.7, 118.0, 64.0, 
62.5, 52.0, 32.4, 30.9, 29.0, 28.06, 27.8, 25.6, 24.2, 18.0. IR (thin film): 2904, 1481, 1441, 
1378, 1277, 1155, 915, 734, 701 cm–1. HRMS calculated for C15H20S2: 264.1006, observed 
264.0991 [M]+.  
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2-Cinnamyl-2-phenyl-1,3-dithiane (1-3ah): The reaction was 
performed following General Procedure A with 2-phenyl-1,3-
dithiane 1-1a (19.6 mg, 0.1 mmol), cinnamyl OBoc 1-2h (34.5 μL, 
0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by 
flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the 
product (25 mg, 80% yield, linear: branched= 2.2 :1) as pale yellow oil. Rf = 0.7 
(Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.02 – 7.91 (m, 2H), 7.42 – 7.36 (m, 
2H), 7.33 – 7.22 (m, 5H), 7.14 – 7.08 (m, 1H), 6.33 (dt, J = 15.7, 1.4 Hz, 1H), 5.97 (dt, J = 
15.8, 7.3 Hz, 1H), 2.89 (dd, J = 7.3, 1.4 Hz, 2H), 2.76 – 2.64 (m, 4H), 1.98 – 1.90 (m, 2H). 
13C{1H} NMR (125 MHz, CDCl3) as a mixture δ 141.5, 137.1, 135.8, 133.6, 130.8, 129.8, 
128.8, 128.4, 128.3, 127.8, 127.2, 127.1, 126.9, 126.2, 123.5, 118.2, 62.6, 58.8, 48.5, 
27.4, 27.4, 24.9. IR (thin film): 2924, 2908, 2283, 1739, 1442, 1239, 1047, 734, 700 cm–1. 
HRMS calculated for C19H21S2: 313.1085, observed 313.1082 [M+H]+. 
 
(E)-2-(3,6-Dimethylhepta-2,5-dien-1-yl)-2-phenyl-1,3-
dithiane (1-3ag): The reaction was performed following 
General Procedure A with 2-phenyl-1,3-dithiane 1-1a (19.6 
mg, 0.1 mmol), E-(3,6-dimethylhepta-2,5-dien-1-yl) OBoc 1-2g (42 μL, 0.15 mmol) and 
NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(27.3 mg, 69% yield, as colorless oil. Rf = 0.8 (Et2O/hexanes 1:5). 1H NMR (500 MHz, 
CDCl3) δ 7.92 (dd, J = 8.2, 1.4 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.23 (d, J = 7.2 Hz, 1H), 
5.14 – 4.95 (m, 2H), 2.76 – 2.59 (m, 5H), 2.04 – 1.88 (m, 5H), 1.67 (s, 3H), 1.57 (s, 3H), 
1.40 (s, 3H). 13C{1H} NMR (125 MHz, CDCl3) δ 141.5, 139.2, 131.2, 129.1, 128.3, 126.7, 
124.2, 117.3, 59.7, 43.4, 39.8, 27.5, 26.5, 25.7, 25.1, 17.6, 16.2. IR (thin film): 2984, 2256, 
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1741, 1447, 1373, 1240, 1047, 918, 734, 607 cm–1.  HRMS calculated for C19H26S2: 
318.1476, observed 318.1481 [M]+.  
 
 Preparation and characterization for tert-butyl ((1S,5S)-5-((tert-
butyldimethylsilyl)methyl)cyclohex-2-en-1-yl) carbonate[30] (1-2j) 
 
 
 
 A solution of NaHCO3 9.98 g (118 mmol, 3.0 equiv) in 40 mL of H2O was added to 5.0 g 
(39.6 mmol, 1.0 equiv) of cyclohex-3-ene-1-carboxylic acid with ice cooling. After the 
suspension dissolved, a solution of KI 40.0 g (237 mmol, 6.0 equiv) and 10.0 g (39.6 mmol, 
1.0 equiv) of iodine in 20 mL of H2O was added. The mixture was warmed up to rt and 
stirred for 24 h. The reaction mixture was extracted with CH2Cl2 (3 x 100 mL), washing 
with saturated Na2S2O3 solution and brine. The organic phase was dried over Na2SO4 and 
concentrated under vacuum. The resulting yellow solid 8.1 g (82%) was dissolved in 100 
mL of THF then 7.2 mL (48.1 mmol, 1.5 equiv) of DBU was added to a mixture and the 
reaction mixture was stirred at reflux for 12 h. Upon being cooled to rt, the mixture was 
poured to 30 mL of 1 M HCl and extracted with Et2O (3 x 20 mL). The combined extracts 
were washed with brine, dried over anhydrous Na2SO4, concentrated under reduced 
pressure and chromatographed on silica gel (20% EtOAc/hexanes) affording 2.26 g (57%) 
of bicycle[3.2.1]oct-2-en-6-one as colorless oil.  
OH
O 1.NaHCO3
I2, KI, H2O
2.DBU, THF
reflux
O
O 1.LiAlH4
THF, 0 oC
2.imidazole
TBDMSCl
DMF, rt
HO
OTBDMS
BocO
OTBDMSnBuLi
Boc2O
THF, -78 to 0 oC
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To the flask with solid LiAlH4 1.1 g (27.3 mmol, 1.5 equiv), 20 mL of dry THF was added. 
The mixture was cooled to 0 °C. A solution of bicycle [3.2.1] oct-2-en-6-one 2.26 g (18.2 
mmol, 1.0 equiv) in 10 mL of dry THF was slowly added to the mixture and stirred for 3 h 
at 0 oC. Rochelle’s salt solution (1 M) 20 mL was added dropwise to quench the reaction, 
once quenched, the mixture was stirred for 1 h and extracted with EtOAc (3 x 15 mL), 
washing with water and brine. The organic phase was dried over anhydrous Na2SO4 and 
concentrated under vacuum to yield 2.25 g (96%) of (1S,5S)-5-(hydroxymethyl)cyclohex-
2-en-1-ol as yellow oil. The crude product was used in next reaction without further 
purification. 
To the flask with imidazole 2.40 g (35.2 mmol, 2.0 equiv) under nitrogen atmosphere was 
added 20 mL of dry DMF and 2.25 g (17.6 mmol, 1.0 equiv) of (1S,5S)-5-
(hydroxymethyl)cyclohex-2-en-1-ol respectively and cooled to 0 oC. To this mixture, a 
solution of 2.65 g (17.6 mmol, 1.0 equiv) of tert-butyldimethylsilyl chloride in 10 mL of DMF 
was added slowly, stirring at 0 oC for 2 h. The reaction mixture then was warmed to rt and 
stirred for 16 h. The reaction was quenched with cold water 20 mL and extracted with Et2O 
(3 x 20 mL), washing with brine. The organic phase was collected and dried over Na2SO4 
and evaporated to dryness. The crude product was purified by flash chromatography on 
silica gel (eluted with hexanes to EtOAc 90:10) to give 1.57 g (37%) of (1S,5S)-5-(((tert-
butyldimethylsilyl)oxy)methyl)cyclohex-2-en-1-ol.  
To a solution of 1.57 g (6.48 mmol, 1.0 equiv) of (1S,5S)-5-(((tert-
butyldimethylsilyl)oxy)methyl)cyclohex-2-en-1-ol in 20 mL of dry THF, after cooled to -78 
oC, nBuLi solution 7.0 mL (1.1 equiv) was added dropwise. After 15 min, the mixture was 
warmed to 0 oC and a solution of Boc2O anhydride 1.56 g (7.13 mmol, 1.1 equiv) in 10 mL 
of dry THF was added slowly. The reaction mixture then was warmed to rt and stirred for 
16 h. The reaction mixture was quench with 10 mL of 1M HCl and extracted with Et2O (3 
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x 20 mL), washing with brine. The organic phase was dried over Na2SO4 and concentrated 
under vacuum. The crude product was purified by flash chromatography on silica gel 
(eluted with hexanes to Et2O 95:5) to give 1.57 g of tert-butyl ((1S,5S)-5-(((tert-
butyldimethylsilyl)oxy)methyl)cyclohex-2-en-1-yl) carbonate as colorless oil. Rf = 0.75 
(Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 5.84 (ddd, J = 9.9, 4.7, 1.8 Hz, 1H), 5.66 
(d, J = 10.1 Hz, 1H), 5.20 (m, 1H), 3.61 – 3.41 (m, 2H), 2.16 (m, 1H), 2.05 (dd, J = 24.7, 
18.3 Hz, 1H), 1.96 – 1.87 (m, 1H), 1.84 – 1.71 (m, 1H), 1.49 (d, J = 1.2 Hz, 9H), 1.44 – 
1.29 (m, 1H), 0.89 (d, J = 1.2 Hz, 9H), 0.04 (d, J = 1.2 Hz, 6H). 13C{1H} NMR (125 MHz, 
CDCl3) δ 153.3, 130.2, 126.9, 81.9, 73.4, 67.3, 35.6, 31.4, 28.1, 27.8, 25.9, 18.3, 1.6, -5.4. 
IR (thin film): 3037, 2930, 2896, 2857, 1738, 1472, 1369, 1329, 1276, 1254, 1165, 1116, 
960, 837, 775, 682, 666, 629 cm–1. HRMS calculated for C19H34O4: 326.2457 observed 
326.2459 [M]+. 
 
Preparation and characterization for β,γ- unsaturated ketones 
 
General Procedure B: An 8 mL reaction vial equipped with a stir bar was charged with 2-
aryl-1,3-dithiane (0.10 mmol, 1.0 equiv). Under a nitrogen atmosphere in a glovebox, a 
solution (from a stock solution) of Cl2Pd(NCPh)2 (1.0 mg, 0.0025 mmol) and SPhos (1.5 
mg, 0.00375 mmol) in 0.5 mL of dry DME was taken up by micropipette and added to the 
reaction vial. After that, the allylic partner (0.15 mmol, 1.5 equiv) was added to the reaction 
mixture by micropipette followed by a solution of NaN(SiMe3)2 (36.7 mg, 0.20 mmol, 2.0 
equiv) in 0.5 mL of dry DME by syringe. After the addition of NaN(SiMe3)2 solution, the 
mixture turned color from pale orange to dark brown. The reaction vial was sealed with a 
closed cap, removed from the glovebox and stirred at rt for 3–16 h. After allylic substitution 
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finished as determined by TLC, the reaction mixture was dried under vacuum and iodine 
(1.3 mg, 0.05 equiv), SDS solution (5.8 mg, 0.2 equiv) in a mixture of H2O: THF (1:3) were 
added respectively with a syringe under air. The reaction mixture was stirred at rt for 16–
24 h. Once the dithiane product was consumed, the mixture’s color changed from dark 
red to light yellow and the reaction mixture was quenched with 3 mL of H2O, extracted with 
15 mL of ethyl acetate (5×3). The organic phase was washed with 5 mL of brine, dried 
over Na2SO4 and concentrated in vacuum. The crude material was loaded onto a silica 
gel column and purified by flash chromatography with 5% ethyl acetate in hexanes. 
 
Cyclohex-2-en-1-yl (p-tolyl)methanone (1-4ba): The reaction was 
performed following General Procedure B with 2-(p-tolyl)-1,3-dithiane 
1-1b (21 mg, 0.1 mmol), cyclohexenyl OBoc 1-2a (30 μL, 0.15 mmol) 
and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 95:5) to give the product 
(18 mg, 90% yield) as colorless oil. Rf = 0.6 (Et2O/hexanes 1:5) 1H NMR (500 MHz, CDCl3) 
δ 7.87 (d, J = 8.0 Hz, 2H), 7.26 (d, J = 8.2 Hz, 2H), 5.91 (m, 1H), 5.84 – 5.64 (m, 1H), 4.06 
(m, 1H), 2.41 (s, 3H), 2.08 (m, 2H), 1.96 (m, 1H), 1.85 (m, 2H), 1.68 (m, 1H). 13C{1H} NMR 
(125 MHz, CDCl3) δ 201.3, 143.5, 133.6, 129.8, 129.2, 128.5, 124.8, 43.7, 25.8, 24.7, 
21.5, 20.9. IR (thin film): 2984, 1740, 1373, 1240, 1046 cm–1. HRMS calculated for 
C14H16O: 200.1201, observed 200.1194 [M]+.  
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 Cyclohex-2-en-1-yl (3-fluorophenyl)methanone (1-4fa): The 
reaction was performed following General Procedure B with 2-(4-
fluorophenyl)-1,3-dithiane 1-1f (21.4 mg, 0.1 mmol), cyclohexenyl OBoc 
1-2a (26 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 95:5) to give the product (16.9 mg, 83% yield) as colorless oil. Rf = 
0.6 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.74 (dt, J = 7.7, 1.3 Hz, 1H), 7.64 
(ddd, J = 9.5, 2.7, 1.6 Hz, 1H), 7.45 (m, 1H), 7.31 – 7.23 (m, 1H), 5.94 (m, 1H), 5.72 (m, 
1H), 4.02 (m, 1H), 2.09 (m, 2H), 1.97 (m, 1H), 1.94 – 1.78 (m, 2H), 1.69 (m, 1H). 13C{1H} 
NMR (125 MHz, CDCl3) δ 200.3, 163.8 (d, 1JC-F = 246.7 Hz), 138.3 (d, 3JC-F = 5.6 Hz), 
130.3, 130.2 (d = 3JC-F = 7.7 Hz), 124.1, 124.0 (d, 4JC-F = 2.8 Hz), 119.8 (d, 2JC-F = 21.5 Hz), 
115.2 (d, 2JC-F = 21.8 Hz), 44.0, 25.6, 24.6, 20.7. IR (thin film): 2937, 2908, 2359, 1684, 
1586, 1439, 667 cm–1. HRMS calculated for C13H14FO: 205.1029, observed 205.1046 
[M+H]+.  
 Cyclohex-2-en-1-yl(thiophen-3-yl)methanone (1-4ia): The reaction 
was performed following General Procedure B with 2-(thiophen-2-yl)-
1,3-dithiane 1-1f (19.6 mg, 0.1 mmol), cyclohexenyl OBoc 1-2a (26 μL, 
0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by 
flash chromatography on silica gel (eluted with hexanes:ethyl acetate 95:5) to give the 
product (13.8 mg, 72% yield) as colorless oil. Rf = 0.6 (Et2O/hexanes 1:5). 1H NMR (500 
MHz, CDCl3) δ 8.08 (dd, J = 2.9, 1.3 Hz, 1H), 7.56 (dd, J = 5.1, 1.3 Hz, 1H), 7.32 (dd, J = 
5.1, 2.9 Hz, 1H), 6.04–5.85 (m, 1H), 5.75 (m, 1H), 3.88 (m, 1H), 2.17 – 2.03 (m, 2H), 1.98 
(m, 1H), 1.93 – 1.81 (m, 2H), 1.73–1.60 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 196.0, 
141.2, 131.9, 130.0, 127.3, 126.1, 124.6, 45.8, 25.8, 24.6, 20.8. IR (thin film): 2933, 2249, 
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1672, 1510, 1410, 1230, 1047, 909, 730 cm–1. HRMS calculated for C11H12OS: 192.0609, 
observed 192.0605 [M]+.  
 
Cyclohex-2-en-1-yl(phenyl)methanone (1-4aa): The reaction was 
performed following General Procedure B with 2-phenyl-1,3-dithiane 
1-1a (19.6 mg, 0.1 mmol), cyclohexenyl OBoc 1-2a (30 μL, 0.15 
mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 95:5) to give the product 
(14.9 mg, 80% yield) as colorless oil. Rf = 0.6 (Et2O/hexanes 1:5) 1H NMR (500 MHz, 
CDCl3) δ 8.04 – 7.88 (m, 2H), 7.63 – 7.52 (m, 1H), 7.52 – 7.42 (m, 2H), 5.92 (dtd, J = 
10.0, 3.7, 2.4 Hz, 1H), 5.86 – 5.64 (m, 1H), 4.08 (m, 1H), 2.15 – 2.02 (m, 2H), 2.02 – 
1.93 (m, 1H), 1.93 – 1.80 (m, 2H), 1.74 – 1.63 (m, 1H).13C{1H} NMR (125 MHz, CDCl3) δ 
201.6, 136.2, 132.7, 130.0, 128.5, 128.4, 124.6, 43.8, 25.7, 24.7, 20.8. IR (thin film): 
3026, 2934, 1682, 1596, 1447, 1210, 960, 695 cm–1. HRMS calculated for C13H14O: 
186.1045, observed 186.1045 [M]+.  
 
 Cyclopent-2-en-1-yl(phenyl)methanone (1-4ab): The reaction was 
performed following General Procedure B with 2-phenyl-1,3-dithiane 1-
1a (19.6 mg, 0.1 mmol), cyclopentenyl OBoc 1-2b (30 μL, 0.15 mmol) 
and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 95:5) to give the product 
(12.2 mg, 71% yield) as colorless oil. Rf = 0.6 (Et2O/hexanes 1:5) 1H NMR (500 MHz, 
CDCl3) δ 8.09 – 7.95 (m, 2H), 7.64 – 7.53 (m, 1H), 7.53 – 7.41 (m, 2H), 5.94 (m, 1H), 
5.86 – 5.72 (m, 1H), 4.49 (m, 1H), 2.52 (m, 1H), 2.44 (m, 1H), 2.37 – 2.20 (m, 2H). 
O
O
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13C{1H} NMR (125 MHz, CDCl3) δ 200.7, 136.5, 133.8, 132.8, 128.9, 128.5, 128.4, 53.8, 
32.3, 26.4. IR (thin film): 3024, 2924, 1682, 1447, 1214, 692 cm–1. HRMS calculated for 
C12H12O: 172.0886, observed 172.0888[M]+.  
 
Cyclohept-2-en-1-yl(phenyl)methanone (1-4ac): The reaction was 
performed following General Procedure B with 2-phenyl-1,3-dithiane 
1-11a (19.6 mg, 0.1 mmol), cycloheptenyl OBoc 1-2c (30 μL, 0.15 
mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 95:5) to give the product 
(10.4 mg, 52% yield) as colorless oil. Rf = 0.6 (Et2O/hexanes 1:5) 1H NMR (500 MHz, 
CDCl3) δ 7.96 (dq, J = 8.2, 1.5, 1.1 Hz, 2H), 7.60 – 7.50 (m, 1H), 7.46 (ddd, J = 8.2, 6.7, 
1.2 Hz, 2H), 6.07 – 5.87 (m, 2H), 4.32 – 4.09 (m, 1H), 2.34 – 2.18 (m, 2H), 2.17 – 2.06 
(m, 1H), 2.06 – 1.95 (m, 1H), 1.79 (m, 1H), 1.75 – 1.67 (m, 1H), 1.64 – 1.56 (m, 1H), 
1.47 – 1.37 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 201.6, 135.9, 133.0, 132.7, 130.9, 
128.5, 128.4, 48.0, 30.8, 30.3, 28.5, 26.4. IR (thin film): 3024, 2923, 1684, 1446, 1210, 
695 cm–1. HRMS calculated for C14H16O: 200.1207, observed 200.1201[M]+.  
 
Preparation and characterization for a sequential allylation-Heck cyclization 
General Procedure C: An 8 mL reaction vial equipped with a stir bar was charged with 2-
(2-bromophenyl-1,3-dithiane 1-1j (27.5 mg, 0.10 mmol, 1.0 equiv). Under a nitrogen 
atmosphere, a solution (from a stock solution) of Cl2Pd(NCPh)2 (1.9 mg, 0.005 mmol) and 
dppe (3.0 mg, 0.0075 mmol) in 1.0 mL of dry DME was taken up by micropipette and 
added to the reaction vial. After that, the allylic partner (0.15 mmol, 1.5 equiv) was added 
to the reaction mixture by micropipette followed by a solution of NaN(SiMe3)2 (36.7 mg, 
O
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0.20 mmol, 2.0 equiv) in 1.0 mL of dry DME by syringe. After the addition of NaN(SiMe3)2 
solution, the mixture turned color from pale orange to dark brown. The reaction vial was 
sealed with a closed cap, removed from the glovebox and stirred at rt for 24–36 h. After 
allylic substitution finished, as determined by TLC, the reaction mixture was dried, and 
inorganic substances were removed by filtration through a pad of silica. The solvent was 
then evaporated in a rotatory evaporator. After that, in the glovebox, the premixed solution 
of Pd(OAc)2 and PPh3 in 1.0 mL MeCN (1.1 mg, 0.005 mmol and 3.9 mg, 0.015 mmol 
respectively) was added by micropipette followed by NEt3 (63 μL, 0.5 mmol, 5.0 equiv). 
The reaction mixture was stirred for 16 h, quenched with a 3 drops of H2O, diluted with 3 
mL of ethyl acetate, extracted with 15 mL of ethyl acetate (5×3). The organic phase was 
washed with 5 mL of brine, dried over Na2SO4 and concentrated in vacuum. The crude 
material was loaded onto a silica gel column and purified by flash chromatography with 
5% ethyl acetate in hexanes. 
 
 (4aS,9aR)-1,2,4a,9a-Tetrahydrospiro[fluorene-9,2'-[1,3]dithiane] (1-
4ia): The reaction was performed following General Procedure C with 2-
(2-bromophenyl)-1,3-dithiane 1-1f (27.5 mg, 0.1 mmol), cyclohexenyl 
OBoc 1-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product 
was purified by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 95:5) 
to give the product (19.4 mg, 71% yield) as colorless oil. Rf = 0.55 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 7.51–7.47 (m, 1H), 7.26 (tt, J = 2.6, 1.5 Hz, 1H), 7.23 (dt, J = 
7.4, 1.2 Hz, 1H), 7.21–7.16 (m, 1H), 6.23 (m, 1H), 5.91 (m, 1H), 4.05 (s, 1H), 3.15 (m, 1H), 
3.07 (m, 1H), 2.99 (m, 1H), 2.82 (m, 2H), 2.20 – 2.08 (m, 3H), 2.08 – 1.99 (m, 1H), 1.99 – 
1.90 (m, 1H), 1.05 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 144.9, 142.3, 128.9, 128.4, 
126.9, 126.0, 124.5, 123.8, 62.0, 48.5, 42.1, 30.1, 27.8, 25.1, 24.7, 23.5. IR (thin film): 
SS
H
H
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3022, 2922, 2941, 2359, 1710, 1456, 1373, 1047, 909, 734 cm–1. HRMS calculated for 
C16H18S2: 274.0850, observed 274.0870 [M]+.  
 
(3aS,8aR)-3a,8a-dihydro-1H-spiro[cyclopenta[a]indene-8,2'-
[1,3]dithiane] (1-4jb): The reaction was performed following General 
Procedure C with 2-(2-bromophenyl)-1,3-dithiane 1-1f (27.5 mg, 0.1 
mmol), cycloheptenyl OBoc 1-2b (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 
mmol). The crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 95:5) to give the product (17.5 mg, 67% yield) as white solid. Crystal 
structure was obtained by slow evaporation with THF at room tempurature. (see X-ray 
determination structure for more detail). Rf = 0.57 (Et2O/hexanes 1:5). 1H NMR (500 MHz, 
CDCl3) δ 7.51 (d, J = 6.7 Hz 1H), 7.28 – 7.24 (m, 2H), 7.15 (d, J = 7.0 Hz, 1H), 6.02–5.97 
(m, 1H), 5.75 (m, 1H), 4.34 (d, J = 7.4 Hz, 1H), 3.85 (dd, J = 17.2, 7.9 Hz, 1H), 3.15 (m, 
1H), 3.07 (m, 1H), 2.99 (m, 2H), 2.82 (m, 2H), 2.17–2.57 (d, J = 14.0 Hz, 1H), 2.08 – 1.99 
(m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 143.48, 131.42, 130.01, 129.25, 127.28, 
124.92, 124.37, 55.05, 54.28, 36.52, 30.16, 28.69, 24.48. IR (thin film): 2925, 2908, 2356, 
1719, 1447, 1373, 1239, 1047, 918, 734 cm–1. HRMS calculated for C15H16S2 260.0693, 
observed 260.0716 [M]+.  
 
3-Methylene-2,3-dihydrospiro[indene-1,2’-1,3-dithiane] (1-4jd): The 
reaction was performed following General Procedure C with 2-(2-
bromophenyl)-1,3-dithiane 1-1f (27.5 mg, 0.1 mmol), allyl OBoc 1-2a (26 
μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified 
by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 95:5) to give the 
SS
H
H
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product (17.6 mg, 75% yield) as colorless oil. Rf = 0.57 (Et2O/hexanes 1:5). 1H NMR (500 
MHz, CDCl3) δ 7.69 – 7.57 (m, 1H), 7.57 – 7.45 (m, 1H), 7.38 – 7.29 (m, 2H), 5.55 (t, J = 
2.4 Hz, 1H), 5.12 (t, J = 2.0 Hz, 1H), 3.60 (t, J = 2.2 Hz, 2H), 3.17 (m, 2H), 2.88 (m, 2H), 
2.21 (m, 1H), 2.15 – 1.92 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 147.0, 145.6, 139.7, 
129.2 (d, J = 7.2 Hz), 125.2, 120.9, 104.8, 56.3, 51.1, 29.3, 24.9. IR (thin film): 2984, 2941, 
2907, 2256, 1742, 1447, 1373, 1239, 1046, 918, 734, 634, 607 cm–1. HRMS calculated 
for C13H14S2: 234.0537, observed 234.0528 [M]+. 
 
Preparation and characterization for telescoped allylic substitution/Heck 
reaction/oxidation sequence 
An 8 mL reaction vial equipped with a stir bar was charged with 2-(2-bromophenyl)-1,3-
dithiane 1-1j (27.5 mg, 0.1 mmol, 1.0 equiv). Under a nitrogen atmosphere in a glovebox, 
a solution (from a stock solution) of Cl2Pd(NCPh)2 (1.9 mg, 0.005 mmol) and dppe (3.0 
mg, 0.0075 mmol) in 1.0 mL of dry DME was taken up by micropipette and added to the 
reaction vial. After that, cyclohexenyl OBoc 1-2b (30 μL, 0.15 mmol, 1.5 equiv) was added 
to the reaction mixture by micropipette followed by a solution of NaN(SiMe3)2 (36.8 mg, 
0.20 mmol, 2.0 equiv) in 1 mL of dry DME by micropipette. After the addition of 
NaN(SiMe3)2, the mixture turned color from pale orange to dark brown. The reaction 
mixture was sealed with a closed cap, removed from the glovebox and stirred at rt for 36 
h. After allylic substitution finished, as determined by TLC, the reaction mixture was diluted 
with 3 mL of ethyl acetate and filtered over a pad of silica. Then the solution was 
concentrated under vacuum. Next, under N2 atmosphere, the premixed solution of 
Pd(OAc)2 (1.1 mg, 0.005 mmol) /PPh3 (39.3 mg, 0.015 mmol) in 1 mL of MeCN was added 
to the reaction vial by micropipette followed by NEt3 (69 μL, 0.5 mmol, 5 equiv). The 
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reaction mixture was stirred for 16 h at 80 oC, After Heck cyclization finished, as 
determined by TLC, the solvent in reaction mixture was removed under vacuum and iodine 
(1.28 mg, 0.05 equiv) and SDS solution (5.78 mg, 0.2 equiv) in a mixture of H2O: THF 
(1:3) were added by syringe under air respectively to obtain dark brown mixture. The 
reaction mixture was stirred for 16 h, quenched with 3 mL of H2O, extracted with 15 mL of 
ethyl acetate (5×3). The organic phase was washed with 5 mL of brine, dried over Na2SO4 
and concentrated in vacuum. The crude material was loaded onto a silica gel column and 
purified by flash chromatography with 5% ethyl acetate in hexanes. 
(3aS,8aR)-3a,8a-Dihydrocyclopenta[a]inden-8(1H)-one (1-5jb): The 
reaction was performed with 2-(2-bromophenyl)-1,3-dithiane 1-1j (27.5 
mg, 0.1 mmol), cycloheptenyl OBoc 1-2b (30 μL, 0.15 mmol) and 
NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 95:5) to give the product 
(17.6 mg, 75% yield) as colorless oil. Rf = 0.57 (Et2O/hexanes 1:5). 1H NMR (500 MHz, 
CDCl3 δ 7.74 (d, J = 7.6 Hz, 1H), 7.69 – 7.56 (m, 1H), 7.51 (t, J = 4.6 Hz, 1H), 7.36 (t, J = 
7.4 Hz, 1H), 5.84 (m, 1H), 5.74 – 5.58 (m, 1H), 4.58 – 4.39 (m, 1H), 3.38 (m, 1H), 2.85 (m, 
1H), 2.69 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 209.5, 157.5, 135.8, 134.8, 131.7, 
130.3, 127.5, 125.5, 124.3, 52.2, 49.7, 35.0. IR (thin film): 3052, 2922, 2856, 1708, 1602, 
1463, 1291, 757, 696 cm–1. HRMS calculated for C12H10O: 170.0732, observed 170.0752 
[M]+.   
 
High-throughput experimentation screening 
Ligands screening of Allylic Alkylation of 2–phenyl-1,3-dithiane (1-1a) and tert-butyl 
cyclohex-2-en-1-yl carbonate (1-2a). 
O
H
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Experiments were set up inside a glovebox under a nitrogen atmosphere. Two 24-well 
aluminum blocks containing 1.0 mL glass vials were predosed with Cl2Pd(NCPh)2 (1.0 
μmol) and the phosphine ligands (2.0 μmol for monodentate ligands and 1.0 μmol for 
bidentate ligands) in THF. The solvent was removed to dryness using a GeneVac and 
NaN(SiMe3)2 (20 μmol) in THF was added to the ligand/catalyst mixture.  The solvent was 
removed on the GeneVac and a parylene stir bar was then added to each reaction vial. 
2–phenyl-1,3-dithiane 1-1a (10 μmol/reaction) and tert-butyl cyclohex-2-en-1-yl carbonate 
1-2a (20 μmol) were then dosed together into each reaction vial as a solution in DME (100 
μL, 0.1 M). The 24-well plates were then sealed and stirred for 3 h at 25 °C. 
Work up: Upon opening the plate to air, 500 μL of a solution of biphenyl (used as internal 
standard) in acetonitrile (0.002 mol/L) was added into each vial. The plate was covered 
again and the vials stirred for 10 min to ensure good homogenization. Into a separate 96-
well LC block was added 700 μL of acetonitrile, followed by 25 μL of the diluted reaction 
mixtures. The LC block was then sealed with a silicon-rubber storage mat and mounted 
on an automated UPLC instrument for analysis. 
 
Entry Ligand Prod/ISa  
1 2–(Di–tert–butylphosphino)–2'–methylbiphenyl (tBu–MePhos) 0.30 
2 rac-2-(Di-tert-butylphosphino)-1,1'-binaphthyl (Trixie Phos) 0.64 
Ph
SS
Ph
SS
H
OBoc Cl2Pd(NCPh)2 10 mol %
 ligands 10-20 mol %
 NaN(SiMe3)2 (2 equiv)
DME, 0.1 M, rt, 3 h
 1-1a              1-2a                                                         1-3aa
1 equiv         1.5 equiv
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3 2-Dicyclohexylphosphino-2'-methylbiphenyl (MePhos) 0.30 
4 Di-tert-butyl(2',4',6' -triisopropyl-3-methoxy-6-methyl-[1,1'-biphenyl]-2-
yl)phosphine (RockPhos) 
0.39 
5 2-Dicyclohexylphosphino-2',6'-bis(N,N-dimethylamino)biphenyl (CPhos) 0.38 
6 2–(Di–tert–butylphosphino)biphenyl (JohnPhos) 0.38 
7 2-(Di-tert-butylphosphino)-2',4',6'- triisopropyl-3,6-dimethoxy-1,1'-
biphenyl (tBu-BrettPhos) 
0.83 
8 2–Dicyclohexylphosphino–2'–(N,N–dimethylamino)biphenyl (DavePhos) 0.74 
9 2-Di-tert-butylphosphino-2′,4′,6′-triisopropylbiphenyl (di-tBuXPhos) 0.73 
10 2-Di-tert-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-triisopropyl-1,1'-
biphenyl (Me4tBuXPhos) 
0.40 
11 5–(Di–tert–butylphosphino)–1',3',5'–triphenyl–1'H–[1,4']bipyrazole 
(BippyPhos) 
0.28 
12 2′–(Dicyclohexylphosphino)acetophenone ethylene ketal  (SymPhos) 
 
0.09 
13 Bis[(dicyclohexyl)(4-diMethylaMinophenyl)phosphine] (ACaPhos) 0.71 
14 Triphenylphosphine (PPh3) 0.64 
15 Bis(dicyclohexylphosphinophenyl) ether (DCEPhos) 0.05 
16 9,9–Dimethyl–4,5–bis(diphenylphosphino)xanthene (Xantphos) 0.73 
17 4,6–Bis(diphenylphosphino)phenoxazine (NiXantphos) 0.38 
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18 rac-BINAP 0.5 μmol 0.04 
19 N–phenyl–2–(di–t–butylphosphino)pyrrole (cataCXium PtB) 0.09 
20 N–phenyl–2–(dicyclohexylphosphino)pyrrole (cataCXium PCy) 1.29 
21 Di–t–butyl–(1–phenylindol–2–yl)phosphane (cataCXium PIntB) 0.63 
22 Butyldi–1–adamantylphosphine (cataCXium A) 0.09 
23 1–(2,4,6–Trimethylphenyl)–2–
(dicyclohexylphosphino)imidazole(cataCXium PICy) 
0.00 
24 Dicyclohexyl–(1–phenylindol–2–yl)phosphane (cataCXium PInCy) 0.60 
25 Benzyldi–1–adamantylphosphine (cataCXium ABn) 0.17 
26 (R)-1-[(SP)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-
butylphosphine (SL-J009-1) 
0.23 
27 1,2,3,4,5–Pentaphenyl–1'–(di–tert–butylphosphino)ferrocene (QPhos) 0.71 
28 1,1'–Bis(diisopropylphosphino)ferrocene (dippf) 1.22 
29 1, 1'-Bis(di-cyclohexylphosphino)ferrocene (DCyPF) 0.91 
30 Tricyclohexylphosphine tetrafluoroborate (PCy3 HBF4) 0.36 
31 PXy3 0.98 
32 Di–tert–butyl(neopentyl)phosphine HBF4 0.25 
33 2-(Dicyclohexylphosphino)biphenyl (Cy-JohnPhos) 0.18 
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34 2-Dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl (XPhos) 0.09 
35 2–Dicyclohexylphosphino–2',6'–dimethoxy–1,1'–biphenyl (SPhos) 1.04 
36 Dicyclohexyl–[3,6–dimethoxy–2–(2,4,6–
triisopropylphenyl)phenyl]phosphane (BrettPhos) 
0.29 
37 N-(dicyclohexylphosphino)-2-(2-tolyl)indole 0.44 
38 Di(1-adamantyl)-2-dimethylaminophenylphosphine (MeDalPhos) 0.00 
39 1–[2–[Bis(t–butyl)phosphino]phenyl]–3,5–diphenyl–1H–pyrazole 
(TrippyPhos) 
0.31 
40 Di(1-adamantyl)-2-morpholinophenylphosphine (MorDalPhos) 0.52 
41 Tri(2-Furyl)phosphine 0.44 
42 (4-(N,N-Dimethylamino)phenyl)di-tert-butyl phosphine (Ata-phos) 0.57 
43 Tri(o-tolyl)phosphine (P(o-tol)3) 0.55 
44 rac-BINAP 1μmol 0.05 
 
aProduct-internal standard ratio. 
 
Pd-catalyzed allylic alkylation of 2-(2-bromophenyl)-1,3-dithiane using 5 different 
ligands. 
To determine the best ligand for Pd-catalyzed allylic alkylation of 2-(2-bromophenyl)-1,3-
dithiane, we examined those top ligands from the previous ligand screening result under 
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optimal condition. The results below showed the dppe is the most suitable ligand to 
approach 1-3jb in good yield, 76%. 
 
ligand % yield of 1-3jbab 
NiXantphos 0 
Xantphos 0 
SPhos 0 
cataCXium PCy 27 
dppe 76 
 
aReaction conducted on 0.1 mmol scale. bYield determined by 1H NMR spectroscopy of the crude 
reaction mixture. 
 
 
Determination of the Relative Stereochemistry of Compound 3aj. 
tert-Butyldimethyl(((1S,5R)-5-(2-phenyl-1,3-dithian-2-
yl)cyclohex-3-en-1-yl)methoxy)silane (1-3aj): The 
reaction was performed following General Procedure A 
with 2-phenyl-1,3-dithiane 1-1a (19.6 mg, 0.1 mmol), 1-2j (40 mg, 0.12 mmol) and 
H
SS
Br
  1-1j               1-2b                                                         1-3jb
1 equiv          1.5 equiv
OBoc Cl2Pd(NCPh)2 5 mol %
 5 ligands 7.5 mol %
 NaN(SiMe3)2 (2 equiv)
DME, 0.1 M, rt, 48 h
SS
Br
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NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 95:5) to give the product 
(39 mg, 93% yield) as colorless oil. Rf = 0.7 (Et2O/hexanes 1:5) 1H NMR (500 MHz, CDCl3) 
δ 7.97 – 7.82 (m, 2H), 7.32 (t, J = 7.8 Hz, 2H), 7.26 – 7.12 (m, 1H), 5.95 (d, J = 10.2 Hz, 
1H), 5.73 (ddd, J = 27.5, 13.7, 11.1 Hz, 1H), 3.32 (ddd, J = 25.9, 9.9, 6.1 Hz, 2H), 2.74 – 
2.47 (m, 5H), 1.96 (t, J = 14.3 Hz, 1H), 1.89 – 1.78 (m, 2H), 1.65 – 1.53 (m, 2H), 1.52 – 
1.44 (m, 1H), 1.11 (dt, J = 12 Hz, 12 Hz, 12 Hz, 1H), 0.77 (s, 9H), -0.08 (d, J = 7.8 Hz, 
6H). 13C{1H} NMR (125 MHz, CDCl3) δ 140.6, 129.8, 128.6, 128.3, 127.2, 126.7, 67.9, 
64.2, 49.2, 36.9, 28.5, 27.9, 27.6 (d, J = 19.6 Hz), 27.2, 25.8 (d, J = 12.8 Hz), 25.4, 18.2, 
0.29, -5.35 (d, J = 3.6 Hz). IR (thin film): 2928, 2854, 1470, 1252, 1115, 836, 776, 732, 
700, 629 cm–1. HRMS calculated for C23H36OS2Si: 420.1977, observed 420.1973 [M]+. 
The relative chemistry of the single diastereomer was established by 1H NMR splitting 
patterns and coupling constants[31],[13b]. 1H NMR spectrum of compound 1-3aj is consistent 
with those of starting carbonate 1-2j. 
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OTBDMS
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CH2OTBDMS
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S S
Ph
H6 (axial) pattern: dt
H6 (eq) pattern: m
JH6 (axial), H1 = 12 Hz (trans)
JH6 (axial), H6(eq) = 12 Hz (same carbon)
JH6 (axial), H5 = 12 Hz (trans)
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X-ray Structure Determination of Compound 1-3ha 
 
 
Compound 6216, C20H22S2, crystallizes in the monoclinic space group P21/c (systematic 
absences 0k0: k=odd and h0l: l=odd) with a=9.2008(7)Å, b=14.4163(10)Å, 
c=12.6651(8)Å, β=101.772(2)°, V=1644.6(2)Å3, Z=4, and dcalc=1.319 g/cm3 . X-ray 
intensity data were collected on a Bruker D8QUEST [1] CMOS area detector employing 
graphite-monochromated Mo-Kα radiation (λ=0.71073Å) at a temperature of 100K. 
Preliminary indexing was performed from a series of thirty-six 0.5° rotation frames with 
exposures of 10 seconds. A total of 1629 frames were collected with a crystal to detector 
distance of 34.0 mm, rotation widths of 0.5° and exposures of 5 seconds: 
 
scan type 2θ ω φ χ Frames 
w 0.00 194.06 0.00 54.72 303 
w 0.00 194.06 72.00 54.72 303 
w 0.00 194.06 144.00 54.72 303 
SS
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scan type 2θ ω φ χ Frames 
f -1.00 345.19 0.00 54.72 720 
 
Rotation frames were integrated using SAINT [2], producing a listing of unaveraged F2 
and σ(F2) values. A total of 56886 reflections were measured over the ranges 5.76 ≤ 2θ ≤ 
55.242°, -11 ≤ h ≤ 11, -18 ≤ k ≤ 18, -16 ≤ l ≤ 15 yielding 3798 unique reflections (Rint = 
0.0422). The intensity data were corrected for Lorentz and polarization effects and for 
absorption using SADABS [3] (minimum and maximum transmission 0.6895, 0.7456). The 
structure was solved by direct methods - SHELXT [4]. There is disorder in the cyclohexene 
ring caused by two possible orientations of the ring: 
 
 
 
Refinement was by full-matrix least squares based on F2 using SHELXL-2014 [5]. All 
reflections were used during refinement. The weighting scheme used was w=1/[σ2(Fo2 )+ 
(0.0338P)2 + 2.2408P] where P = (Fo2 + 2Fc2)/3. Non-hydrogen atoms were refined 
anisotropically and hydrogen atoms were refined using a riding model. Refinement 
converged to R1=0.0442 and wR2=0.1164 for 3596 observed reflections for which F > 
4σ(F) and R1=0.0462 and wR2=0.1173 and GOF =1.231 for all 3798 unique, non-zero 
reflections and 218 variables. The maximum Δ/σ in the final cycle of least squares was 
SS SS
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0.000 and the two most prominent peaks in the final difference Fourier were +0.34 and -
0.33 e/Å3. 
 
Table 1-1S. lists cell information, data collection parameters, and refinement data. Figure 
1-1S is an ORTEP representation of the molecule with 50% probability thermal ellipsoids 
displayed. 
 
Figure 1-S1. ORTEP drawing of the title compound with 50% thermal ellipsoids. 
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Table 1-S1.  Summary of Structure Determination of Compound 1-3ha 
 
Empirical formula  C20H22S2  
Formula weight  326.49  
Temperature/K  100  
Crystal system  monoclinic  
Space group  P21/c  
a  9.2008(7)Å  
b  14.4163(10)Å  
c  12.6651(8)Å  
β  101.772(2)°  
Volume  1644.6(2)Å3  
Z  4  
dcalc  1.319 g/cm3  
μ  0.318 mm-1  
F(000)  696.0  
Crystal size, mm  0.32 × 0.28 × 0.15  
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2θ range for data collection      5.76 - 55.242°  
Index ranges  -11 ≤ h ≤ 11, -18 ≤ k ≤ 18, -16 ≤ l ≤ 15  
Reflections collected  56886  
Independent reflections  3798[R(int) = 0.0422]  
Data/restraints/parameters  3798/12/218  
Goodness-of-fit on F2  1.231  
Final R indexes [I>=2σ (I)]  R1 = 0.0442, wR2 = 0.1164  
Final R indexes [all data]  R1 = 0.0462, wR2 = 0.1173  
Largest diff. peak/hole  0.34/-0.33 eÅ-3  
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X-ray Structure Determination of Compound 1-4jb 
 
       
 
Compound 6238, C15H16S2, crystallizes in the orthorhombic space group Pca21 
(systematic absences h0l:  h=odd and 0kl:  l=odd) with a=13.8091(14)Å, b=7.7013(6)Å, 
c=24.177(3)Å, V=2571.2(5)Å3, Z=8, and dcalc=1.345 g/cm3 . X-ray intensity data were 
collected on a Bruker APEXII [1] CCD area detector employing graphite-monochromated 
Mo-Kα radiation (λ=0.71073Å) at a temperature of 100K. Preliminary indexing was 
performed from a series of thirty-six 0.5° rotation frames with exposures of 10 seconds. A 
total of 936 frames were collected with a crystal to detector distance of 37.2 mm, rotation 
widths of 0.5° and exposures of 5 seconds: 
 
scan type 2θ ω φ χ Frames 
f -23.00 315.83 -346.00 28.88 722 
w 17.00 -33.26 -175.56 82.07 104 
w 17.00 -38.92 -41.64 83.36 110 
 
H
S S
H
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Rotation frames were integrated using SAINT [2], producing a listing of unaveraged F2 
and σ(F2) values. A total of 20250 reflections were measured over the ranges 5.29 ≤ 2θ ≤ 
50.95°, -16 ≤ h ≤ 16, -9 ≤ k ≤ 9, -29 ≤ l ≤ 29 yielding 4781 unique reflections (Rint = 0.0391). 
The intensity data were corrected for Lorentz and polarization effects and for absorption 
using SADABS [3] (minimum and maximum transmission 0.6907, 0.7542). The structure 
was solved by direct methods - ShelXS-97 [4]. Refinement was by full-matrix least squares 
based on F2 using SHELXL-2017 [5]. All reflections were used during refinement. The 
weighting scheme used was w=1/[σ2(Fo2 )+ (0.0448P)2 + 1.1427P] where P = (Fo2 + 
2Fc2)/3. Non-hydrogen atoms were refined anisotropically and hydrogen atoms were 
refined using a riding model. Refinement converged to R1=0.0317 and wR2=0.0801 for 
4445 observed reflections for which F > 4σ(F) and R1=0.0353 and wR2=0.0824 and GOF 
=1.043 for all 4781 unique, non-zero reflections and 308 variables. The maximum Δ/σ in 
the final cycle of least squares was 0.000 and the two most prominent peaks in the final 
difference Fourier were +0.95 and -0.20 e/Å3. 
Table 1-S1. lists cell information, data collection parameters, and refinement data. 
Figures 1-1S. and 1-2S. are ORTEP representations of the molecule with 50% probability 
thermal ellipsoids displayed. 
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Figure 1-S2. ORTEP drawing of molecule no. 1 of the asymmetric unit with 50% thermal 
ellipsoids. 
 
Figure 1-S3. ORTEP drawing of molecule no. 2 of the asymmetric unit with 50% thermal 
ellipsoids. 
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Table 1-S2.  Summary of Structure Determination of Compound 1-4jb 
Empirical formula  C15H16S2 
Formula weight  260.40 
Temperature/K  100  
Crystal system  orthorhombic 
Space group  Pca21  
a  13.8091(14)Å  
b  7.7013(6)Å  
c  24.177(3)Å  
Volume  2571.2(5)Å3  
Z  8 
dcalc  1.345 g/cm3  
μ  0.388 mm-1  
F(000)  1104.0  
Crystal size, mm  0.32 × 0.28 × 0.03  
2θ range for data collection      5.29 - 50.95°  
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Index ranges  -16 ≤ h ≤ 16, -9 ≤ k ≤ 9, -29 ≤ l ≤ 29  
Reflections collected  20250  
Independent reflections  4781[R(int) = 0.0391]  
Data/restraints/parameters  4781/1/308  
Goodness-of-fit on F2  1.043 
Final R indexes [I>=2σ (I)]  R1 = 0.0317, wR2 = 0.0801  
Final R indexes [all data]  R1 = 0.0353, wR2 = 0.0824  
Largest diff. peak/hole  0.95/-0.20 eÅ-3  
Flack parameter 0.30(10) 
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CHAPTER 2 
The Reactions of 2-Aryl-1,3-Dithianes and [1.1.1]Propellane 
2.1 Introduction 
Bicyclo[1.1.1]pentanes (BCPs) have recently attracted attention from synthetic and 
medicinal chemists due to their potential as bioisosteres of phenyl groups in bioactive 
molecules.[1] In the past decade, medicinal chemists have demonstrated the high promise 
of BCPs for the optimization of drug performance, such as in BMS’s BCP-BMS-708163,[2] 
BCP-resveratrol,[3] and BCP-darapladib.[4] These BCP analogues demonstrate improved 
pharmacological properties without compromising potency. Despite considerable interest 
from the medicinal chemistry community, the incorporation of BCPs into a broad variety 
of structural classes found in bioactive molecules remains an unsolved challenge. 
Recently, many protocols for the monofunctionalization of BCPs[5] as well as 
unsymmetrically 1,3-difunctionalized BCP derivatives[6] have been reported, which fill gaps 
major literature gaps for the BCP analogues of anilines, biaryls, fluoroarenes, and α-aryl 
ketones. Prior to these disclosures, all of which were reported in the past five years, no 
reliable methods to access BCP analogues of these scaffolds were known, reflecting the 
nascency of BCP synthesis for medicinal chemistry. Along these lines, we noticed a major 
gap in the literature for the synthesis of BCP ketones:  the addition of 1-lithio-BCPs to 
nitriles, as reported by Wiberg, produces an extremely limited scope of diarylketones in 
modest yields (Scheme 2-1a).[7]  Wiberg’s pioneering study also describes the addition of 
acyl radicals to [1.1.1]propellane, but this method suffers from poor chemoselectivity and 
narrow substrate scope. Despite the abundance of diarylketones in FDA-approved drugs, 
such as Ketoprofen[8], Fenofibrate[9] (Tricor), Mebendazole[10] (Vermox) and Tolcapone[11] 
(Tasmar) (Scheme 1b), no synthetic route to BCP analogues of these targets are known. 
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To address this critical gap, we aimed to develop a method for the synthesis of BCP 
ketones via the reactivity of 2-aryl-1,3-dithiane anions and [1.1.1]propellane.  
 
Scheme 2-1. Previous synthesis of BCP ketones, examples of bioactive diaryl ketones, 
general reactivity of dithianes, and synthesis of BCP dithianes. 
Beginning with Corey and Seebach’s 1965 disclosure of metallated dithianes and their 
addition to electrophiles,[12] dithianes have been used to achieve a variety of carbon-
carbon bond formations, finding utility from simple synthetic transformations to the 
synthesis of natural products.[13] Recent reports demonstrate new and unexpected 
reactivity of 1,3-dithianes, such as for the synthesis of pyridines and photochemical 
addition to electrophiles.[14] A notable case of new reactivity of dithianes is the Smith 
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group’s development of anion-relay chemistry using 2-silyl-1,3-dithianes.[15] 2-Aryl-1,3-
dithianes could be used as pronucleophiles for palladium-mediated arylation[16] and allylic 
substitution[17] in a deprotonative cross coupling process. To enable synthetic access to 
BCP ketones and to explore new reactivity of 1,3-dithianes, we describe herein the 
addition of 2-aryl-1,3-dithianes to [1.1.1]propellane, an unprecedented transformation 
which furnishes BCP analogues of a valuable pharmacophore. BCP dithianes are readily 
deprotected to the corresponding ketones. We also demonstrate that these BCP dithianes 
are readily transformed to geminal difluoromethanes and esters. Computational 
investigations indicate a two-electron pathway for the reaction, demonstrating 2-aryl-1,3-
dithiyl anions to be competent nucleophiles for addition to [1.1.1]propellane. To the best 
of our knowledge, these computational investigations are the first of their kind to support 
a purely anionic pathway for C—C bond formation to [1.1.1propellane. 
 
2.2 Results and discussion 
We explored the propellylation of aryl dithianes using 2-phenyl-1,3-dithiane (2-2a) as a 
pronucleophile and [1.1.1]propellane (2-1). Propellylation using 2 equiv LiN(SiMe3)2 and 
THF at room temperature, conditions which previous studies had demonstrated as 
suitable to generate dithiyl anions, produced BCP product 2-3a in 5% AY (assay yield) 
after 16 h (Table 1, entry 1). Increasing the temperature to 60 °C slightly improved the AY 
to 20% (entry 2). Switching to 2 equiv NaN(SiMe3)2 offered a modest improvement to 58% 
AY of product 2-3a (entry 3). Further increasing the reaction temperature to 80 °C and 
switching to DME solvent gave 89% AY (entry 4). Product 2-3a was isolated in 93% yield 
by raising the loading of NaN(SiMe3)2 to 2.5 equiv (entry 5). A substoichiometric loading 
of base (20 mol%) promoted the reaction comparatively slowly to generate product 2-3a 
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in 43% yield with 52% conversion of starting material after 48 h (entry 6). Thus, we 
employed the conditions in entry 5 with 2.5 equiv NaN(SiMe3)2 in DME at 80 °C for 16 h. 
 
Table 2-1. Optimization of propellylation of 2-1a[a] 
 
 
Entry M (equiv) Solvent T (oC) Yield[b](%) SM[c](%) 
1 Li (2) THF rt 5 >90 
2 Li (2) THF 60 20 81 
3 Na (2) THF 60 58 43 
4 Na (2) DME 80 89 8 
5 Na (2.5) DME 80 96 (93[d]) Trace 
6 Na (0.2) DME 80[e] 43 52 
[a] Reactions conducted on 0.1 mmol scale and 0.1 M. [b] Assay yields determined by 1H NMR 
spectroscopy of the crude reaction mixture using 0.1 mmol CH2Br2 as an internal standard. [c] 
Amount of dithiane starting material remaining as determined by 1H NMR spectroscopy. [d] 
Yield of isolated product. [e] 48 h reaction time. 
 
2.2.1 Scope of Propellylation 
With the optimized conditions in hand, we explored the scope of propellylation with 2-aryl-
1,3-dithiane pronucleophiles (Table 2). Pronucleophiles with electron neutral groups gave 
H
SS MN(SiMe3)2  
solvent, temp, 16 h Ph
SS
Ph
     2-2a           2 equiv                                            2-3a
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the corresponding products in excellent yields (2-3a–3b, 93–96%). Pronucleophiles with 
electron donating groups in the 4-position (Me, tBu, OMe, SMe, CºCH, NMe2) underwent 
propellylation to provide good to excellent yields of the corresponding products (2-3c–3h, 
54–96%). Notably, the alkyne-containing pronucleophile 2-2g reacted exclusively at the 
dithiane methine position despite the acidity of the C(sp)-H bond, highlighting the excellent 
chemoselectivity of this method. In the case of 2-2h which contains the strongly electron 
donating 4-N,N-dimethylamino group, increasing the base loading to 4 equiv NaN(SiMe3)2 
gave 54% yield. Pronucleophiles with electron withdrawing groups or halogens (3-OMe, 
4-F, 4-Br, 3-F, 3-CF3, 4-BPin) reacted to form the desired products in excellent yields (2-
3i–3n, 75–97%). Surprisingly, pronucleophile 2-2n, which bears a boronate ester, was 
well-tolerated under the reaction conditions. Sterically hindered pronucleophiles bearing 
polycyclic aromatics (1-naphthyl, 9-phenanthryl, 9-anthracenyl) formed the desired 
products in good yields using 3 equiv base (2-3o–3q, 64–71%). To demonstrate the 
potential value of this method to medicinal chemistry, we next examined the scope of 
heterocycles in the propellylation reaction. Gratifyingly, a number of heterocycles were 
tolerated under the optimal conditions. The 3-furyl dithiane 2-2r reacted to afford 2-3r in 
60% yield. Thiophenes also underwent propellylation to provide good to excellent yields 
of the corresponding products (2-3s–3u, 76–95%). Most nitrogen-containing 
pronucleophiles decomposed under the standard reaction conditions (Table 2-1, entry 5). 
By switching to 3 equiv LiN(SiMe3)2 base instead of NaN(SiMe3)2, good yields of the 
corresponding products were obtained from 3-pyridyl-, 4-pyridyl-, 5-isoquinolyl-, and N-
methyl 5-indolyl-derived dithianes (2-3v–3y, 65–85%). To evaluate the scalability of our 
method, the propellylation of 2-(3-thiophene)-1,3-dithiane 2-2s was conducted on a 4.0 
mmol scale, providing the corresponding product 2-3s (94% yield, 1.01 g; 0.1 mmol scale 
= 95% yield), demonstrating excellent reaction efficiency upon scale-up. 
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Table 2-2. Scope of propellylation[a]. 
 
[a] Reactions conducted on 0.1 mmol scale and 0.1 M. [b] 4 equiv NaN(SiMe3)2 [c] 3 equiv 
LiN(SiMe3)2. [d] 3 equiv NaN(SiMe3)2.  
 
 
H
SS NaN(SiMe3)2 2.5 equiv
DME (0.1M) 
80 oC, 16 h
Ar Ar
SS
2-2a— 2y      2 equiv                                             2-3a—3y
H
MeO H3CS Me2N
OMe
F Br
F CF3
BO
O
2-3a, 93%        2-3b, 96%         2-3c, 86%            2-3d, 90%
2-3e, 96%          2-3f, 75%          2-3g, 81%         2-3h, 54%[b]
2-3i, 92%     2-3j, 97%     2-3k, 84%[c]      2-3l, 95%    2-3m, 75%
2-3n, 75%            2-3o, 70%[d]     2-3p, 64%[d]       2-3q, 71%[d]
SO
SS
N NN N
2-3r, 60%        2-3s, 95%,           2-3t, 79%           2-3u, 76%
                4.0 mmol, 94%, 1.01g
2-3v, 85%[c]        2-3w, 78%[c]        2-3x, 65%[c]       2-3y, 69%
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2.2.2 Transformations of BCP dithanes 
To demonstrate the chemical robustness of BCP dithiane products, we studied several 
transformations of BCP dithiane products. Deprotection of dithianes worked well for a 
variety of BCP dithianes, affording ketone products in good yield without the need for 
substantial reoptimization of Barik’s procedure (Scheme 2a).[18] BCP aryl ketones derived 
from dithianes 2-3b, 2-3k and the heterocycle 2-3s were obtained in good yields from 
deprotection (75–81%). Additionally, using a modified version of Katzenellenbogen’s 
procedure,[19] aryl dithianes, including thiophene heterocycles, were successfully 
converted to BCP aryl difluoromethanes in good yield. BCP dithiane 2-3e underwent 
difluorination smoothly to provide 2-5e in 83% yield within 15 min whereas heterocycles 
2-5t and 2-5u required longer reaction time (1 h) to furnish the difluorinated products in 
good yield (72% and 86% yield, respectively, Scheme 2b). Access to the BCP 
difluoromethyl core is unprecedented in the current literature. Notable diaryl 
difluoromethanes, for which BCP aryl difluoromethanes are potential biosteres, include 
Ledipasvir (GS-5885), a potent inhibitor for the treatment of hepatitis C.[20] 
1,3-Dithianes derived from other thiols were also successful in the propellylation reaction. 
A BCP product derived from thiophenol was prepared as 2-3z (see SI for details). 
Hydrolysis of dithioacetal 2-3z to ketone 2-4z using 8 equiv m-CPBA in CHCl3 at room 
temperature proceeded in excellent yield (91%). Ketone 2-4z could be further transformed 
to ester 2-6z via Baeyer-Villiger oxidation[21] using 4 equiv mCPBA at 50 oC in excellent 
yield (96%, Scheme 2-2c). 
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Scheme 2-2. Synthesis of BCP ketone derivatives, synthesis of gem-difluoro BCP 
compounds, transformations of BCP dithioacetal [a] reaction time 15 min. i) 8 equiv 
mCPBA, CHCl3, rt, 16 h. ii) 4 equiv mCPBA, CHCl3, 50 oC, 24 h.   
 
2.2.3 Computational study 
We next turned our attention to the reaction mechanism.  While most reactions involving 
dithiane pronucleophiles are proposed to proceed via 2 electron processes, examples 
involving one electron processes are well known [22]. To better understand the mechanism 
of the propellylation reaction, computational studies were undertaken for the reaction of 
2-2a with [1.1.1]propellane (1). DFT calculations were performed using Gaussian 09. All 
Ar
SS
2-4b, 75%                2-4k, 79%               2-4s, 81%
30% H2O2 
I2 0.05 equiv
SDS 0.2 equiv
THF:H2O (3:1)
rt, 24 h
Ar
S
Ar
SS
NIS 2 equiv
70% HF in Py 4 equiv
DCM, -78 oC, 1 h Ar
F F
MeO
F F
S
F F
2-5e, 83%[a]                 2-5t, 72%              2-5u, 86%
S
F F
Ph
S
Ph
S Ph
2-3b, 2-3k, 2-3s                                      2-4b, 2-4k, 2-4s
2-3e, 2-3t, 2-3u                                         2-5e, 2-5t, 2-5u
Br
O O O
O(a)
(b)
Ph
2-3z   2-4z, 91%                         2-6z, 96%
O
Ph
O
i ii
(c)
O
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geometry optimizations and vibrational frequency calculations of stationary points and 
transition states (TSs) were carried out at the UB3LYP level of theory with 6-31+G(d,p) 
basis set for all atoms. Single point energies and solvent effects in 1,4-dioxane were 
computed at the UM06-2X level of theory with 6-311+G(d,p) basis set for all atoms, using 
the gas-phase optimized structures. Solvation energies were calculated by a self-
consistent reaction field (SCRF) using the SMD solvation model. 
Calculations suggest that the reaction of dithiane 2-2a with [1.1.1]propellane proceeds via 
a two-electron pathway (Figure 1). The first step of the process involves the deprotonation 
of substrate 2-2a by NaN(SiMe3)2 to obtain INT1. This anion reacts with [1.1.1]propellane 
via TSEquat. or TSAxial to afford INT2. A subsequent proton transfer from 2-2a leads to 
formation of the desired product and regeneration of INT1.  
A second mechanistic pathway, involving a single-electron transfer from INT1 to 
[1.1.1]propellane[22] was also considered. This pathway would proceed through an 
electron-transfer from INT1 to [1.1.1]propellane (see SI for details). Calculations showed 
that this process is highly unlikely due to the high free energy of these radical 
intermediates (57.8 kcal/mol). 
Due to the abundance of one-electron pathways that are proposed for reactions of 
[1.1.1]propellane,[23] a pathway involving 2-aryl-1,3-dithiyl radicals with [1.1.1]propellane 
was also considered. However, formation of the 2-aryl-1,3-dithiyl radical is not evident 
under the reaction conditions described above. Thus, the two-electron pathway (Figure 1) 
is most likely to be operative. To our knowledge, this computational study is the first to 
invoke an exclusively two-electron pathway for σ-bond cleavage of [1.1.1]propellane by 
an anionic nucleophile. To support these computational results, we conducted the 
propellylation of 2-2a with nBuLi in DME and got 50% yield of 2-3a. Since DME might be 
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sufficiently acidic to serve as a proton source in the propellylation of 2-2a, the solvent was 
changed to cyclohexane. Under these conditions, near quantitative deprotonation was 
observed but only 4% of 2-3a was produced (see SI for details). Despite a modest barrier 
for addition of anionic INT1 to [1.1.1]propellane, we propose that the successful outcome 
hinges on protonation of BCP carbanion INT2 by dithiane (or hexamehtyldisiylamine) 
which provides a thermodynamic driving force for the overall process. 
 
Figure 2-1. Energy profile for the reaction of 2-2a with [1.1.1]-propellane. Relative energy 
values calculated with SMD-1,4-dioxane-UM06-2X/6-311+G(d,p)//UB3LYP/6-31+G(d,p). 
 
 
2.3 Conclusion 
In conclusion, we have disclosed an efficient procedure to synthesize 26 new dithiane 
BCPs, in good to excellent yields. The reaction tolerates a broad substrate scope and is 
scalable. These products can be transformed into their corresponding ketones, which are 
potential bioisosteres of diaryl ketones. BCP dithianes can also be transformed to gem-
+
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difluoro BCPs and and BCP esters. All products presented are novel and fill a substantial 
gap in both the synthetic and medicinal chemistry literatures by providing access to BCP 
analogues of pharmacophores with demonstrated biological activity. Computational 
results suggest a two-electron pathway is most likely for this propellylation reaction. 
 
2.4 Experimental 
General Methods: All reactions were performed under nitrogen using oven-dried 
glassware and standard Schlenk or vacuum line techniques. Air- and moisture-sensitive 
solutions were handled under nitrogen and transferred via syringe. Anhydrous DME and 
acetonitrile were purchased from Sigma-Aldrich and used as solvents without further 
purification. Unless otherwise stated, reagents were commercially available and used as 
purchased without further purification. Chemicals were obtained from Sigma-Aldrich, 
Acros, TCI America or Matrix Scientific. TLC was performed with Merck TLC Silicagel60 
F254 plates and detection was under UV light at 220 nm. Silica gel (230–400 mesh, 
Silicycle) was used for flash chromatography. The 1H NMR and 13C{1H} NMR spectra 
were obtained using a Bruker AM-500 Fourier-transform NMR spectrometer at 500 and 
125 MHz, respectively. Chemical shifts are reported in units of parts per million (ppm) 
downfield from tetramethylsilane (TMS), and all coupling constants are reported in hertz. 
The infrared spectra were obtained with KBr plates using a Perkin-Elmer Spectrum 100 
Series FTIR spectrometer. High resolution mass spectrometry (HRMS) data were 
obtained on a Waters LC-TOF mass spectrometer (model LCT-XE Premier) using 
chemical ionization (CI) or electrospray ionization (ESI) in positive or negative mode, 
depending on the analyte. Melting points were determined on a Unimelt Thomas-Hoover 
melting point apparatus. 
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Preparation of 2-Aryl-1,3-Dithianes: Dithianes were synthesized according to the 
literature procedures.[16a, 24] 
Preparation of a [1.1.1]propellane stock solution: The synthesis procedure and 
determination of stock solution concentration was determined based on literature 
procedure[5b] with our adaptation for distillation.[5d] Standard stock solutions are between 
1-1.3 M in Et2O. 
 
Preparations and characterizations for the reaction of 2-aryl-1,3-dithianes and 
[1.1.1]propellane. 
 
General Procedure A: An 8 mL reaction vial equipped with a stir bar was charged with 2-
aryl-1,3-dithiane (0.10 mmol, 1.0 equiv) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol, 2.5 equiv) 
under a nitrogen atmosphere in the glovebox. DME (1 mL, 0.1 M in dithiane) was added 
to the reaction vial by syringe. Next a solution of [1.1.1]propellane in diethyl ether solution 
(0.20 mmol, 2.0 equiv) was added to the light-yellow reaction mixture using a micropipette 
(Fisher Scientific, 200 µL tip). The pale-yellow reaction mixture was sealed with a cap, 
transferred out of the glovebox and was stirred at 80 ºC for 16 h. The dark brown reaction 
mixture then was quenched with 3 drops of H2O, diluted with 3 mL of ethyl acetate, and 
filtered over a pad of silica. The pad was rinsed with 6 mL of ethyl acetate (2x3 mL), and 
the solution was concentrated under vacuum. The thick yellow crude material was loaded 
onto a silica gel column and purified by flash chromatography with 2% ethyl acetate in 
hexanes. 
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2-(Bicyclo[1.1.1]pentan-1-yl)-2-phenyl-1,3-dithiane (2-3a): The 
reaction was performed following General Procedure A with 2-phenyl-1,3-
dithiane 2-2a (19.6 mg, 0.1 mmol), [1.1.1]propellane solution in Et2O  (0.20 
mmol) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(24.4 mg, 93% yield) as a white solid: mp = 94-96 oC. Rf = 0.85 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 7.94 – 7.87 (m, 2H), 7.38 (t, J = 7.8 Hz, 2H), 7.29 – 7.22 (m, 
1H), 2.70 – 2.60 (m, 4H), 2.45 (s, 1H), 1.95 – 1.81 (m, 2H), 1.65 (s, 6H).13C{1H}  NMR 
(125 MHz, CDCl3) δ 139.4, 129.2, 128.2, 126.7, 60.4, 50.1, 48.1, 27.3, 26.6, 24.8. IR (thin 
film): 2973, 2872, 1441, 1310, 1252, 1196, 1032, 841, 733 cm–1. HRMS calculated for 
C15H18S2: 262.0850, observed 262.0865 [M]+.   
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(naphthalen-2-yl)-1,3-dithiane (2-
3b):  
The reaction was performed following General Procedure A with 2-
(naphthalen-2-yl)-1,3-dithiane 2-2b (24.6 mg, 0.1 mmol), [1.1.1]propellane solution in Et2O 
(0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol). The crude product was purified by 
flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the 
product (30 mg, 96% yield) as a pale yellow solid: mp = 120-121 oC. Rf = 0.80 
(Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.38 (d, J = 2.0 Hz, 1H), 8.02 (dd, J = 
8.7, 2.0 Hz, 1H), 7.96 – 7.78 (m, 3H), 7.58 – 7.42 (m, 2H), 2.79 – 2.59 (m, 4H), 2.45 (d, J 
= 5.8 Hz, 1H), 1.98 – 1.82 (m, 2H), 1.70 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 137.1, 
133.4, 132.2, 128.6, 128.4, 127.8, 127.3, 127.1, 126.1, 125.9, 60.4, 50.1, 48.2, 27.4, 26.7, 
24.8. IR (thin film): 2974, 2907, 1593, 1508, 1391, 1198, 781, 734, 630 cm–1. HRMS 
calculated for C19H20S2: 312.1006, observed 312.1016 [M]+.  
SS
SS
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2-(Bicyclo[1.1.1]pentan-1-yl)-2-(p-tolyl)-1,3-dithiane (2-3c): The 
reaction was performed following General Procedure A with 2-(p-tolyl)-
1,3-dithiane 2-2c (21.0 mg, 0.1 mmol), [1.1.1]propellane solution in 
Et2O (0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol). The crude product was purified 
by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the 
product (23.8 mg, 86% yield) as a white solid: mp = 138-140 oC. Rf = 0.80 (Et2O/hexanes 
1:5). 1H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 8.2 Hz, 2H), 7.17 (d, J = 8.0 Hz, 2H), 2.75 
– 2.52 (m, 4H), 2.44 (s, 1H), 2.36 (s, 3H), 1.87 (ddd, J = 10.6, 8.7, 5.0 Hz, 2H), 1.66 (s, 
6H). 13C{1H} NMR (125 MHz, CDCl3) δ 136.3, 136.2, 129.2, 129.0, 60.3, 50.2, 48.1, 27.3, 
26.5, 24.9, 20.9. IR (thin film): 2976, 2908, 2874, 1501, 1410, 1256, 1195, 1020, 862, 829, 
791, 764, 510 cm–1. HRMS calculated for C16H20S2: 276.1006, observed 276.0996 [M]+.  
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(4-(tert-butyl)phenyl)-1,3-
dithiane (2-3d): The reaction was performed following General 
Procedure A with 2-(4-(tert-butyl)phenyl)-1,3-dithiane 2-2d (25.2 mg, 
0.1 mmol), [1.1.1]propellane solution in Et2O (0.20 mmol) and 
NaN(SiMe3)2 (46.0 mg, 0.25 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(26.7 mg, 90% yield) as a white solid: mp = 131-134 oC. Rf = 0.80 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 7.86 – 7.69 (m, 2H), 7.44 – 7.30 (m, 2H), 2.75 – 2.56 (m, 4H), 
2.43 (s, 1H), 1.99 – 1.81 (m, 2H), 1.68 (s, 6H), 1.33 (s, 9H). 13C{1H} NMR (125 MHz, 
CDCl3) δ 149.3, 136.2, 128.8, 125.0, 60.2, 50.3, 48.1, 34.3, 31.4, 27.3, 26.5, 24.9. IR (thin 
film): 2965, 2907, 2874, 1499, 1392, 1362, 1257, 1195, 1017, 865, 844, 566 cm–1. HRMS 
calculated for C19H26S2: 318.1476, observed 318.1492 [M]+.  
SS
SS
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2-(Bicyclo[1.1.1]pentan-1-yl)-2-(4-methoxyphenyl)-1,3-dithiane 
(2-3e): The reaction was performed following General Procedure A 
with 2-(4-methoxyphenyl)-1,3-dithiane 2-2e (22.6 mg, 0.1 mmol), 
[1.1.1]propellane solution in Et2O (0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol). 
The crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (28.0 mg, 96% yield) as a pale yellow 
solid: mp = 90-91 oC. Rf = 0.70 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.88 – 
7.72 (m, 2H), 6.98 – 6.84 (m, 2H), 3.83 (s, 3H), 2.73 – 2.57 (m, 4H), 2.44 (s, 1H), 2.00 – 
1.78 (m, 2H), 1.65 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ158.2, 131.4, 130.5, 113.4, 
60.0, 55.2, 50.4, 48.0, 27.3, 26.5, 24.9. IR (thin film): 2973, 2906, 2873, 1604, 1503, 1463, 
1292, 1248, 1183, 1036, 836, 772 cm–1. HRMS calculated for C16H20OS2: 292.0956, 
observed 292.0956 [M]+.  
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-9(4-(methylthio)phenyl)-1,3-
dithiane (2-3f): The reaction was performed following General 
Procedure A with 2-(4-(methylthio)phenyl)1,3-dithiane 2-2f (31.2 
mg, 0.1 mmol), [1.1.1]propellane solution in Et2O (0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 
0.25 mmol). The crude product was purified by flash chromatography on silica gel (eluted 
with hexanes:ethyl acetate 98:2) to give the product (23.1 mg, 75% yield) as a pale yellow 
solid: mp = 83-86 oC. Rf = 0.80 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.89 – 
7.70 (m, 2H), 7.31 – 7.17 (m, 2H), 2.68 – 2.58 (m, 4H), 2.51 (d, J = 1.1 Hz, 3H), 2.45 (s, 
1H), 1.94 – 1.78 (m, 2H), 1.65 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 136.8, 136.4, 
129.8, 126.0, 60.1, 50.1, 48.0, 27.3, 26.6, 24.8, 15.5. IR (thin film): 2974, 2907, 1484, 
SS
MeO
SS
H3CS
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1421, 1254, 1195, 1093, 1014, 860, 831 cm–1. HRMS calculated for C16H20S3: 308.0727, 
observed 308.0729 [M]+.  
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(4-ethynylphenyl)-1,3-
dithiane (2-3g): The reaction was performed following General 
Procedure A with 2-(4-ethynylphenyl)-1,3-dithiane 2-2g (22.0 mg, 
0.1 mmol), [1.1.1]propellane solution in Et2O (0.20 mmol) and 
NaN(SiMe3)2 (46.0 mg, 0.25 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(23.2 mg, 81% yield) as a white solid: mp = 75-78 oC. Rf = 0.70 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 7.93 – 7.80 (m, 2H), 7.55 – 7.45 (m, 2H), 3.09 (s, 1H), 2.71 – 
2.55 (m, 4H), 2.45 (s, 1H), 1.96 – 1.81 (m, 2H), 1.67 (s, 6H). 13C{1H} NMR (125 MHz, 
CDCl3) δ 140.6, 132.04, 129.2, 120.4, 83.4, 77.2, 60.0, 49.8, 48.0, 27.2, 26.5, 24.6. IR 
(thin film): 3288, 2975, 2907, 2874, 2360, 2107, 1491, 1422, 1254, 1197, 845, 789 cm–1. 
HRMS calculated for C17H18S2: 286.0850, observed 286.0850 [M]+.  
 
4-(2-(Bicyclo[1.1.1]pentan-1-yl)-1,3-dithian-2-yl)-N,N-
dimethylaniline (2-3h): The reaction was performed following 
General Procedure A with 4-(1,3-dithiane-2-yl)-N,N-dimethylaniline 
2-2h (23.9 mg, 0.1 mmol), [1.1.1]propellane solution in Et2O (0.20 mmol) and NaN(SiMe3)2 
(73.6 mg, 0.4 mmol). The crude product was purified by flash chromatography on silica 
gel (eluted with hexanes:ethyl acetate 95:5) to give the product (16.5 mg, 54% yield) as a 
pale yellow solid: mp = 122-124 oC. Rf = 0.70 (Et2O/hexanes 1:5). 1H NMR (500 MHz, 
CDCl3) δ 7.80 – 7.63 (m, 2H), 6.81 – 6.58 (m, 2H), 2.98 (s, 6H), 2.75 – 2.53 (m, 4H), 2.43 
(s, 1H), 1.96 – 1.78 (m, 2H), 1.70 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 161.2, 148.9, 
SS
H
SS
Me2N
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130.2, 112.0, 60.3, 50.6, 48.1, 40.5, 27.3, 26.5, 25.0. IR (thin film): 2972, 2906, 2873, 
1607, 1513, 1350, 1257, 1194, 1160, 823, 786 cm–1. HRMS calculated for C17H23NS2: 
305.1272, observed 305.1260 [M]+.  
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(3-methoxyphenyl)-1,3-dithiane (2-3i): 
The reaction was performed following General Procedure A with 2-(3-
methoxyphenyl)-1,3-dithiane 2-2i (31.2 mg, 0.1 mmol), [1.1.1]propellane 
solution in Et2O (0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (26.8 mg, 92% yield) as a white solid: mp 
= 90-91 oC. Rf = 0.70 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.53 – 7.47 (m, 
2H), 7.29 (t, J = 7.9 Hz, 1H), 6.81 (ddd, J = 8.2, 2.5, 1.0 Hz, 1H), 3.83 (s, 3H), 2.76 – 2.57 
(m, 4H), 2.44 (s, 1H), 1.97 – 1.82 (m, 2H), 1.69 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 
13C{1H} NMR (125 MHz, CDCl3) δ 159.8, 141.4, 129.1, 121.7, 115.2, 111.9, 60.3, 55.3, 
50.0, 48.1, 27.4, 26.3, 24.7. IR (thin film): 2973, 2907, 2873, 1594, 1474, 1422, 1313, 
1283, 1239, 1195, 1050, 804, 787, 694 cm–1. HRMS calculated for C16H20OS2: 292.0956, 
observed 292.0971 [M]+.  
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(4-fluorophenyl)-1,3-dithiane (2-
3j): The reaction was performed following General Procedure A with 
2-(4-fluorophenyl)-1,3-dithiane 2-2j (31.2 mg, 0.1 mmol), 
[1.1.1]propellane solution in Et2O (0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol). 
The crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (27.2 mg, 96% yield) as a white solid. Rf 
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= 0.80 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.87 (ddd, J = 9.0, 4.4, 1.6 Hz, 
2H), 7.05 (ddt, J = 8.8, 6.6, 1.8 Hz, 2H), 2.76 – 2.56 (m, 4H), 2.46 (d, J = 2.6 Hz, 1H), 
2.05 – 1.79 (m, 2H), 1.66 (d, J = 1.6 Hz, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 162.6 
(d,1JC-F = 246.25 Hz), 135.2 (d, 4JC-F = 3.75 Hz), 130.9 (d, 3JC-F = 7.5 Hz), 114.94 (d, 2JC-F 
= 21.25 Hz), 59.7, 50.1, 47.9, 27.2, 26.5, 24.7. IR (thin film): 2975, 2908, 2874, 1598, 
15001422, 1223, 1157, 843, 805, 566, 523 cm–1. HRMS calculated for C15H17FS2: 
280.0756, observed 280.0773 [M]+.  
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(4-bromophenyl)-1,3-dithiane (2-
3k): The reaction was performed following General Procedure A with 
2-(4-bromophenyl)-1,3-dithiane 2-2k (27.5mg, 0.1 mmol), 
[1.1.1]propellane solution in Et2O (0.20 mmol) and LiN(SiMe3)2 (50.4 mg, 0.3 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (28.5 mg, 84% yield) as a thick yellow oil. 
Rf = 0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.86 – 7.70 (m, 2H), 7.59 – 
7.41 (m, 2H), 2.71 – 2.54 (m, 4H), 2.46 (s, 1H), 1.99 – 1.80 (m, 2H), 1.65 (s, 6H). 13C{1H} 
NMR (125 MHz, CDCl3) δ 138.9, 131.2, 131.1, 120.9, 59.8, 49.8, 47.9, 27.2, 26.5, 24.6. 
IR (thin film): 2925, 2852, 1480, 1445, 1420, 1274, 1168, 1042, 963, 745 cm–1. HRMS 
calculated for C15H17BrS2: 339.9955, observed 339.9977 [M]+.  
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(3-fluorophenyl)-1,3-dithiane (2-3l): 
The reaction was performed following General Procedure A with 2-(3-
fluorophenyl)-1,3-dithiane 2-2l (31.2 mg, 0.1 mmol), [1.1.1]propellane 
solution in Et2O (0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol). The 
SS
F
SS
Br
82 
 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (26.6 mg, 95% yield) as a pale yellow 
solid: mp = 94-95 oC. Rf = 0.80 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.74 – 
7.61 (m, 2H), 7.34 (td, J = 8.0, 6.1 Hz, 1H), 6.96 (tdd, J = 8.2, 2.6, 0.9 Hz, 1H), 2.73 – 2.56 
(m, 4H), 2.46 (s, 1H), 1.99 – 1.79 (m, 2H), 1.66 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 
13C NMR (126 MHz, CDCl3) δ 164.1 (d,1JC-F = 243.75 Hz), 142.8 (d, 3JC-F = 6.25 Hz), 129.6 
(d, 3JC-F = 8.75), 124.9 (d, 4JC-F = 2.5 Hz), 116.3 (d, 2JC-F = 23.75 Hz), 113.7 (d, 2JC-F = 21.25 
Hz), 59.8, 49.8, 48.1, 27.4, 26.5, 24.6. IR (thin film): 2976, 2908, 2871, 1584, 1483, 1422, 
1229, 1196, 878, 790, 764, 687 cm–1. HRMS calculated for C15H17FS2: 280.0756, 
observed 280.0760 [M]+.  
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(3-(trifluoromethyl)phenyl)-1,3-
dithiane (2-3m) :The reaction was performed following General 
Procedure A with 2-(3-(trifluoromethyl)phenyl)-1,3-dithiane 2-2m (31.2 
mg, 0.1 mmol), [1.1.1]propellane solution in Et2O (0.20 mmol) and 
NaN(SiMe3)2 (46.0 mg, 0.25 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(24.8 mg, 75% yield) as a white solid: mp = 104-106 oC. Rf = 0.80 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 8.29 – 8.17 (m, 1H), 8.12 (dt, J = 7.3, 1.8 Hz, 1H), 7.60 – 7.46 
(m, 2H), 2.71 – 2.63 (m, 2H), 2.57 (m, 2H), 2.47 (s, 1H), 2.01 – 1.83 (m, 2H), 1.67 (s, 6H). 
13C{1H} NMR (125 MHz, CDCl3) δ 141.2, 132.6, 130.9 (q, 2JC-F = 31.25 Hz), 126.0 (q, 4JC-
F = 2.5 Hz), 127.5 (q, 1JC-F = 271.25 Hz), 126.0 (q, 3JC-F = 3.75 Hz) 123.7 (q, 3JC-F = 3.75 
Hz), 59.8, 49.8, 48.0, 27.3, 26.7, 24.6. IR (thin film): 2964, 2904, 2874, 1426, 1322, 1166, 
1121, 1068, 817, 700 cm–1. HRMS calculated for C16H17F3S2: 330.0724, observed 
330.0714 [M]+.  
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2-(4-(2-(Bicyclo[1.1.1]pentan-1-yl)-1,3-dithian-2-yl)phenyl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2-3n): The reaction 
was performed following General Procedure A with 2-(4-(1,3-
dithian-2-yl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 2-
2n (32.2 mg, 0.1 mmol), [1.1.1]propellane solution in Et2O (0.20 mmol) and NaN(SiMe3)2 
(46.0 mg, 0.25 mmol). The crude product was purified by flash chromatography on silica 
gel (eluted with hexanes:ethyl acetate 98:2) to give the product (29.1 mg, 75% yield) as a 
white solid: mp = 230-233 oC. Rf = 0.50 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 
7.99 – 7.89 (m, 2H), 7.89 – 7.76 (m, 2H), 2.75 – 2.56 (m, 4H), 2.43 (s, 1H), 1.94 – 1.81 
(m, 2H), 1.65 (s, 6H), 1.36 (s, 12H). 13C{1H} NMR (125 MHz, CDCl3) δ 147.6, 142.7, 134.7, 
128.5, 83.7, 60.4, 49.8, 48.0, 27.3, 26.5, 24.8, 24.7. IR (thin film): 2976, 2907, 1605, 1395, 
1248, 1145, 1090, 844, 727, 655 cm–1. HRMS calculated for C21H29BO2S2: 338.1702, 
observed 338.1712 [M]+.  
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(naphthalen-1-yl)-1,3-dithiane (2-
3o): The reaction was performed following General Procedure A with 
2-(naphthalen-1-yl)-1,3-dithiane 2-2o (24.6 mg, 0.1 mmol), 
[1.1.1]propellane solution in Et2O  (0.20 mmol) and NaN(SiMe3)2 (55.2 mg, 0.30 mmol). 
The crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (21.9 mg, 70% yield) as a yellow thick oil. 
Rf = 0.80 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 9.32 (d, J = 8.6 Hz, 1H), 8.38 
(dd, J = 7.6, 1.4 Hz, 1H), 7.87 – 7.77 (m, 2H), 7.50 – 7.39 (m, 3H), 2.69 (m, 4H), 2.39 (s, 
1H), 1.93 (ddt, J = 21.5, 15.4, 8.6 Hz, 2H), 1.84 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 
135.4, 133.8, 132.1, 131.5, 129.1, 128.7, 128.4, 125.1, 124.8, 123.6, 61.4, 50.7, 50.0, 
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28.1, 25.6, 24.5. IR (thin film): 2974, 2907, 2873, 1595, 1508, 1391, 1198, 781, 734, 630 
cm–1. HRMS calculated for C19H20S2: 312.1006, observed 312.1014 [M]+.  
 
2-(4-(2-(Bicyclo[1.1.1]pentan-1-yl)-2-(phenanthren-9-yl)-1,3-
dithiane (2-3p): The reaction was performed following General 
Procedure A with 2-(phenanthren-9-yl)-1,3-dithiane 2-2p (31.2 mg, 
0.1 mmol), [1.1.1]propellane solution in Et2O (0.20 mmol) and 
NaN(SiMe3)2 (55.2 mg, 0.3 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(23.1 mg, 64% yield) as a yellow thick oil. Rf = 0.80 (Et2O/hexanes 1:5). 1H NMR (500 
MHz, CDCl3) δ 9.35 (dd, J = 8.7, 1.4 Hz, 1H), 8.74 (dd, J = 8.3, 1.6 Hz, 1H), 8.70 – 8.62 
(m, 2H), 7.95 (dt, J = 7.7, 1.6 Hz, 1H), 7.67 (ddd, J = 8.3, 7.0, 1.5 Hz, 1H), 7.61 (tdd, J = 
7.8, 2.7, 1.3 Hz, 2H), 7.52 (ddt, J = 8.5, 6.8, 1.5 Hz, 1H), 2.71 (m, 4H), 2.41 (s, 1H), 1.98 
– 1.87 (m, 7H), 1.88 – 1.78 (m, 1H).13C{1H} NMR (125 MHz, CDCl3) δ 133.1, 132.0, 131.9, 
131.3, 130.7, 130.4, 129.3, 129.2, 127.1, 126.6, 125.9, 124.2, 122.8, 122.2, 61.3, 50.3, 
29.7, 28.1, 25.6, 24.5.IR (thin film): 3057, 2907, 2872, 2360, 2340, 1736, 1591, 1492, 
1447, 1371, 1238, 1199, 780, 741, 655 cm–1. HRMS calculated for C23H22S2: 362.1163, 
observed 362.1173 [M]+.  
 
2-(4-(2-(Bicyclo[1.1.1]pentan-1-yl)-2-(anthracen-9-yl)-1,3-dithiane 
(2-3q): The reaction was performed following General Procedure A with 
2-(anthracen-9-yl)-1,3-dithiane 2-2q (31.2 mg, 0.1 mmol), 
[1.1.1]propellane solution in Et2O (0.20 mmol) and NaN(SiMe3)2 (55.2 
mg, 0.3 mmol). The crude product was purified by flash chromatography on silica gel 
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(eluted with hexanes:ethyl acetate 98:2) to give the product (25.7 mg, 71% yield) as a light 
yellow thick oil. Rf = 0.80 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 9.35 (dd, J = 
8.7, 1.3 Hz, 1H), 8.74 (dd, J = 8.3, 1.4 Hz, 1H), 8.66 (d, J = 9.5 Hz, 2H), 7.94 (dd, J = 7.7, 
1.5 Hz, 1H), 7.66 (ddd, J = 8.3, 7.0, 1.4 Hz, 1H), 7.61 (dddd, J = 7.9, 7.0, 2.8, 1.2 Hz, 2H), 
7.52 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H), 2.71 (m, 4H), 2.40 (s, 1H), 1.96 – 1.87 (m, 7H), 1.82 
(m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ133.0, 131.9, 131.8, 131.2, 130.6, 130.3, 129.3, 
129.1, 127.0, 126.5, 125.8, 124.1, 122.7, 122.1, 61.2, 50.5, 50.2, 28.0, 25.5, 24.4. IR (thin 
film): 2972, 2906, 2340, 1699, 1591, 1492, 1431, 1419, 1361, 1248, 1118, 781, 742, 656 
cm–1. HRMS calculated for C23H22S2: 362.1163, observed 362.1171 [M]+.  
 
3-(2-(Bicyclo[1.1.1]pentan-1-yl)-1,3-dithiane-2-yl)furan (2-3r): The 
reaction was performed following General Procedure A with 3-(1,3-
dithiane-2-yl)furan 2-2r (18.6 mg, 0.1 mmol), [1.1.1]propellane solution in 
Et2O (0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol). The crude product was purified 
by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the 
product (15.2 mg, 60% yield) as a white solid: mp = 102-105 oC. Rf = 0.80 (Et2O/hexanes 
1:5). 1H NMR (500 MHz, CDCl3) δ 7.48 (dd, J = 1.7, 0.8 Hz, 1H), 7.40 (t, J = 1.8 Hz, 1H), 
6.43 (dd, J = 1.8, 0.9 Hz, 1H), 2.91 – 2.73 (m, 2H), 2.66 (m, 2H), 2.48 (s, 1H), 1.98 (m, 
1H), 1.91 – 1.79 (m, 1H), 1.74 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 143.2, 142.6, 
127.2, 111.8, 52.3, 49.7, 48.0, 27.3, 26.0, 25.0. IR (thin film): 3127, 2975, 2909, 2873, 
1500, 1416, 1265, 1194, 1158, 1024, 873, 823, 800, 601 cm–1. HRMS calculated for 
C13H16OS2: 252.0643, observed 252.0640 [M]+.  
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(thiophen-3-yl)-1,3-dithiane (2-3s): The 
reaction was performed following General Procedure A with 2-(thiophen-
3-yl)-1,3-dithiane 2-2s (20.2 mg, 0.1 mmol), [1.1.1]propellane solution in 
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Et2O (0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol). The crude product was purified 
by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the 
product (25.5 mg, 95% yield) as a white solid: mp = 95-98 oC. Rf = 0.80 (Et2O/hexanes 
1:5). 1H NMR (500 MHz, CDCl3) δ 7.45 (dt, J = 3.1, 1.4 Hz, 1H), 7.37 – 7.14 (m, 2H), 2.83 
– 2.72 (m, 2H), 2.72 – 2.62 (m, 2H), 2.46 (s, 1H), 1.99 – 1.91 (m, 1H), 1.91 – 1.80 (m, 1H), 
1.71 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ142.72, 129.19, 125.29, 124.72, 56.5, 
49.90, 48.20, 27.52, 26.22, 24.98. IR (thin film): 2974, 2907, 2873, 1422, 1256, 1211, 
1195, 1146, 1009, 838, 814, 761 cm–1. HRMS calculated for C13H16S3: 268.0414, observed 
268.0415 [M]+.  
 
2-(Bicyclo[1.1.1]pentan-1-yl)-2-(3-methylthiophen-2-yl)-1,3-dithiane 
(2-3t): The reaction was performed following General Procedure A with 2-
(3-methylthiophen-2-yl)-1,3-dithiane 2-2t (21.6 mg, 0.1 mmol), 
[1.1.1]propellane solution in Et2O (0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 0.25 mmol). 
The crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (25.5 mg, 95% yield) as a pale yellow 
solid: mp = 85-86 oC. Rf = 0.80 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.08 (d, 
J = 5.2 Hz, 1H), 6.79 (d, J = 5.2 Hz, 1H), 3.06 – 2.89 (m, 2H), 2.81 – 2.66 (m, 2H), 2.46 
(s, 1H), 2.37 (s, 3H), 1.97 (dtt, J = 13.7, 3.9, 2.9 Hz, 1H), 1.92 – 1.83 (m, 1H), 1.79 (s, 
6H).13C{1H} NMR (125 MHz, CDCl3) δ 139.1, 134.7, 133.2, 123.4, 56.6, 50.6, 48.6, 28.2, 
26.2, 24.5, 16.6. IR (thin film): 2974, 2908, 2873, 2359, 1652, 1558, 1418, 1252, 1195, 
707 cm–1. HRMS calculated for C14H18S3: 282.0571, observed 282.0574 [M]+.  
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3-(2-(Bicyclo[1.1.1]pentan-1-yl)-1,3-dithian-2-
yl)benzo[b]thiophene (2-3u): The reaction was performed following 
General Procedure A with 3-(1,3-dithiane-2-yl)benzothiophene 2-2u 
(31.2 mg, 0.1 mmol), [1.1.1]propellane solution in Et2O (0.20 mmol) and NaN(SiMe3)2 
(46.0 mg, 0.25 mmol). The crude product was purified by flash chromatography on silica 
gel (eluted with hexanes:ethyl acetate 98:2) to give the product (24.2 mg, 76% yield) as a 
white solid: mp = 80-84 oC. Rf = 0.80 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 
8.82 – 8.61 (m, 1H), 7.86 (d, J = 2.4 Hz, 1H), 7.84 – 7.70 (m, 1H), 7.33 – 7.26 (m, 2H), 
2.82 – 2.72 (m, 2H), 2.68 (dt, J = 14.3, 3.6 Hz, 2H), 2.38 (s, 1H), 1.95 – 1.86 (m, 2H), 1.77 
(s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 141.7, 137.3, 134.4, 128.9, 126.2, 123.6, 122.8, 
122.5, 57.4, 49.9, 49.1, 27.7, 25.5, 24.6. IR (thin film): 3095, 3059, 2975, 2907, 2873, 
1498, 1451, 1420, 1276, 1197, 1025, 887, 749 cm–1. HRMS calculated for C17H18S3: 
318.0571, observed 318.0557 [M]+.  
 
3-(2-(Bicyclo[1.1.1]pentan-1-yl)-1,3-dithian-2-yl)pyridine (2-3v): The 
reaction was performed following General Procedure A with 3-(1,3-
dithian-2-yl)pyridine 2-2v (19.7 mg, 0.1 mmol), [1.1.1]propellane solution 
in Et2O (0.20 mmol) and LiN(SiMe3)2 (50.4 mg, 0.3 mmol). The crude product was purified 
by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 75:25) to give the 
product (22.4 mg, 85% yield) as a white solid: mp = 101-103 oC. Rf = 0.30 (ethyl 
acetate/hexanes 1:4). 1H NMR (500 MHz, CDCl3) δ 9.12 (d, J = 2.0 Hz, 1H), 8.51 (dd, J = 
4.6, 1.1 Hz, 1H), 8.20 (dt, J = 8.0, 1.8 Hz, 1H), 7.31 (dd, J = 8.0, 4.7 Hz, 1H), 2.67 (dt, J = 
14.5, 3.6 Hz, 2H), 2.59 (td, J = 11.9, 3.3 Hz, 2H), 2.48 (s, 1H), 1.96-1.84 (m, 2H), 1.67 (s, 
6H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 151.1, 148.1, 137.1, 135.6, 123.0, 58.1, 50.1, 
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48.1, 27.3, 27.0, 24.7 ppm; IR (thin film): 2981, 2909, 2874, 1567, 1468, 1411, 1326, 738 
cm-1; HRMS calculated for C14H17NS2 = 263.0802, observed 264.0862 [M+H]+.  
4-(2-(Bicyclo[1.1.1]pentan-1-yl)-1,3-dithian-2-yl)pyridine (2-3w): The 
reaction was performed following General Procedure A with 4-(1,3-
dithian-2-yl)pyridine 2-2w (19.7 mg, 0.1 mmol), [1.1.1]propellane solution 
in Et2O (0.20 mmol) and LiN(SiMe3)2 (50.4 mg, 0.3 mmol). The crude product was purified 
by flash chromatography on silica gel (eluted with 2% methanol in dichloromethane) to 
give the product (20.5 mg, 78% yield) as a white solid: mp = 88-92 oC. Rf = 0.16 (2% 
methanol in dichloromethane). 1H NMR (500 MHz, CDCl3) δ 8.62 (d, J = 5.9 Hz, 2H), 7.80 
(dd, J = 4.7, 1.5 Hz, 2H), 2.65 (dt, J = 10.8, 3.6 Hz, 2H), 2.55 (td, J = 11.9, 3.3 Hz, 2H), 
2.48 (s, 1H), 1.94-1.86 (m, 2H), 1.66 (s, 6H) ppm; 13C{1H} NMR (125 MHz, CDCl3): δ 150.3, 
149.6, 124.2, 59.3, 49.3, 48.2, 27.4, 26.7, 24.6 ppm; IR (thin film): 2869, 1592, 1414, 1318, 
1249, 1235, 838 cm-1; HRMS calculated for C14H17NS2 = 263.0802, observed 263.0798 
[M]+  
 
5-(2-(Bicyclo[1.1.1]pentan-1-yl)-1,3-dithian-2-yl)isoquinoline (2-3x): 
The reaction was performed following General Procedure A with 5-(1,3-
dithian-2-yl)isoquinoline 2-2x (31.2 mg, 0.1 mmol), [1.1.1]propellane 
solution in Et2O (0.20 mmol) and LiN(SiMe3)2 (50.4 mg, 0.3 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 70:30) to give the product (20.4 mg, 65% yield) as a white solid: 
mp = 124-130 oC. Rf = 0.60 (ethyl acetate/hexanes 1:1). 1H NMR (500 MHz, CDCl3) δ 9.20 
(d, J = 1.0 Hz, 1H), 9.10 (dt, J = 6.4, 0.9 Hz, 1H), 8.54 (dd, J = 7.6, 1.2 Hz, 1H), 8.41 (d, J 
= 6.4 Hz, 1H), 7.88 (dt, J = 8.1, 1.1 Hz, 1H), 7.59 (t, J = 7.8 Hz, 1H), 2.68 (dt, J = 14.4, 3.8 
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Hz, 2H), 2.58 (t, J = 12.9 Hz, 2H), 2.38 (s, 1H), 1.96 – 1.87 (m, 1H), 1.86 – 1.79 (m, 1H), 
1.77 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 153.2, 141.1, 135.3, 135.0, 133.6, 130.3, 
128.6, 126.2, 120.6, 60.6, 50.4, 49.6, 27.8, 25.7, 24.3. IR (thin film): 2975, 2907, 2873, 
1614, 1583, 1482, 1421, 1378, 1198, 1044, 829, 759, 650 cm–1. HRMS calculated for 
C18H19NS2: 313.0959, observed 313.0965 [M]+.  
 
4-(2-(Bicyclo[1.1.1]pentan-1-yl)-1,3-dithiane-2-yl)-1-methyl-1H-indole 
(2-3y): The reaction was performed following General Procedure A with 
4-(1,3-dithian-2-yl)-1-methyl-1H-indole 2-2y (31.2 mg, 0.1 mmol), 
[1.1.1]propellane solution in Et2O (0.20 mmol) and NaN(SiMe3)2 (46.0 mg, 
0.25 mmol). The crude product was purified by flash chromatography on silica gel (eluted 
with hexanes:ethyl acetate 98:2) to give the product (21.7 mg, 69% yield) as a white solid: 
mp = 136-138 oC. Rf = 0.65 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.76 (dt, J 
= 7.4, 0.9 Hz, 1H), 7.37 (dt, J = 3.3, 0.8 Hz, 1H), 7.33 – 7.17 (m, 2H), 6.98 (d, J = 3.2 Hz, 
1H), 3.79 (s, 3H), 2.81 – 2.58 (m, 4H), 2.36 (s, 1H), 1.97 – 1.76 (m, 2H), 1.72 (s, 6H). 
13C{1H} NMR (125 MHz, CDCl3) δ 138.1, 131.4, 127.3, 126.8, 122.7, 120.9, 108.5, 104.3, 
61.2, 50.5, 49.0, 32.9, 27.8, 25.6, 24.6. IR (thin film): 3422, 3054, 2966, 2873, 1723, 1561, 
1515, 1487, 1446, 1388, 1286, 1195, 1088, 867, 749 cm–1. HRMS calculated for 
C18H21NS2: 315.1115, observed 315.1113 [M]+.  
 
The reaction of 2z and [1.1.1]propellane[a] 
 
Entry MN(SiMe3)2 x equiv 3z (% yield) 
Ph
S
Ph
S Ph
Ph
S
Ph
S
H
Ph MN(SiMe3)2 x equiv
DME (0.1 M), 80 oC, 16 h
2-2z                 2 equiv                                              2-3z
SS
N
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1 LiN(SiMe3)2  2 equiv 94 (91[b]) 
2 NaN(SiMe3)2 2 equiv 26 
[a] Reactions conducted with 0.1 mmol, 0.1 M of thioacetal and the AY% was 
determined by crude 1H NMR. [b] Isolated yield. 
                
(Bicyclo[1.1.1]pentan-1-yl(phenyl)methylene)bis(phenylsulfane) (2-
3z): The reaction was performed following General Procedure A with 
(phenylmethylene)bis(phenylsulfane) 2-2z (19.6 mg, 0.1 mmol), 
[1.1.1]propellane solution in Et2O (0.20 mmol) and LiN(SiMe3)2 (33.6 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (34.1 mg, 91% yield) as a yellow oil. Rf = 
0.85 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.94 – 7.68 (m, 2H), 7.34 (m, 4H), 
7.30 – 7.20 (m, 3H), 7.19 – 7.10 (m, 6H), 2.34 (s, 1H), 1.74 (s, 6H). 13C{1H} NMR (125 
MHz, CDCl3) δ 139.6, 134.0, 133.3, 129.0, 128.1, 127.8, 127.3, 127.2, 71.3, 52.4, 50.6, 
27.0. IR (thin film): 3057, 2978, 2911, 2875, 1668, 1581, 1479, 1437, 1230, 1025, 882, 
738, 689 cm–1. HRMS calculated for C15H18S2: 262.0850, observed 262.0865 [M]+.  
 
Gram-scale synthesis: In the glovebox, a 100 mL Schlenk bomb was filled with a solution 
of 2-(thiophen-3-yl)-1,3-dithiane 2-2s (0.8 g, 4.0 mmol) in 20 mL DME. A solution of 
NaN(SiMe3)2 (1.84 g, 10.0 mmol) in 20 mL DME was then added to the bomb, providing a 
light red, clear solution. Next, [1.1.1]propellane (6.68 mL of 1.2 M solution in Et2O, 8.0 
mmol) was added to the Schlenk bomb. The flask was capped, removed from the glovebox 
and heated to 80 oC. After 16 h, the dark brown solution was cooled down to rt and 
quenched by 10 mL H2O. The solvent in the reaction mixture was removed under reduced 
pressure. The residue was redissolved in 20 mL ethyl acetate, extracted with H2O (2 x 10 
mL). The combined organic layers were washed with 10 mL brine, dried over Na2SO4 and 
Ph
S
Ph
S Ph
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concentrated to give thick orange oil. The crude was purified by flash chromatography on 
silica gel (2% ethyl acetate in hexanes) to give 2-3s a light yellow solid (1.01 g, 94%). 
 
Bicyclo[1.1.1]pentan-1-yl(phenyl)methanone (2-4z): A 20 mL vial 
reaction vial was charged with a solution of (bicyclo[1.1.1]pentan-1-
yl(phenyl)methylene)bis(phenylsulfane) 2-3z (37.4 mg, 0.1 mmol) in 5 mL 
CH2Cl2 as a clear solution. The vial was cooled to 0 oC in aj ice bath and a solution of 
mCPBA (138.1 mg, 0.8 mmol) in 5 mL CH2Cl2 was added dropwise to the reaction vial to 
form a light-yellow solution. The reaction mixture was allowed to warm up to room 
temperature and stirred for 16 h. When the reaction was complete, as judged by TLC, the 
mixture was cooled to 0 oC and quenched with 0.1 M NaOH (5 mL) and extracted with 
CH2Cl2 (3 x 5 mL). The combined organic layers were washed with brine, dried over 
Na2SO4 and concentrated under vacuum to get a yellow thick oil. The crude product was 
purified by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 95:5) to 
give the product (15.6 mg, 91% yield) as a light-yellow oil. Rf = 0.5 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 7.99 (dq, J = 7.1, 1.2 Hz, 2H), 7.53 (dddd, J = 8.8, 6.8, 2.5, 1.2 
Hz, 1H), 7.49 – 7.39 (m, 2H), 2.56 (d, J = 1.1 Hz, 1H), 2.33 (s, 6H).13C{1H} NMR (125 MHz, 
CDCl3) δ 197.1, 136.5, 132.6, 128.8, 128.3, 53.2, 49.3, 28.3. IR (thin film): 2974, 2915, 
2877, 2361, 1723, 1660, 1625, 1596, 1352, 1311, 1210, 117, 1060, 988, 885 cm–1. HRMS 
calculated for C12H12O: 172.0888, observed 172.0886 [M]+.  
 
Bicyclo[1.1.1]pentan-1-yl benzoate (2-6z): A 20 mL reaction vial was 
charged with a solution of bicyclo[1.1.1]pentan-1-yl(phenyl)methanone 2-
4z (17.2 mg, 0.1 mmol) in 5 mL CHCl3. To the clear solution was added 
O
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mCPBA as a solid (69.0 mg, 0.4 mmol), which generated a white cloudy suspension. The 
reaction mixture was heated to 50 oC and stirred for 16 h. The reaction mixture was 
allowed to cool down to room temperature and quenched with 3 mL a solution of K2CO3 
(10%w/w) and extracted with CH2Cl2 (3x5 mL). The combined organic layers were washed 
with brine, dried over Na2SO4, and concentrated under reduced pressure. The pale yellow 
crude oil was purified by flash chromatography on silica gel (eluted with hexanes:ethyl 
acetate 97:3) to give the product (18 mg, 96% yield) as a colorless oil. Rf = 0.65 
(Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.09 – 7.95 (m, 2H), 7.55 (ddt, J = 8.0, 
7.0, 1.3 Hz, 1H), 7.43 (td, J = 7.6, 1.0 Hz, 2H), 2.60 (s, 1H), 2.28 (s, 6H). 13C{1H} NMR 
(125 MHz, CDCl3) δ 165.8, 132.8, 130.4, 129.5, 128.2, 64.7, 53.3, 20.9. IR (thin film): 
3000, 2919, 2883, 1724, 1451, 1282, 1217, 1175, 1093, 928, 706 cm–1. HRMS calculated 
for C12H12O2: 188.0837, observed 188.0845 [M]+.  
 
General Procedure B for hydrolysis:  
An 8 mL reaction vial was filled with a solution of BCP dithiane (0.1 mmol) in 3 ml THF 
and a solution of sodium dodecyl sulfate, SDS (0.2 equiv) in 1 mL H2O. The biphasic 
mixture was stirred at room temperature for 5 min then iodine (solid, 0.05 equiv) and 30% 
H2O2 (0.2 ml/0.1 mmol) was added to the reaction mixture forming a dark orange, clear 
solution. The reaction mixture was stirred at rt for 18-24 h. After the reaction was complete, 
as determined by TLC, the yellow mixture was quenched with 2 mL of a saturated solution 
of Na2S2O3 and extracted with CH2Cl2 (3 x 5 mL). The combined organic layers were 
washed with brine, dried over Na2SO4 and concentrated under reduced pressure to give 
a crude product as a thick yellow oil. The crude was purified by flash column 
chromatography with 5% ethyl acetate in hexanes.  
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Bicyclo[1.1.1]pentan-1-yl(naphthalen-2-yl)methanone (2-4b): 
The reaction was performed following General Procedure B with 2-
(bicyclo[1.1.1]pentan-1-yl)-2-(naphthalen-2-yl)-1,3-dithiane 2-3b 
(31.2 mg, 0.1 mmol). The crude product was purified by flash chromatography on silica 
gel (eluted with hexanes:ethyl acetate 95:5) to give the product (16.6 mg, 75% yield) as a 
colorless oil. Rf = 0.50 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.55 (t, J = 1.1 
Hz, 1H), 8.03 (dd, J = 8.7, 1.7 Hz, 1H), 8.00 – 7.92 (m, 1H), 7.91 – 7.84 (m, 2H), 7.57 (m, 
2H), 2.62 (s, 1H), 2.41 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 197.3, 135.3, 133.9, 
132.4, 130.7, 129.6, 128.4, 128.3, 127.8, 126.7, 124.5, 53.5, 49.5, 28.5. IR (thin film): 
3058, 2976, 2915, 2878, 2360, 2340, 1722, 1659, 1626, 1467, 1353, 1314, 1213, 1137, 
861, 762 cm–1. HRMS calculated for C16H14O: 223.1123, observed 223.1127 [M]+.  
 
Bicyclo[1.1.1]pentan-1-yl(4-bromophenyl)methanone (2-4k): The 
reaction was performed following General Procedure B with 2-
(bicyclo[1.1.1]pentan-1-yl)-2-(4-bromophenyl)-1,3-dithiane 2-3k (31.2 
mg, 0.1 mmol). The crude product was purified by flash chromatography on silica gel 
(eluted with hexanes:ethyl acetate 95:5) to give the product (17.6 mg, 79% yield) as a 
colorless oil. Rf = 0.60 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.96 – 7.79 (m, 
2H), 7.67 – 7.52 (m, 2H), 2.58 (s, 1H), 2.31 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 
196.2, 135.2, 131.7, 130.4, 127.9, 53.3, 49.2, 28.5. IR (thin film): 2979, 2910, 2878, 1665, 
1582, 1482, 1396, 1316, 1212, 1171, 1067, 985, 882, 788, 724 cm–1. HRMS calculated 
for C12H11BrO: 249.9993, observed 249.9993 [M]+. 
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Bicyclo[1.1.1]pentan-1-yl(thiophen-3-yl)methanone (2-4s): The 
reaction was performed following General Procedure B with 2-
(bicyclo[1.1.1]pentan-1-yl)-2-(thiophen-3-yl)-1,3-dithiane 2-3s (31.2 mg, 
0.1 mmol). The crude product was purified by flash chromatography on silica gel (eluted 
with hexanes:ethyl acetate 95:5) to give the product (14.5 mg, 81% yield) as a colorless 
oil. Rf = 0.50 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.15 (dd, J = 2.9, 1.2 Hz, 
1H), 7.59 (dd, J = 5.1, 1.2 Hz, 1H), 7.30 (dd, J = 5.1, 2.9 Hz, 1H), 2.56 (s, 1H), 2.29 (s, 
6H). 13C{1H} NMR (125 MHz, CDCl3) δ 191.45, 140.8, 132.83, 127.65, 125.83, 52.9, 49.5, 
28.0. IR (thin film): 3112, 2977, 2916, 2877, 1657, 1511, 1413, 1298, 1221, 1164, 998, 
871, 836, 781, 706 cm–1. HRMS calculated for C10H10OS: 178.0452, observed 178.0444 
[M]+. 
 
General Procedure C 
In a 15 mL centrifuge tube, a suspension of N-iodosuccinimide, NIS (2 equiv) in 0.5 mL 
CH2Cl2 was cooled to -78 oC and stirred for 10 min. A solution of 70% HF in Pyridine (4 
equiv) was added dropwise to the mixture and stirred at -78oC for 5 min. Then, a cold 
solution of BCP dithiane in 0.5 mL CH2Cl2 was added dropwise. The dark red mixture was 
stirred at -78 oC for 15 min to 1 h. When the reaction was complete, as judged by TLC, 
the mixture was allowed to warm up to ambient temperature and quenched by dropwise 
addition of a solution of saturated NaHCO3 5 mL and the mixture was stirred for 10 min or 
until no bubbles were observed. The orange mixture was extracted by CH2Cl2 (3x5 mL), 
washed with a solution of saturated Na2S2O3 (5 mL), brine (5 mL), dried with Na2SO4 and 
concentrated under vacuum. The yellow thick oil crude was purified by flash column 
chromatography with 2% Et2O in hexanes.  
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1-(Difluoro(4-methoxyphenyl)methyl)bicyclo[1.1.1]pentane (2-
5e): The reaction was performed following General Procedure C 
with 2-(bicyclo[1.1.1]pentan-1-yl)-2-(4-methoxyphenyl)-1,3-dithiane 
2-3e (29.2 mg, 0.1 mmol). The crude product was purified by flash chromatography on 
silica gel (eluted with hexanes:Et2O 98:2) to give the product (18.6 mg, 83% yield) as a 
pale yellow oil. Rf = 0.85 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.27 (m, 
2H), 7.00 – 6.85 (m, 2H), 3.82 (s, 3H), 2.51 (s, 1H), 1.82 (s, 6H). 13C{1H} NMR (125 MHz, 
CDCl3) δ 160.3, 127.6 (2JC-F= 27.5 Hz), 126.5 (3JC-F = 6.25), 118.6 (1JC-F = 241.25 Hz), 
113.4, 55.1, 48.0, 46.3 (2JC-F = 37.5 Hz), 27.3. IR (thin film): 2975, 2914, 2878, 1656, 1600, 
1574, 1509, 1460, 1419, 1312, 1259, 1215, 1165, 1029, 984, 883, 857, 844, 795, 618, 
507 cm–1. HRMS calculated for C13H14F2O: 224.1013, observed 224.1022 [M]+.  
 
 2-(Bicyclo[1.1.1]pentan-1-yldifluoromethyl)-3-methylthiophene (2-
5t): The reaction was performed following General Procedure C with 2-
(bicyclo[1.1.1]pentan-1-yl)-2-(3-methylthiophen-2-yl)-1,3-dithiane 2-3t (31.8 mg, 0.1 
mmol). The crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:Et2O 98:2) to give the product (15.4 mg, 72% yield) as a colorless oil. Rf = 0.85 
(Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.22 (d, J = 5.0 Hz, 1H), 6.84 (dt, J = 
5.0, 1.8 Hz, 1H), 2.55 (s, 1H), 2.30 (s, 3H), 1.91 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) 
δ 136.7, 131.0, 130.3 (2JC-F = 31.5 Hz), 124.7, 118.3 (1JC-F = 241.9 Hz), 48.5, 46.6 (2JC-F = 
36.5 Hz), 27.3, 14.5. IR (thin film): 2923, 2852, 1463, 1377, 1207, 1071, 423 405 cm–1. 
HRMS calculated for C11H12F2S: 214.0632, observed 214.0628 [M]+.  
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 3-(Bicyclo[1.1.1]pentan-1-yldifluoromethyl)benzo[b]thiophene 
(2-5u): The reaction was performed following General Procedure C 
with 3-(2-(bicyclo[1.1.1]pentan-1-yl)-1,3-dithian-2-
yl)benzo[b]thiophene 2-3u (31.8 mg, 0.1 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:Et2O 98:2) to give the product (21.6 
mg, 86% yield) as a colorless oil. Rf = 0.85 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) 
δ 7.93 – 7.88 (m, 1H), 7.88 – 7.82 (m, 1H), 7.57 (s, 1H), 7.45 – 7.32 (m, 2H), 2.49 (s, 1H), 
1.89 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ 140.5, 136.0, 131.3 (2JC-F = 28.75 Hz), 
125.7 (3JC-F = 7.5 Hz), 124.6, 124.4, 123.6 (3JC-F = 3.75 Hz), 122.6, 118.1 (1JC-F = 238.75 
Hz), 48.6, 46.2 (2JC-F = 36.25 Hz), 26.8. IR (thin film): 2984, 2917, 2881, 1524, 1460, 1428, 
1321, 1208, 1124, 1069, 1052, 931, 889, 823, 757, 735 cm–1. HRMS calculated for 
C14H12F2S: 250.0628, observed 250.0618 [M]+.  
Details of Computational Studies for Determination of the Mechanism 
Optimizations of intermediates and transition states were performed using Gaussian 09[25] 
with unrestricted-spin DFT using UB3LYP functional and basis set 6-31+G(d,p) all atoms 
in the gas phase. For all species, vibrational frequencies were also computed at the 
specified level of theory to obtain thermal Gibbs free energy corrections (at 298 K) and to 
characterize the stationary points as transition states or minima. Single point energy 
calculations were performed on the optimized geometries in 1,4-dioxane solvent using 
SMD solvation model, UM06-2X functional, and basis set 6-311+G(d,p) for all atoms. 
Calculated single-point energies were converted to the enthalpies and Gibbs free energies 
using corrections from gas-phase frequency calculations (Figure 2-S1).  
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Figure 2-S1. Energy profiles for propellylations of 2-phenyl-1,3-dithiane via a two-electron 
pathway (1a) and a single-electron transfer pathway (1b). The blue line represents free 
energies for equatorial phenyl dithiane and the black line represents free energies for axial 
phenyl dithiane. The enthalpy free energies are shown in the bracket.  
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The propellylation of 2a with n-BuLi in different solvents[a] 
 
 
 
 
Entry Base (x equiv) Solvent (0.1 M) %Yield of 2-3a  
1 nBuLi (1.1) DME 50% 
2 nBuLi (1.1) THF 27% 
3 nBuLi (1.1) Cyclohexane 4% (90%[b]) 
[a] Reactions conducted with 0.2 mmol following General Procedure D and the AY% was 
determined by crude 1H NMR. [b] Result from the propellylation of 2-2a with 2.5 equiv 
NaN(SiMe3)2 in Cyclohexane (0.1 M) at 80 oC for 16 h  
 
 
The propellylation of 2a with nBuLi 
General Procedure D: An 8 mL reaction vial equipped with a stir bar was charged with 
2-phenyl-1,3-dithiane 2-2a (39.2 mg, 0.20 mmol, 1.0 equiv) under a nitrogen atmosphere 
in the glovebox at room temperature. Solvent (2 mL, 0.1 M in dithiane) was added to the 
reaction vial by syringe. Notably, the solvent was purchased from Acros, used as 
solvents without further purification and kept in the presence of molecular sieves. The 
reaction vial was sealed with a fresh cap and transferred out of the glovebox. The 
colorless solution was cooled to 0 oC and n-BuLi (1.55 M, 140 µL) was added dropwise 
to the reaction mixture over 2 min providing a bright yellow solution that was stirred at 0 
H
SS Base
solvent, 
0 oC to 80 oC, 16 h
Ph
SS
Ph
     2-2a           2 equiv                                            2-3a
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oC. After 2.5 h, the mixture was allowed to warm to rt and a solution of [1.1.1]propellane 
in diethyl ether solution (0.40 mmol, 2.0 equiv) was added to the bright-yellow reaction 
mixture using a syringe. Next the resulting light-yellow mixture was stirred at 80 oC for 16 
h. The dark brown reaction mixture then was quenched with 10 drops of D2O, diluted 
with 5 mL of ethyl acetate, and filtered over a pad of silica. The pad was rinsed with 10 
mL of ethyl acetate (2x5 mL), and the solution was concentrated under vacuum 
providing the yellow thick oil. The yield of orange crude was determined by 1H NMR.  
 
The propellylation of 2-2a-d 
 
The reaction of 2a-d and [1.1.1]propellane was conducted in 0.1 mmol scale following 
General Procedure A. Notably, the reaction mixture was quenched with 5 drops of D2O. 
Analysis of the crude mixture by 1H NMR determined the percent incorporation of 
deuterium  and proton at BCP bridgehead position as 65% and 25%, respectively. 
(overall yield = 90%). This result supported our hypothesis that DME (or THF) could be a 
proton source in the propellylation of dithianes.  
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CHAPTER 3 
Ligand-Free Palladium-Catalyzed Allylic Amination of Hydrazone Derivatives 
3.1 Introduction 
The development of tools for introducing nitrogen functionality into building blocks 
has become one of the major focus for synthetic chemists due to the prevalence of 
nitrogen- in bioactive pharmaceutical compounds[1]. N-Alkylated hydrazones are one of 
the important classes of nitrogen-containing compounds, which are widely studied due to 
their significant applications in various aspects of chemistry[2]. Studies from the medicinal 
chemistry community indicate that N-alkylated hydrazone derivatives possess diverse 
biological and pharmacological properties, such as antimicrobial, analgesic, anti-
inflammatory, antiplatelet, and antitumoral activities[3].  
Given their utility, several methods to prepare hydrazines have been reported.  
Keith’s pioneering synthesis of such compounds described the Mitsunobu reaction with 
Tosyl- and Boc-hydrazones as pronucleophiles.  This method, however, suffers from 
narrow substrate scope. Boc-hydrazones required electron-withdrawing substituents to 
achieve good reactivities[4] (Scheme 1a). Wang reported the first example of 
organocatalytic asymmetric allylic alkylation of hydrazones using an expensive catalyst, 
(DHQD)2PHAL, providing N-alkylated hydrazones with excellent regio- and 
enantioselectivity (up to 94% ee). However, the scope of electrophiles was limited. Only 
Morita-Baylis-Hillman (MBH) carbonates were reported as successful electrophile for this 
chemistry[5] (Scheme 3-1b) Alternatively, a transition-metal-catalyzed allylic amination was 
reported by the Xioa group using a Pd/phosphoramidite thioether complex for asymmetric 
allylic alkylation of hydrazones[6] (Scheme 3-1c).  However, the electrophile scope was 
limited, and the synthesis of ligands was time-consuming and costly.  
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Recently, an approach for cross-coupling reactions in the absence of added 
ligands has attracted increasing attention[7].  Advantages of ligand-free systems is that 
they are more cost effective and also avoid contamination of the desired products by the 
ligand after reaction workup[8].  
 
 
Scheme 3-1. Previous synthesis of N-alkylated hydrazones and ligand-free allylic 
alkylation of hydrazones. 
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Herein we report a ligand-free palladium-catalyzed allylic amination of hydrazone 
derivatives with a variety of cyclic and acyclic electrophiles to form N-alkylated hydrazones 
in good to excellent yields. To demonstrate the utility of this approach, a one-pot allylic 
substitution-Fischer indole cyclization to provide building blocks for the preparation of 
antifungal drugs[9] is presented. Mechanistic study by probing the stereochemistry of the 
reaction has indicated that hydrazone nucleophile acts as a “soft” nucleophile (double 
inversion mechanism) involving an exo-attack of the metallated hydrazine on the π-allyl 
palladium intermediate. 
 
3.2 Results and discussion 
We carried out optimization studies using 1-(diphenylmethylene)-2-
phenylhydrazine 3-1a as a pronucleophile and tert-butylcyclohex-2-enyl carbonate 3-2a 
as an electrophile. We started the allylic amination reaction using conditions similar to 
those used previous allylic alkylation of 2-aryl-1,3-dithianes, which involved Pd(OAc)2 (10 
mol %), NIXANTPHOS[10] (20 mol %), NaN(SiMe3)2 (3 equiv) in THF solvent at room 
temperature. After 16 h, the allylic amination product 3-3aa was produced in 80% assay 
yield (AY) as determined by 1H NMR of the crude reaction mixture (Table 3-1, entry 1). 
Next, we conducted the control reaction without catalyst to check background reaction 
(entry 2). No allylation product was observed without Pd(OAc)2. Surprisingly, however, 
when we conducted the allylic amination with only Pd(OAc)2 (10 mol %) and NaN(SiMe3)2 
(3 equiv), the desired product was obtained in 87% AY (entry 3). We next examined the 
effect of reducing palladium loading. Decreasing the loading of Pd(OAc)2 from 10 mol % 
to 1 mol % afforded 3-3aa in 88% AY (entry 4), but further reducing Pd(OAc)2 loading to 
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0.1 mol % resulted in a drop to 61% AY (entry 5). Reducing the amount of base from 3 to 
2 equivalent provided 97% AY (entry 6). We also found that the allylic amination afforded 
near quantitative conversion of 3-3aa in 96% AY in only 2 h (entry 7).  Thus, the optimized 
conditions in entry 7 were employed to examine the scope of pronucleophiles and 
electrophiles. 
 
Table 3-1. Optimization of allylic amination of 3-1aa,b 
 
Entry x:y 
(mol %) 
z 
(equiv) 
Time (h) Assay Yield 
(%) 
1 10:20 3 16 80 
2 0:0 3 16 0 
3 10:0 3 16 87 
4 1:0 3 16 88 
5 0.1:0 3 16 61 
6 1:0 2 16 97 
7 1:0 2 2 96 
Ph
H
N N
Ph
Ph
OBoc
Pd(OAc)2 x mol%
NIXANTPHOS y mol%
NaN(SiMe3)2 z equiv
THF (0.1 M), rt, time
Ph N N
Ph
Ph
3-1a 3-2a
1.5 equiv
3-3aa
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aReactions conducted on 0.1 mmol scale. bAssay Yield determined by 1H NMR spectroscopy of the 
crude reaction mixture. 
 
3.2.1. Scope of electrophiles in Ligand-free Palladium-Catalyzed Allylic Amination 
reaction. 
With the optimized conditions in hand, we explored allylic amination with 1-
(diphenylmethylene)-2-phenylhydrazine 3-1a and a variety of allyl electrophilic partners. 
As summarized in Table 3-2, Our catalytic system shows board substrate scope. The 
cyclohexenyl OBoc electrophile furnished allylated product 3-3aa in 98% isolated yield. 
Other cyclic electrophiles, such as cyclopentenyl and cycloheptenyl OBoc derivatives 
reacted to afford 3-3ab and 3-3ac in excellent yields (91% and 92% respectively). Linear 
allylic carbonate derivatives also reacted effectively. The parent allyl OBoc and 2-Me allyl 
OBoc underwent allylic amination providing 3-3ad and 3-3ae in excellent yield (≥ 98%). 
Notably, for unsymmetrical η3-allyl groups, nucleophiles tend to attack the π-allyl 
palladium complex at the less substituted side.[11] The allylation with Boc-protected 
cinnamyl alcohol 3-2f and prenyl alcohol 3-2g reacted selectively to provide only linear 
product 3-3af and 3-3ag in excellent yield, 90% and 89%.  
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Table 3-2. Scope of electrophiles in allylic amination with 3-1aab 
 
aReactions conducted on 0.1 mmol scale. bIsolated yield after chromatographic purification. 
 
3.2.2. Scope of C-substituted hydrazone in Ligand-Free Palladium-Catalyzed Allylic 
Amination reaction. 
The scope of C-substituted hydrazone pronucleophiles reacting with tert-butyl 
cyclohex-2-en-yl carbonate 3-2a was examined under optimal conditions. (E)-1-
Benzylidene-2-phenylhydrazine provided the product 3-3ba in 97% yield. Gratifyingly, a 
number of heterocycles were tolerated under the optimal conditions. Pronucleophiles with 
nitrogen-containing groups underwent allylic amination to provide excellent yields of the 
corresponding products (3-3ca–3fa, 93–97%). The 3-thiophene-substituted 
pronucleophile reacted to provide 3-3ga in 97% yield. Symmetrically substituted 
pronucleophile with electron donating groups (4-Me and 4-OMe) gave the corresponding 
Ph
H
N N
Ph
Ph
Pd(OAc)2 1 mol%
NaN(SiMe3)2 2 equiv
THF, rt, 2 h Ph N N
Ph
Ph
Ph N N
Ph
Ph Ph N N
Ph
Ph
Ph N N
Ph
Ph Ph
N N
Ph
Ph Ph N N
Ph
Ph Ph N N
Ph
Ph
Ph
3-3ab, 91% 3-3ac, 92%
3-3ad, 99% 3-3ae, 98% 3-3af, 90% 3-3ag, 89%
3-1a                3-2a—2g
                       1.5 equiv
OBoc
R n
n = 0-2
R n
3-3aa—3ag
Ph N N
Ph
Ph
3-3aa, 98%
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products in excellent yields (3-3ha–3ia, 95–98%). The symmetrically substituted 
pronucleophile bearing 4-Cl groups reacted to form the desired product 3ja in 98% yield. 
 
Table 3-3. Scope of C-substituted hydrazones with 3-2aa,b. 
 
aReactions conducted on 0.1 mmol scale. bIsolated yield after chromatographic purification. 
 
 
Ph
H
N N
Ph, H
Ar
OBoc
Pd(OAc)2 1 mol%
NaN(SiMe3)2 2 equiv
THF, rt, 2 h Ph N N
Ph, H
Ar
Ph N N
H
Ph Ph N N
H
N
Ph N N
H
NH
Ph N N
H
S
Ph N N
H
N
3-3ba, 97% 3-3ca, 97%
3-3ea, 94% 3-3ga, 97%
3-3da, 93%
Ph N N
H
N
3-3fa, 94%
3-1a—1j 3-2a
1.5 equiv
Ph N N
OMe
OMe
Ph N N
Cl
Cl
3-3ha, 95% 3-3ia, 98%
3-3aa—3ja
Ph N N
Me
Me
3-3ja, 98%
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3.2.3. Scope of N-substituted hydrazone in Ligand-Free Palladium-Catalyzed Allylic 
Amination reaction. 
We next examined the scope of substitution on the terminal nitrogen of the 
hydrazone. With established reaction conditions, only (E)-1-benzylidene-2-(p-
tolyl)hydrazone provided the allylated product 3-3a’a in 60% yield. Under ligand-free 
conditions, other pronucleophiles did not react to provide the expected products. We 
therefore set out to examine the impact of ligands with these substrates.  Using 
NIXANTPHOS ligand (2 mol %), we were able to observe the allylated products in 
excellent yields (Table 3-4). Pentafluorophenyl and 2-pyridine hydrazones generated the 
products 3-3b’a and 3-3c’a in 92% and 95% yield, respectively. In the case of the amide-
containing pronucleophile 3-3d’, increasing the temperature to 60 oC gave 85% yield of 
the expected product in 16 h. Notably, the size of substituents on nitrogen influenced the 
selectivity for N- versus C-allylation. The allylic alkylation of N-tert-butylhydrazone gave 
the C-allylated product selectively in good yield (80%). The same observation was 
reported for the arylation of hydrazones.[12] 
To evacuate the scalability of this method, we conducted the allylic amination of 3-
1a with allyl OBoc on a 3.5 mmol scale (Scheme 3-1a). We found equivalent reaction 
efficiency on both the milligram and gram scales, obtaining 1.05 g of the expected product 
(96% yield). Hydrolysis of 3-3aa with 1M HCl provided amine 3-4 in 89% yield. 
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Table 3-4. Scope of N-substituted hydrazones with 3-2aa,b   
  
aReactions conducted on 0.1 mmol scale. bIsolated yield after chromatographic purification. 
cReaction conducted with Pd(OAc)2 1 mol %. d60 oC and 16 h.  
 
 
Scheme 3-1. Gram-scale synthesis of 3-3ad and hydrolysis of 3-3aa. 
R
H
N N
Ph
H
OBoc
Pd(OAc)2 1 mol%
NIXANTPHOS 2 mol%
NaN(SiMe3)2 2 equiv
THF, rt, 2 h
R N N
Ph
H
N N
H
Ph
N N
H
Ph
N N
H
Ph
F
F
F
F
F
O
3-3b’a, 92%
3d’a, 85%d
N N
H
Ph
N
3-3a’a 60%c 3-3c’a, 95%
3-1a’—5a’        3-2a
                      1.5 equiv
3-3a’a—3e’a
N N
Ph
3e’a, C-Pdt: 80%c
O
H
N
PPh2 PPh2
NIXANTPHOS
Ph
H
N N
Ph
Ph
OBoc
Pd(OAc)2 1 mol%
NaN(SiMe3)2 2 equiv
THF (0.1 M), rt, 2 h Ph
N N
Ph
Ph
3-3ad, 96% (1.05 g)  3-1a                       3-2d
3.5 mmol               1.5 equiv
Ph N N
Ph
Ph Ph N NH2
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THF, 50 oC
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(a)
(b)
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3.2.4. Probing the stereochemistry of the allylic amination. 
  The nucleophiles in Tsuji-Trost reaction are divided into two classed based on the 
pKa of the pronucleophile[13]: (1) “hard” nucleophile with pKa values > 25 and (2) “soft” 
nucleophile with pKa values < 25. These two classes pronucleophiles can be differentiated 
by the stereochemistry of the allylation product using a probe substrate. In case of “hard” 
nucleophiles, the nucleophile will attack the metal center of the π-allyl palladium complex 
followed by reductive elimination to provide a single inversion of allylated product. On the 
other hand, “soft” nucleophiles attack directly on π-allyl ligand providing net retention of 
stereochemistry (via double inversion). 
To define which pathway was effective in our allylic amination, 1-(diphenylmethylene)-2-
phenylhydrazine 3-1a (pka = 22) was reacted with cis-disubstituted stereoprobe 3-2h 
affording the allylated product in 95% yield as a single diastereomer (Scheme 3-2). 1H 
NMR spectrum indicated that the structure was consistent with cis-isomer, which indicates 
that 1-(diphenylmethylene)-2-phenylhydrazine acts as a “soft” nucleophile. This result is 
consistent with our previous works using diphenylmethane[14] (pKa = 33) and 2-phenyl-
1,3-dithiane pronucleophiles (pKa = 31).[15] 
 
Scheme 3-2. Stereoprobe study indicating that the reaction proceeds via the double 
inversion or soft nucleophile pathway. 
 
Ph
H
N N
Ph
Ph
OBoc
TBDMSO
Ph N N
Ph
Ph
TBDMSO
Pd(OAc)2 1 mol%
NaN(SiMe3)2 2 equiv
THF (0.1 M), rt, 3 h
3-3ah, 95%
single diastereomer
3-1a                              3-2h
                                   2 equiv
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3.2.5. Development of a one-pot allylation-Fischer indole cyclization.  
To further demonstrate the synthetic value of our method, we conducted the 
synthesis of antifungal drug derivative via a tandem allylation-Fischer indole cyclization. 
Indole core structures are important building blocks in many pharmacologically active 
compounds.[16] Considering the differences between allylic alkylation and Fischer indole 
cyclization, we explored the reaction conditions separately. Based on the Fischer indole 
cyclization literatures, high temperature and the addition of Bronsted or Lewis acids are 
required.[17]  
The first step of the indole synthesis is the reaction in (Scheme 3-1a). We next 
employed 1.5 equiv of cyclohexanone and 2 equiv of concentrated HCl at 80 oC in ethanol, 
but the cyclization product was observed in only 5% AY. We next studied different acids, 
including sulfuric acid and p-toluenesulfonic acid monohydrate.  Based on these 
experiments, it was found that p-toluenesulfonic acid monohydrate, p-TsOH •H2O (2 
equiv) at 80 oC was the better, which afforded the desired product in 92% yield (see SI for 
details). We hypothesize that the p-TsOH •H2O provides enough water to facilitate 
hydrolysis of the N-allyl hydrazone.[16a] Based on this result, we examined a one-pot 
allylation-Fischer indole cyclization of 3-1a and allyl OBoc 3-2d (Scheme 3-3). After 
completion of allylation, as determined by TLC, the reaction mixture was filtered through 
a pad of silica to remove the catalyst. The reaction mixture was dried under vacuum and 
redissolved in EtOH then p-toluenesulfonic acid (2 equiv) and cyclohexanone (1.5 equiv) 
were added to the reaction mixture respectively. After 2 h, the desired product 3-5 was 
obtained in 88% yield over the two steps. 
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Scheme 3-3. A one-pot allylation-Fischer indole cyclizationab 
 
3.3 Conclusion 
In summary, we have successfully developed ligand-free palladium-catalyzed 
allylic amination of hydrazone derivatives. This method is effective and applicable for a 
variety of substrates in good to excellent yields and also economical due to low palladium 
loading and ligand-free conditions. In addition, we demonstrated an example of tandem 
allylation-Fischer indole cyclization to afford the core structure of antifungal drug.  We also 
revealed a mechanistic study of ligand-free palladium-catalyzed allylic amination of 
hydrazine. The results suggested that under our reaction conditions, hydrazone 
nucleophile behaves as a “soft” nucleophile which attacks on the π-allyl palladium 
intermediate.  
 
3.4 Experimental 
General Methods: All reactions were performed under nitrogen using oven-dried 
glassware and standard Schlenk or vacuum line techniques. Air- and moisture-sensitive 
solutions were handled under nitrogen and transferred via syringe. Anhydrous THF was 
purchased from Sigma-Aldrich and used as solvents without further purification. Unless 
otherwise stated, reagents were commercially available and used as purchased without 
NPh
H
N N
Ph
Ph
OBoc
3-1a 3-2d
1) Pd(OAc)2 1 mol%
     NaN(SiMe3)2 2 equiv
     THF, rt, 3h
2) cyclohexanone 1.5 equiv
     TsOH H2O 2 equiv
     EtOH, 80 oC, 2 h
3-5, 88%
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further purification. Chemicals were obtained from Sigma-Aldrich, Acros, TCI America or 
Matrix Scientific. TLC was performed with Merck TLC Silicagel60 F254 plates and 
detection was under UV light at 220 nm. Silica gel (230–400 mesh, Silicycle) was used for 
flash chromatography. The 1H NMR and 13C{1H} NMR spectra were obtained using a 
Bruker AM-500 Fourier-transform NMR spectrometer at 500 and 125 MHz, respectively. 
Chemical shifts are reported in units of parts per million (ppm) downfield from 
tetramethylsilane (TMS), and all coupling constants are reported in hertz. The infrared 
spectra were obtained with KBr plates using a Perkin-Elmer Spectrum 100 Series FTIR 
spectrometer. High resolution mass spectrometry (HRMS) data were obtained on a 
Waters LC-TOF mass spectrometer (model LCT-XE Premier) using chemical ionization 
(CI) or electrospray ionization (ESI) in positive or negative mode, depending on the 
analyte. Melting points were determined on a Unimelt Thomas-Hoover melting point 
apparatus. 
 
Preparations and characterizations for ligand-free palladium-catalyzed allylic 
amination of hydrazones. 
General Procedure A: An 8 mL reaction vial equipped with a stir bar was charged with 
hydrazone derivatives (0.1 mmol, 1.0 equiv). Under a nitrogen atmosphere in the 
glovebox, the stock solution was prepared using Pd(OAc)2 (2.2 mg, 0.01 mmol) in 5 mL 
dry THF and the clear, light orange solution was stirred for 5 min at rt. A 0.5 mL solution 
(from stock solution) which contains Pd(OAc)2 (0.22 mg, 0.001 mmol) in 0.5 mL dry THF 
was taken up by syringe and added to the reaction vial. After that, allylic electrophile 
(0.15 mmol, 1.5 equiv) was added to the reaction mixture using micropipette (Fisher 
Scientific, 200 μL Tip). A solution of NaN(SiMe3)2 (36.8 mg, 0.20 mmol, 2.0 equiv) in 0.5 
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mL of dry THF was added to the reaction vial by syringe. After the addition of the 
NaN(SiMe3)2 solution, the mixture turned color from pale orange to bright yellow. The 
reaction mixture was sealed with a closed cap, transferred out of the glovebox and was 
stirred at rt for 2 h. Next, the cap was removed, and the reaction mixture was opened to 
air and quenched with 3 drops of H2O. The light brown mixture was diluted with 3 mL of 
ethyl acetate and filtered over a pad of silica. The pad was rinsed with 6 mL ethyl 
acetate (2×3), and the solution was concentrated under vacuum. The crude material was 
loaded onto a silica gel column and purified by flash chromatography with 2% ethyl 
acetate in hexanes. 
 
 1-(Cyclohex-2-en-1-yl)-2-(diphenylmethylene)-1-phenylhydrazine 
(3-3aa): The reaction was performed following General Procedure A with 
(Z)-1-benzylidene-2-phenylhydrazine 3-1a (27.2 mg, 0.1 mmol), 
cyclohexenyl OBoc 3-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (34.4 mg, 98% yield) as a yellow oil. Rf = 
0.8 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.61 (m, 2H), 7.39 – 7.27 (m, 3H), 
7.14 (dd, J = 3.8, 2.6 Hz, 3H), 7.10 – 6.97 (m, 4H), 6.88 – 6.71 (m, 3H), 5.89 – 5.64 (m, 
2H), 4.25 – 4.08 (m, 1H), 2.17 – 1.91 (m, 3H), 1.83 (dd, J = 9.5, 4.5 Hz, 2H), 1.63 – 1.49 
(m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 161.3, 150.4, 139.1, 137.1, 129.6, 129.1, 129.0, 
128.7, 128.1, 128.0, 127.9, 127.5, 127.4, 122.8, 122.2, 63.8, 26.6, 25.0, 21.3. IR (thin 
film): 3057, 3023, 2931, 1594, 1488, 1443, 1227, 1070, 758, 693, 640 cm–1. HRMS 
calculated for C25H25N2 [M+H]+: 353.2018, observed 353.2001.  
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1-(Cyclopent-2-en-1-yl)-2-(diphenylmethylene)-1-phenylhydrazine 
(3-3ab): The reaction was performed following General Procedure A with 
(Z)-1-benzylidene-2-phenylhydrazine 3-1a (27.2 mg, 0.1 mmol), 
cyclopentenyl OBoc 3-2b (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (30.8 mg, 91% yield) as a yellow oil. Rf = 
0.8 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.63 – 7.54 (m, 2H), 7.35 (ddd, J = 
6.1, 3.6, 1.4 Hz, 1H), 7.33 – 7.28 (m, 2H), 7.21 – 7.11 (m, 3H), 7.07 – 6.98 (m, 4H), 6.80 
(ddd, J = 8.5, 7.5, 1.5 Hz, 3H), 5.93 (ddd, J = 6.4, 4.2, 2.2 Hz, 1H), 5.78 – 5.65 (m, 1H), 
4.82 – 4.62 (m, 1H), 2.53 – 2.41 (m, 1H), 2.34 – 2.23 (m, 1H), 2.17 (ddd, J = 13.4, 9.0, 4.5 
Hz, 1H), 2.00 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 162.6, 150.9, 139.0, 137.0, 134.1, 
131.4, 129.1, 128.7, 128.1, 128.0, 127.9, 127.6, 127.4, 122.0, 121.9, 73.8, 31.8, 27.0. IR 
(thin film): 3056, 2926, 2847, 1594, 1488, 1443, 1359, 1317, 1219, 1067, 1028, 912, 755, 
693 cm–1. HRMS calculated for C24H23N2 [M+H]+: 339.1861, observed 339.1861. 
 
1-(Cyclohept-2-en-1-yl)-2-(diphenylmethylene)-1-phenylhydrazine 
(3-3ac): The reaction was performed following General Procedure A with 
(Z)-1-benzylidene-2-phenylhydrazine 3-1a (27.2 mg, 0.1 mmol), 
cycloheptenyl OBoc 3-2c (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (33.7 mg, 92% yield) as a yellow oil. Rf = 
0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.63 (dd, J = 8.2, 1.3 Hz, 2H), 7.38 
– 7.28 (m, 3H), 7.17 – 7.11 (m, 3H), 7.08 (dd, J = 6.7, 3.1 Hz, 2H), 7.01 (dd, J = 10.6, 5.2 
Hz, 2H), 6.86 – 6.79 (m, 2H), 6.78 – 6.72 (m, 1H), 6.11 (d, J = 11.5 Hz, 1H), 5.77 (m, 1H), 
4.18 (t, J = 18.8 Hz, 1H), 2.28 – 2.10 (m, 1H), 2.06 – 1.86 (m, 4H), 1.66 (m, 1H), 1.51 – 
1.42 (m, 1H), 1.36 – 1.29 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 161.7, 150.3, 139.0, 
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137.0, 136.0, 129.7, 129.2, 128.7, 128.1, 128.0, 127.9, 127.6, 127.4, 121.8, 121.7, 68.9, 
32.3, 29.0, 28.7, 26.6. IR (thin film): 3057, 2923, 1738, 1594, 1487, 1443, 1239, 1046, 
758, 694 cm–1. HRMS calculated for C26H27N2 [M+H]+: 367.2174, observed 367.2179. 
 
1-Allyl-2-(diphenylmethylene)-1-phenylhydrazine (3-3ad): The 
reaction was performed following General Procedure A with (Z)-1-
benzylidene-2-phenylhydrazine 3-1a (27.2 mg, 0.1 mmol), ally OBoc 3-
2d (26 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was 
purified by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to 
give the product (30.8 mg, 99% yield) as a yellow oil. Rf = 0.75 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 7.73 – 7.53 (m, 2H), 7.41 – 7.31 (m, 6H), 7.28 (dt, J = 6.7, 2.4 
Hz, 2H), 7.25 – 7.18 (m, 2H), 7.13 – 7.01 (m, 2H), 6.97 – 6.79 (m, 1H), 5.55 (ddt, J = 17.1, 
10.5, 5.4 Hz, 1H), 5.20 – 4.88 (m, 2H), 3.97 (dt, J = 5.4, 1.7 Hz, 2H). 13C{1H} NMR (125 
MHz, CDCl3) δ 160.5, 150.1, 139.2, 136.9, 133.5, 129.4, 128.8, 128.7, 128.7, 128.4, 128.2 
128.1, 120.3, 116.9, 116.4, 56.4. IR (thin film): 3025, 2931, 1589, 1562, 1489, 1446, 1267, 
1147, 753, 693 cm–1. HRMS calculated for C22H21N2 [M+H]+: 313.1705, observed 
313.1704. 
 
2-(Diphenylmethylene)-1-(2-methylallyl)-1-phenylhydrazine (3-3ae): 
The reaction was performed following General Procedure A with (Z)-1-
benzylidene-2-phenylhydrazine 3-1a (27.2 mg, 0.1 mmol), 2-methyl allyl 
OBoc 3-2e (26 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product 
was purified by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) 
to give the product (31.9 mg, 98% yield) as a yellow oil. Rf = 0.75 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 7.57 (dd, J = 8.0, 1.4 Hz, 2H), 7.39 – 7.30 (m, 6H), 7.25 (m, 
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4H), 7.15 – 7.07 (m, 2H), 6.87 (dd, J = 15.2, 7.9 Hz, 1H), 4.75 (s, 1H), 4.70 (s, 1H), 3.89 
(s, 2H), 1.43 (s, 3H). 13C{1H} NMR (126 MHz, CDCl3) δ 156.2, 150.0, 139.7, 139.6, 136.8, 
129.0, 128.9, 128.8, 128.5, 128.4, 128.1, 127.9, 120.0, 116.0, 112.3, 58.7, 19.9. IR (thin 
film): 3057, 2983, 1740, 1595, 1492, 1444, 1372, 1240, 1046, 766, 751, 692 cm–1. HRMS 
calculated for C23H23N2 [M+H]+: 327.1861, observed 327.1848. 
 
1-Cinnamyl-2-(diphenylmethylene)-1-phenylhydrazine (3-3af): 
The reaction was performed following General Procedure A with (Z)-
1-benzylidene-2-phenylhydrazine 3-1a (27.2 mg, 0.1 mmol), cinnamyl 
OBoc 3-2f (35 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product 
was purified by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) 
to give the product (35.1 mg, 90% yield) as a yellow oil. Rf = 0.75 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 7.71 – 7.55 (m, 2H), 7.33 (m, 8H), 7.27 – 7.15 (m, 7H), 7.14 – 
7.07 (m, 2H), 6.97 – 6.81 (m, 1H), 6.28 (d, J = 16.0 Hz, 1H), 5.85 (m, 1H), 4.25 – 4.01 (m, 
2H). 13C{1H} NMR (125 MHz, CDCl3) δ 160.8, 150.2, 139.0, 137.0, 136.8, 131.5, 129.4, 
129.1, 128.8, 128.7, 128.6, 128.4, 128.3, 128.0, 127.2, 126.2, 125.4, 120.3, 116.3, 56.5. 
IR (thin film): 3057, 3024, 2925, 2359, 1596, 1493, 1443, 1314, 1120, 1072, 964, 753, 
731, 692 cm–1. HRMS calculated for C28H25N2 [M+H]+: 389.2018, observed 389.2018. 
 
2-(Diphenylmethylene)-1-(2-methylallyl)-1-phenylhydrazine (3-3ag): 
The reaction was performed following General Procedure A with (Z)-1-
benzylidene-2-phenylhydrazine 3-1a (27.2 mg, 0.1 mmol), 3-methylbut-
2-en-1-yl OBoc 3-2g (31 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (30.3 mg, 89% yield) as a yellow oil. Rf = 
0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.60 (m, 2H), 7.40 – 7.36 (m, 1H), 
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7.36 – 7.31 (m, 5H), 7.30 – 7.26 (m, 2H), 7.23 – 7.19 (m, 2H), 7.02 (dd, J = 8.7, 1.0 Hz, 
2H), 6.86 (t, J = 7.3 Hz, 1H), 5.01 (m, 1H), 3.94 (d, J = 6.1 Hz, 2H), 1.58 (s, 3H), 1.45 (s, 
3H). 13C{1H} NMR (125 MHz, CDCl3) δ 161.3, 150.1, 139.1, 136.9, 133.8, 129.3, 128.8, 
128.5, 128.4, 128.2, 128.1, 127.9, 120.6, 119.9, 116.3, 52.4, 25.4, 17.8. IR (thin film): 
3057, 2924, 2359, 2341, 1595, 1490, 1443, 1336, 1120, 1027, 751, 692, 667 cm–1. HRMS 
calculated for C24H25N2 [M+H]+: 341.2018, observed 341.2018.  
 
1-((1R,5S)-5-(((tert-
Butyldimethylsilyl)oxy)methyl)cyclohex-2-en-1-yl)-2-
(diphenylmethylene)-1-phenylhydrazine (3-3ah): The 
reaction was performed following General procedure A with (Z)-1-benzylidene-2-
phenylhydrazine 3-1a (32.6 mg, 0.12 mmol), tert-butyl ((1S,5S)-5-(((tert-
butyldimethylsilyl)oxy)methyl)cyclohex-2-en-1-yl) carbonate 3-2h (33 μL, 0.1 mmol) and 
NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(47.1 mg, 95% yield) as a colorless oil. Rf = 0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, 
CDCl3) δ δ 7.68 – 7.62 (m, 2H), 7.42 – 7.32 (m, 3H), 7.21 – 7.13 (m, 3H), 7.12 – 7.07 (m, 
2H), 7.07 – 7.00 (m, 2H), 6.88 – 6.77 (m, 3H), 5.88 (d, J = 10.4 Hz, 1H), 5.82 (ddt, J = 9.8, 
4.6, 2.2 Hz, 1H), 4.34 – 4.21 (m, 1H), 3.60 – 3.46 (m, 2H), 2.14 (m, 1H), 1.97 – 1.80 (m, 
3H), 1.75 (dt, J = 12 Hz, 12 Hz, 12 Hz, 1H), 0.93 (s, 9H), 0.07 (s, 6H). 13C{1H} NMR (125 
MHz, CDCl3) δ. 150.26, 139.10, 137.11, 130.11, 129.16, 128.79, 128.12, 128.05, 127.97, 
127.82, 127.62, 127.46, 122.61, 122.23, 68.09, 65.09, 36.79, 29.44, 28.70, 25.92, 18.31, 
-5.35. IR (thin film): 3404, 3058, 3026, 2927, 2893, 2855, 1594, 1488, 1443, 1255, 1117, 
836, 775, 694 cm–1. HRMS calculated for C32H41N2OSi [M+H]+: 497.2988, observed 
497.2988. 
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The relative chemistry of the single diastereomer was established by 1H NMR splitting 
patterns and coupling constants. [13,14]  1H NMR spectrum of compound 3-3ah is consistent 
with those of the starting carbonate 3-2h. 
 
 
 
 
 (E)-2-Benzylidene-1-(cyclohex-2-en-1-yl)-1-phenylhydrazine (3-
3ba): The reaction was performed following General Procedure A with 
(E)-1-benzylidene-2-phenylhydrazine 3-1b (19.6 mg, 0.1 mmol), 
cyclohexenyl OBoc 3-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (26.7 mg, 97% yield) as a yellow oil. Rf = 
0.8 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.07–7.81 (m, 2H), 7.48 – 7.32 (m, 
2H), 7.27–7.23 (m, 1H), 5.93 (m, 1H), 5.86 – 5.71 (m, 1H), 2.81–2.49 (m, 5H), 1.88 (m, 
H6(axial) 
H6(eq) 
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JH6 (axial), H1 = 12 Hz (trans)
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Ph
N
N
Ph
Ph
122 
 
4H), 1.65 (m, 1H), 1.60 – 1.42 (m, 2H), 1.35 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 
145.6, 136.9,134.0, 129.3, 129.2, 129.0, 128.3, 127.3, 125.7, 124.4, 124.2, 59.7, 26.4, 
24.8, 21.4. IR (thin film): 3024, 2935, 1588, 1561, 1488, 1446, 1229, 1146, 1025, 918, 
753, 693, 655 cm–1. HRMS calculated for C19H21N2 [M+H]+: 277.1705, observed 277.1701. 
 
(E)-3-((2-(Cyclohex-2-en-1-yl)-2-phenylhydrazineylidene)methyl)-
1-methyl-1H-pyrrole (3-3ca): The reaction was performed following 
General Procedure A with (E)-1-methyl-3-((2-
phenylhydrazineylidene)methyl)-1H-pyrrole 3-1c (19.9 mg, 0.1 mmol), 
cyclohexenyl OBoc 3-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (27.0 mg, 97% yield) as a yellow oil. Rf = 
0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.60 (s, 1H), 7.33 (dd, J = 10.6, 5.1 
Hz, 2H), 7.22 – 7.17 (m, 2H), 7.08 (t, J = 7.3 Hz, 1H), 6.63 – 6.58 (m, 1H), 6.16 (dd, J = 
3.6, 1.8 Hz, 1H), 6.11 – 6.04 (m, 1H), 5.87 (d, J = 10.3 Hz, 1H), 5.85 – 5.79 (m, 1H), 4.56 
– 4.33 (m, 1H), 3.89 (s, 3H), 2.03 (d, J = 2.9 Hz, 2H), 1.91 (m, 2H), 1.88 – 1.78 (m, 1H), 
1.70 – 1.58 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 146.7, 132.9, 129.7, 129.4, 129.1, 
129.0 125.6, 123.8, 123.7, 112.0, 107.5, 60.3, 37.0, 26.4, 24.9, 21.4. IR (thin film): 3023, 
2934, 1592, 1527, 1489, 1433, 1296, 1215, 1126, 1054, 750, 701, 667 cm–1. HRMS 
calculated for C18H22N3 [M+H]+: 280.1814, observed 280.1794. 
(E)-3-((2-(Cyclohex-2-en-1-yl)-2-
phenylhydrazineylidene)methyl)pyridine (3-3da): The reaction 
was performed following General Procedure A with (E)-3-((2-
phenylhydrazineylidene)methyl)pyridine 3-1d (19.7 mg, 0.1 mmol), cyclohexenyl OBoc 3-
2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was 
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purified by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to 
give the product (25.7 mg, 93% yield) as a yellow oil. Rf = 0.65 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 8.63 (d, J = 2.1 Hz, 1H), 8.41 (dd, J = 4.8, 1.7 Hz, 1H), 7.93 (dt, 
J = 8.0, 1.9 Hz, 1H), 7.44 – 7.36 (m, 2H), 7.35 (s, 1H), 7.27 – 7.18 (m, 4H), 5.87 (s, 2H), 
4.60 (ddd, J = 8.7, 5.8, 3.0 Hz, 1H), 2.13 – 2.04 (m, 2H), 2.01 (dp, J = 9.1, 3.4 Hz, 1H), 
1.98 – 1.91 (m, 1H), 1.74 – 1.62 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 147.4, 147.2, 
144.6, 133.0, 132.0, 129.6, 129.2, 129.0, 128.8, 125.3, 124.9, 123.4, 60.2, 26.7, 24.7, 
21.2. IR (thin film): 3026, 2931, 1579, 1555, 1490, 1418, 1149, 1022, 801, 753, 707, 624 
cm–1. HRMS calculated for C18H20N3 [M+H]+: 278.1657, observed 278.1637. 
 
(E)-3-((2-(Cyclohex-2-en-1-yl)-2-
phenylhydrazineylidene)methyl)-1H-pyrrole (3-3ea): The reaction 
was performed following General Procedure A with (E)-3-((2-
phenylhydrazineylidene)methyl)-1H-pyrrole 3-1e (18.5 mg, 0.1 
mmol), cyclohexenyl OBoc 3-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (24.9 mg, 0.20 
mmol). The crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (26.2 mg, 94% yield) as a yellow oil. Rf = 
0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.91 (s, 1H), 7.34 (dd, J = 8.5, 7.2 
Hz, 2H), 7.23 – 7.18 (m, 2H), 7.11 (t, J = 7.3 Hz, 1H), 6.78 (q, J = 2.1 Hz, 1H), 6.17 (q, J 
= 2.8 Hz, 1H), 6.13 (dt, J = 3.6, 1.9 Hz, 1H), 5.84 (dtt, J = 13.1, 10.1, 3.3 Hz, 2H), 4.49 
(ddt, J = 8.5, 5.6, 2.8 Hz, 1H), 2.04 (ddt, J = 7.4, 4.8, 2.7 Hz, 2H), 1.95 (dd, J = 11.1, 6.0 
Hz, 1H), 1.92 – 1.79 (m, 2H), 1.64 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 146.2, 130.0, 
129.9, 129.6, 129.4, 129.2, 129.1, 129.0, 124.1, 118.9, 109.2, 60.0, 26.3, 24.8, 21.4. IR 
(thin film): 3429, 3023, 2934, 1592, 1490, 1450, 1235, 1128, 1083, 1028, 723, 700, 668 
cm–1. HRMS calculated for C17H20N3 [M+H]+: 266.1657, observed 266.1659. 
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 (E)-3-((2-(Cyclohex-2-en-1-yl)-2-
phenylhydrazineylidene)methyl)-1-methyl-1H-indole (3-3fa): 
The reaction was performed following  General Procedure A with 
(E)-1-methyl-3-((2-phenylhydrazineylidene)methyl)-1H-indole 3-
1f (24.9 mg, 0.1 mmol), cyclohexenyl OBoc 3-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 
(36.7 mg, 0.20 mmol). The crude product was purified by flash chromatography on silica 
gel (eluted with hexanes:ethyl acetate 98:2) to give the product (30.9 mg, 94% yield) as a 
yellow oil. Rf = 0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.38 (d, J = 7.8 Hz, 
1H), 7.94 (d, J = 20.1 Hz, 1H), 7.38 – 7.31 (m, 2H), 7.31 – 7.24 (m, 4H), 7.24 – 7.17 (m, 
1H), 7.11 – 7.03 (m, 2H), 5.97 (d, J = 10.2 Hz, 1H), 5.91 – 5.76 (m, 1H), 4.53 (s, 1H), 3.74 
(d, J = 20.1 Hz, 3H), 2.15 – 1.94 (m, 4H), 1.92 – 1.81 (m, 1H), 1.74 – 1.62 (m, 1H). 13C{1H} 
NMR (126 MHz, CDCl3) δ 147.6, 137.7, 137.1, 130.0, 129.7, 129.1, 129.0, 125.4, 123.6, 
123.3, 122.7, 122.6, 120.5, 113.4, 109.1, 60.5, 32.9, 26.5, 25.1, 21.6. IR (thin film): 3052, 
2935, 1656, 1598, 1534, 1470, 1369, 1333, 1126, 1074, 786, 747, 696 cm–1. HRMS 
calculated for C22H24N3 [M+H]+: 330.1970, observed 330.1951. 
 
 
(E)-1-(Cyclohex-2-en-1-yl)-1-phenyl-2-(thiophen-3-
ylmethylene)hydrazine (3-3ga): The reaction was performed 
following  General Procedure A with (E)-1-phenyl-2-(thiophen-3-
ylmethylene)hydrazine 3-1g (20.2 mg, 0.1 mmol), cyclohexenyl OBoc 
3-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was 
purified by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to 
give the product (27.3 mg, 97% yield) as a yellow oil. Rf = 0.75 (Et2O/hexanes 1:5). 1H 
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NMR (500 MHz, CDCl3) δ 7.53 (s, 1H), 7.47 (d, J = 5.0 Hz, 1H), 7.36 (dd, J = 11.2, 4.4 Hz, 
2H), 7.24 (dd, J = 5.8, 2.1 Hz, 3H), 7.16 – 7.09 (m, 2H), 5.87 (t, J = 11.3 Hz, 2H), 4.56 (d, 
J = 2.8 Hz, 1H), 2.04 (s, 2H), 2.00 – 1.77 (m, 3H), 1.73 – 1.60 (m, 1H). 13C{1H} NMR (125 
MHz, CDCl3) δ 145.6, 140.1, 130.4, 129.4, 129.3, 129.1, 125.7, 125.0, 124.5, 124.4, 121.5, 
59.7, 26.4, 24.9, 21.4. IR (thin film): 3404, 3024, 2934, 1595, 1489, 1448, 1236, 1170, 
1126, 773, 698 cm–1. HRMS calculated for C17H19N2S [M+H]+: 283.1269, observed 
283.1269. 
 
1-(Cyclohex-2-en-1-yl)-2-(di-p-tolylmethylene)-1-
phenylhydrazine (3-3ha): The reaction was performed following 
General Procedure A with 1-(bis(4-methylphenyl)methylene)-2-
phenylhydrazine 3-2h (30.5 mg, 0.1 mmol),cyclohexenyl OBoc 3-
2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was 
purified by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to 
give the product (36.1 mg, 95% yield) as a yellow oil. Rf = 0.8 (Et2O/hexanes 1:5). 1H NMR 
(500 MHz, CDCl3) 7.51 (dd, J = 8.6, 2.2 Hz, 2H), 7.11 (s, 2H), 7.07 – 7.00 (m, 2H), 6.96 
(s, 4H), 6.87 – 6.81 (m, 2H), 6.78 (td, J = 7.2, 1.2 Hz, 1H), 5.88 – 5.58 (m, 2H), 4.17 (tt, J 
= 6.4, 2.8 Hz, 1H), 2.35 (s, 3H), 2.26 (s, 3H), 2.11 – 1.89 (m, 3H), 1.88 – 1.70 (m, 2H), 
1.61 – 1.47 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 164.2, 150.5, 139.4, 137.4, 136.4, 
134.1, 129.7, 128.9, 128.6, 128.6, 128.2, 128.1, 128.0, 121.4, 121.4, 63.2, 26.3, 25.0, 
21.4, 21.3, 21.2. IR (thin film): 3027, 2938, 1596, 1491, 1299, 1257, 1184, 1093, 831, 756, 
732, 696 cm–1. HRMS calculated for C27H29N2 [M+H]+: 381.2331, observed 381.2337. 
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2-(Bis(4-methoxyphenyl)methylene)-1-(cyclohex-2-en-1-
yl)-1-phenylhydrazine (3-3ia): The reaction was performed 
following General Procedure A with 1-(bis(4-
methoxyphenyl)methylene)-2-phenylhydrazine 3-2i (33.2 mg, 
0.1 mmol),cyclohexenyl OBoc 3-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 
mmol). The crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (40.3 mg, 98% yield) as a yellow oil. Rf = 
0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.64 – 7.50 (m, 2H), 7.13 – 6.97 
(m, 4H), 6.90 – 6.82 (m, 4H), 6.79 (td, J = 7.2, 1.2 Hz, 1H), 6.74 – 6.66 (m, 2H), 5.75 (ddt, 
J = 9.8, 4.7, 2.4 Hz, 1H), 5.72 – 5.64 (m, 1H), 4.17 (m, 1H), 3.81 (s, 3H), 3.75 (s, 3H), 2.04 
(m, 1H), 2.01 – 1.89 (m, 2H), 1.80 (m, 2H), 1.54 (ddt, J = 11.8, 9.7, 5.0 Hz, 1H). 13C{1H} 
NMR (125 MHz, CDCl3) δ 164.5, 160.8, 159.0, 150.5, 131.9, 130.2, 129.8, 129.6, 128.9, 
128.1, 121.1, 120.8, 113.3, 112.8, 77.1, 63.0, 55.2, 55.0, 26.1, 25.0, 21.5. IR (thin film): 
3023, 2928, 1594, 1488, 1299, 1246, 1180, 1093, 825, 754, 729, 696 cm–1. HRMS 
calculated for C27H29N2O2 [M+H]+: 413.2229, observed 413.2219. 
 
2-(Bis(4-chlorophenyl)methylene)-1-(cyclohex-2-en-1-yl)-1-
phenylhydrazine (3-3ja): The reaction was performed following 
General Procedure A with 1-(bis(4-chlorophenyl)methylene)-2-
phenylhydrazine 3-1j (34.1 mg, 0.1 mmol), cyclohexenyl OBoc 3-
2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was 
purified by flash chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to 
give the product (41.1 mg, 98% yield) as a yellow oil. Rf = 0.75 (Et2O/hexanes 1:5). 1H 
NMR (500 MHz, CDCl3) δ 7.55 – 7.44 (m, 2H), 7.34 – 7.21 (m, 2H), 7.14 – 7.06 (m, 2H), 
7.05 – 6.97 (m, 2H), 6.96 – 6.87 (m, 2H), 6.81 (dd, J = 17.4, 10.0 Hz, 1H), 6.80 – 6.70 (m, 
2H), 5.90 – 5.72 (m, 2H), 4.18 – 4.06 (m, 1H), 2.12 – 2.03 (m, 1H), 2.03 – 1.90 (m, 2H), 
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1.91 – 1.76 (m, 2H), 1.63 – 1.52 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ 156.6, 150.0, 
140.9, 137.3, 135.2, 135.1, 133.5, 130.2, 129.4, 129.3, 128.8, 128.2, 127.8, 123.8, 123.2, 
64.2, 26.9, 25.0, 21.2. IR (thin film): 3026, 2934, 2835, 1594, 1486, 1396, 1309, 1227, 
1090, 1012, 931, 834, 721, 697, 655 cm–1. HRMS calculated for C25H22Cl2N2 [M+H]+: 
421.1238, observed 421.1262. 
 
 (E)-2-Benzylidene-1-(cyclohex-2-en-1-yl)-1-(p-tolyl)hydrazine 
(3-3a’a): The reaction was performed following General Procedure 
A with (E)-1-benzylidene-2-(p-tolyl)hydrazine 3-1a’ (21.0 mg, 0.1 
mmol), cyclohexenyl OBoc 3-2a (30 μL, 0.15 mmol) and 
NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The crude product was purified by flash 
chromatography on silica gel (eluted with hexanes:ethyl acetate 98:2) to give the product 
(17.4 mg, 60% yield) as a yellow oil. Rf = 0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, 
CDCl3) δ 7.57 – 7.47 (m, 2H), 7.33 (d, J = 5.1 Hz, 1H), 7.32 – 7.26 (m, 2H), 7.23 – 7.16 
(m, 3H), 7.16 – 7.10 (m, 2H), 5.96 – 5.88 (m, 1H), 5.88 – 5.79 (m, 1H), 4.50 (m, 1H), 2.36 
(s, 3H), 2.08 – 1.95 (m, 3H), 1.85 (m, 2H), 1.65 (m, 1H). 13C{1H} NMR (125 MHz, CDCl3) 
δ 142.3, 136.9, 135.0, 133.6, 129.7, 129.4, 129.2, 128.2, 127.1, 125.9, 125.5, 60.7, 27.10, 
24.8, 21.2, 20.9. IR (thin film): 3024, 2933, 1588, 1560, 1506, 1446, 1229, 1125, 753, 693 
cm–1. HRMS calculated for C20H23N2 [M+H]+: 291.1861, observed 291.1861. 
 
General Procedure B: An 8 mL reaction vial equipped with a stir bar was charged with 
the hydrazone derivative (0.1 mmol, 1.0 equiv). Under a nitrogen atmosphere in the 
glovebox, a solution (from stock solution) of Pd(OAc)2 (0.22 mg, 0.001 mmol) and 
NIXANTPHOS (1.11 mg, 0.002 mmol) in 0.5 mL of dry THF was taken up by syringe and 
added to the reaction vial. After that, allylic electrophile (0.15 mmol, 1.5 equiv) was 
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added to the reaction mixture using micropipette (Fisher Scientific, 200 μL Tip). A 
solution of NaN(SiMe3)2 (36.8 mg, 0.20 mmol, 2.0 equiv) in 0.5 mL of dry THF was 
added to the reaction vial by syringe. After the addition of NaN(SiMe3)2 solution, the 
mixture turned color from light green to dark orange. The reaction mixture was sealed 
with a cap, transferred out of the glovebox and was stirred at rt for 2 h. Next, the reaction 
mixture was quenched with 3 drops of H2O, diluted with 3 mL of ethyl acetate, and 
filtered over a pad of silica. The pad was rinsed with 6 mL ethyl acetate (2×3), and the 
solution was concentrated under vacuum. The crude material was loaded onto a silica 
gel column and purified by flash chromatography with 2% ethyl acetate in hexanes. 
 
 (E)-2-Benzylidene-1-(cyclohex-2-en-1-yl)-1-
(perfluorophenyl)hydrazine (3-3b’a): The reaction was 
performed following General Procedure B with 1-
(diphenylmethylene)-2-phenylhydrazine 3-1a (28.6 mg, 0.1 mmol), 
cyclohexenyl OBoc 3-2h (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 0.20 mmol). The 
crude product was purified by flash chromatography on silica gel (eluted with 
hexanes:ethyl acetate 98:2) to give the product (33.7 mg, 92% yield) as a colorless oil. Rf 
= 0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.55 – 7.48 (m, 2H), 7.37 – 7.28 
(m, 2H), 7.24 (m, 1H), 7.06 (t, J = 2.5 Hz, 1H), 5.88 (dtd, J = 9.6, 3.6, 2.1 Hz, 1H), 5.80 (d, 
J = 10.5 Hz, 1H), 4.36 (m, 1H), 2.12 – 1.91 (m, 4H), 1.89 – 1.79 (m, 1H), 1.64 (m, 1H). 
13C{1H} NMR (125 MHz, CDCl3) δ 140.9, 135.5, 134.5, 131.4, 128.4, 128.1, 126.6, 126.0, 
61.5, 27.7, 24.8, 20.1. IR (thin film): 3028, 2935, 1595, 1488, 1370, 1147, 1079, 981, 912, 
754, 693 cm–1. HRMS calculated for C19H16F5N2 [M+H]+: 367.1234, observed 367.1234. 
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 (E)-2-(2-Benzylidene-1-(cyclohex-2-en-1-yl)hydrazineyl)pyridine 
(3-3c’a): The reaction was performed following General Procedure B 
with (E)-2-(2-benzylidenehydrazineyl)pyridine 3-1c’ (19.7 mg, 0.1 
mmol), cyclohexenyl OBoc 3-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 
(36.7 mg, 0.20 mmol). The crude product was purified by flash chromatography on silica 
gel (eluted with hexanes:ethyl acetate 98:2) to give the product (26.3 mg, 95% yield) as a 
colorless oil. Rf = 0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.34 – 8.08 (m, 
2H), 7.69 (d, J = 8.6 Hz, 1H), 7.66 – 7.61 (m, 2H), 7.57 (m, 1H), 7.36 (dd, J = 10.5, 4.7 
Hz, 2H), 7.31 – 7.25 (m, 1H), 6.75 (m, 1H), 6.42 – 6.27 (m, 1H), 5.89 (m, 1H), 5.83 (d, J = 
10.3 Hz, 1H), 2.30 – 2.21 (m, 1H), 2.21 – 2.13 (m, 2H), 2.05 – 1.96 (m, 1H), 1.95 – 1.82 
(m, 2H). 13C{1H} NMR (125 MHz, CDCl3) δ 157.9, 146.6, 137.3, 136.9, 136.5, 129.9, 128.7, 
128.4, 128.0, 126.0, 115.2, 110.7, 51.7, 24.7, 22.8, 22.4. IR (thin film): 3022, 2927, 1588, 
1463, 1433, 1289, 1132, 1006, 923, 754, 691 cm–1. HRMS calculated for C18H20N3 [M+H]+: 
278.1657, observed 278.1660. 
 
 (E)-N'-Benzylidene-N-(cyclohex-2-en-1-yl)benzohydrazide (3-
3d’a): The reaction was performed following the General 
Procedure B with (E)-N'-benzylidenebenzohydrazide 3-1d’ (22.4 
mg, 0.1 mmol), cyclohexenyl OBoc 3-2a (30 μL, 0.15 mmol) and NaN(SiMe3)2 (36.7 mg, 
0.20 mmol). The crude product was purified by flash chromatography on silica gel (eluted 
with hexanes:ethyl acetate 98:2) to give the product (25.8 mg, 85% yield) as a colorless 
oil. Rf = 0.75 (Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 8.29 (s, 1H), 7.75 – 7.60 
(m, 2H), 7.47 – 7.35 (m, 5H), 7.30 (dd, J = 6.4, 3.6 Hz, 3H), 6.02 – 5.89 (m, 1H), 5.83 (t, 
J = 11.8 Hz, 2H), 2.27 – 2.10 (m, 3H), 2.09 – 1.94 (m, 2H), 1.86 (dt, J = 13.0, 6.9 Hz, 1H). 
13C{1H} NMR (125 MHz, CDCl3) δ 171.2, 136.0, 134.9, 129.8, 129.6, 129.4, 129.3, 128.5, 
128.3, 127.2, 126.9, 24.5, 24.3, 22.0. IR (thin film): 3058, 2924, 1657, 1607, 1409, 1385, 
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1331, 1229, 1151, 1127, 939, 893, 756, 693 cm–1. HRMS calculated for C20H21N2O [M+H]+: 
305.1654, observed 305.1656.  
 
Gram-scale synthesis of 3-3ad: A 100 mL rounded-bottom flask with a stir bar was filled 
with (Z)-1-benzylidene-2-phenylhydrazine 3-1a (0.95 g, 3.5 mmol). Under a nitrogen 
atmosphere in a glovebox, a solution of Pd(OAc)2 (8.9 mg, 0.04 mmol) in 15 mL dry THF 
was taken up by syringe and added to the reaction flask at room temperature. Next, allyl 
OBoc (1.06 mL, 5.3 mmol) was added to the reaction mixture using syringe. A solution of 
NaN(SiMe3)2 (1.28 g, 7.0 mmol) in 20 mL DME was then added to the flask, providing a 
bright yellow, clear solution. The flask was capped, removed from the glovebox and stirred 
at room temperature. After 2 h, the cap was removed, and the reaction mixture was 
opened to air and quenched with 10 mL of H2O and extracted with EtOAc (2 x 10 mL). 
The combined organic layers were washed with 10 mL brine, dried over Na2SO4 and 
concentrated to give thick orange oil. The oil was purified by flash chromatography on 
silica gel (2% ethyl acetate in hexanes) to give 3-3ad as a light-yellow oil (1.01 g, 94%). 
 
 
Preparation and characterization of 1-(cyclohex-2-en-1-yl)-1-phenylhydrazine (3-4) 
 
 An 8 mL reaction vial was filled with a solution of 1-(cyclohex-2-en-1-yl)-
2-(diphenylmethylene)-1-phenylhydrazine 3-3aa (35.2 mg, 0.1 mmol) in 1 
mL THF at room temperature then 1 M HCl (0.5 mL) was added to the 
clear yellow solution. The reaction mixture was heated at 50 oC and stirred 
for 16 h. After the reaction was complete as determined by TLC, the mixture was allowed 
to warm up to rt and cooled to 0 oC and quenched with 0.5 mL of a 1 M NaOH solution 
N
NH2
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and extracted with EtOAc (3 x 3 mL). The combined organic layers were washed with 
brine, dried over Na2SO4, filtered and concentrated under reduced pressure. The crude 
material was purified by flash chromatography with 10% ethyl acetate in hexanes to give 
a desired product (16.7 mg, 89% yield) as a pale-yellow oil. Rf = 0.10 (Et2O/hexanes 1:5). 
1H NMR (500 MHz, CDCl3) δ 7.24 (m, 2H), 7.17 – 6.98 (m, 2H), 6.87 – 6.73 (m, 1H), 6.06 
– 5.92  (m, 1H), 5.70 – 5.58 (m, 1H), 4.47 (m, 1H), 3.36 (s, 2H), 2.14 – 1.94 (m, 2H), 1.94 
– 1.82 (m, 2H), 1.78 – 1.62 (m, 2H). 13C{1H} NMR (125 MHz, CDCl3) δ 151.3, 132.1, 128.9, 
127.9, 118.3, 114.3, 57.6, 24.9, 23.9, 21.5. IR (thin film): 3346, 3056, 3018, 2932, 2835, 
1595, 1491, 1449, 1257, 1136, 1076, 878, 858, 811, 725, 692, 615 cm–1. HRMS calculated 
for C12H17N2 [M+H]+: 189.1392, observed 189.1392. 
 
Optimizations of Fisher indole cyclization of 3-3ad with cyclohexanonea 
 
 
Entry Lewis acid % Yield of 3-5 
1 Conc. HCl 5 
2 H2SO4 10 
3 TsOH•H2O 92 
a Reactions conducted on 0.1 mmol scale and the crude yields were determined by 1H NMR. 
 
Preparation and characterization of 9-allyl-2,3,4,9-tetrahydro-1H-fluorene (3-5) 
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 An 8 mL reaction vial equipped with a stir bar was charged with (Z)-1-
benzylidene-2-phenylhydrazine 3-1a (27.2 mg, 0.1 mmol). Under a 
nitrogen atmosphere in the glovebox, a solution (from stock solution) of 
Pd(OAc)2 (0.22 mg, 0.0001 mmol) in 0.5 mL of dry THF was taken up by syringe and 
added to the reaction vial at room temperature. Next, allyl OBoc 3-2d (26 µL, 0.15 mmol) 
was added to the reaction mixture using a glass syringe. A solution of NaN(SiMe3)2 (36.8 
mg, 0.20 mmol, 2.0 equiv) in 0.5 mL of dry THF was added to the reaction vial by syringe. 
The reaction mixture was sealed with cap, transferred out of the glovebox and was stirred 
at rt for 3 h. After the completion of allylation, as monitiored by TLC, the volatile materials 
removed under vacuum and the crude mixture was redissolved in 2 mL of EtOH. Next, p-
toluenesulfonic acid (38.0 mg, 0.20 mmol) and cyclohexanone (17 µL, 0.15 mmol) were 
added, respectively, at room temperature. The yellow mixture was stirred at 80 ºC. After 
12 h, the reaction mixture was dried under vacuum and the crude material was loaded 
onto a silica gel column and purified by flash chromatography with 2% ethyl acetate in 
hexanes to give a desired product (19.5 mg, 92% yield) as a pale-yellow oil. Rf = 0.70 
(Et2O/hexanes 1:5). 1H NMR (500 MHz, CDCl3) δ 7.47 (d, J = 7.7 Hz, 1H), 7.28 – 7.21 (m, 
1H), 7.12 (t, J = 7.4 Hz, 1H), 7.06 (t, J = 7.4 Hz, 1H), 5.91 (m, 1H), 5.09 (d, J = 10.2 Hz, 
1H), 4.89 (d, J = 17.1 Hz, 1H), 4.62 (d, J = 4.7 Hz, 2H), 2.82 – 2.59 (m, 4H), 2.01 – 1.76 
(m, 4H). 13C{1H} NMR (125 MHz, CDCl3) δ 136.1, 135.3, 133.7, 127.3, 120.4, 118.6, 117.6, 
116.0, 109.5, 108.73, 44.9, 23.1, 23.1, 21.9, 21.0. IR (thin film): 3386, 2924, 1706, 1656, 
1612, 1484, 1460, 1366, 1325, 1132, 750, 723 cm–1. HRMS calculated for C15H18N [M+H]+: 
212.1439, observed 212.1410. 
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CHAPTER 4 
Synthesis of Criegee Intermediate Precursors 
4.1 Introduction 
Criegee intermediates[1], carbonyl oxides generated from ozonolysis of alkenes, 
play key roles in the troposphere. The decomposition of Criegee intermediates is 
considered as an important source of atmospheric hydroxyl (OH) radicals[2], called the 
atmosphere’s detergent since they are responsible for the removal of both ozone and 
alkenes[3]. The measurement of OH radical produced from the ozonolysis of alkene 
through Criegee intermediate formation has proved to be difficult, because OH radical can 
react quickly with the parent alkene or other decomposition products[4]. Recently, 
formaldehyde oxide, the simplest Criegee intermediate produced in the atmosphere from 
the ozonolysis of isoprene, was detected and characterized in research laboratories[5]. The 
Criegee intermediate CH2OO is generated from the photolysis of CH2I2 in the presence of 
O2. Based on these novel experiments, scientists have developed interests in the study of 
larger alkanes. The most common alkene in the atmosphere is isoprene, the most 
abundant volatile organic compound in the Earth’s troposphere after methane[6]. Studies 
of Criegee intermediates formed from isoprene could provide insight on the production of 
OH radicals, which are arguably the most atmospherically relevant. 
The ozonolysis of isoprene generates three different Criegee intermediates: 
formaldehyde oxide (CH2OO), methyl vinyl ketone oxide (MVK-oxide) and methacrolein 
oxide (MARC-oxide) Scheme 4-1. The ozonolysis starts by the cycloaddition of ozone 
forming two different primary ozonides[3]. The decomposition of each five-membered ring 
intermediate gives access to three Criegee intermediates (formaldehyde oxide, MVK-
oxide and MARC-oxide) and their corresponding carbonyl compounds.  
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Scheme 4-1 Criegee intermediates and carbonyl co-products from isoprene ozonolysis. 
 
To study these reactive species in laboratory, Criegee intermediate precursors 
were synthesized. (Z/E)-1,3-Diiodobut-2-ene 4-1 and (E)-1,3-diiodo-2-methylprop-1-ene 
4-2 were proposed as the desired precursors. UV photolysis of 1,3-diiodobut-2-ene 
precursors 4-1 and 4-2 creates resonance-stabilized monoiodoalkene radicals that react 
with O2 to generate MVK-oxide and MACR-oxide respectively Scheme 4-2. 
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Scheme 4-2 Synthetic route used to generate MVK-oxide and MACR-oxide from 4-1 and 
4-2 precursors respectively 
 
4.2. Results and Discussion 
Initially, we synthesized the Criegee intermediate precursor (Z/E)-1,3-diiodobut-2-
ene 4-1 following Manickam procedure [7] as shown in Scheme 4-3A. The one-pot 
synthesis was conducted from propargyl alcohol and trimethylsilyl iodide in the presence 
of zinc chloride as a catalyst at rt for 16 h. However, the desired product 4-1 was obtained 
in low yield (30%). To improve the yield, we a modified procedure by Gras [8] that does not 
require a zinc chloride catalyst, as shown in Scheme 4-2B, the reaction of trimethylsilyl 
iodide with propargyl alcohol gave the corresponding product 4-1 in 84% yield with Z/E ~ 
5/1 in shorter time (1 h). The purification step could be difficult since the compound is very 
non-polar, and the impurities came out together with the desired product with normal flash 
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column chromatography on silica gel. Notably, it was necessary to purify the crude mixture 
through a 22 inch long flash column chromatography on silica gel with hexanes to obtain 
good purity of the desired compound.  
 
 
Scheme 4-3 Synthesis of MVK-OO precursor (Z/E)-1,3-diiodobut-2-ene 4-1 following the 
methods of Refs. 7 (2A) and 8 (2B), respectively. 
 
The synthesis of (E)-1,3-diiodo-2-methylprop-1-ene 4-2 is more challenging, 
because a multistep synthesis is required to give access to the desired compound. The 
first step of our synthesis was a methylation of diethyl malonate to geneate diethyl 
methylmalonate A in excellent yield, 97% (Scheme 4-4) following Artok’s procedure. [9] 
Subsequently, based on Rudolph’s protocol, [10] deprotonation of A in the presence of NaH 
in diethyl ether was followed by alkylation with iodoform to generate diiodide B in 80% 
yield. Hydrolysis of B gave the carboxylic acid C in 55% yield. The obtained carboxylic 
acid C was subjected to LiAlH4 reduction to furnish alcohol D in 52% yield. Using a 
modified version of Ghosh’s procedure, [11] alcohol D was treated with methanesulfonyl 
OH
ZnCl2 (15 mol%)
TMSI (2.2 equiv)
CH2Cl2
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I I
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OH TMSI (2.2 equiv)
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I
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but-2-ene
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2A.
2B.
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chloride (MsCl), triethylamine, and catalytic 4-dimethylaminopyridine (DMAP) to provide 
mesylated E in 82% yield.  The highly reactive allylic mesylate E was used without further 
purification.  In the final step, mesylate E was reacted with sodium iodide in acetone at 
room temperature.  Notably, the substitution reaction was conducted in the absence of 
light because the product is light sensitive.  After 6 h of reaction time, the desired yellow 
oil 4.2 was obtained in 85% yield as a single diastereomer. 
 
 
Scheme 4-4 Synthesis of MARC-OO precursor 4-2. 
 
These compounds were successful used to generate the Criegee intermediates 
upon photolysis in the presence of oxygen[7], enabiling the study of these reactive 
compounds.    
 
4.3. Experimental Section 
4.3.1. Synthesis of (Z/E)-1,3-diiodobut-2-ene  
EtO
O
OEt
O
EtO
O
OEt
O
EtO OEt
O O
CHI2
I OH
O
I OHI OMsI I
Na(s) 1 equiv
CH3I 1.05 equiv
EtOH, 80 oC, 10 h
A B
1) 60% NaH 1.2 equiv
Et2O, reflux, 3 h
2) CHI3 1 equiv
reflux, 24 h
1) KOH 2 equiv
EtOH:H2O (3:1)
reflux, 24 h
2) 12M HCl
C
LiAlH4 1.1 equiv
THF, 0 oC to rt 
16 h
NEt3 2 equiv
MsCl 1.4 equiv
DMAP 0.1 equiv
CH2Cl2
0 oC to rt, 8 h
NaI 1.5 equiv
acetone, rt, 6 h
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Anhydrous zinc chloride (0.290 g, 2.13 mmol) was added under a nitrogen 
atmosphere to a solution of but-2-yn-1-ol (1.00 g, 14.2 mmol) in dry dichloromethane (10 
mL).  In a dark fume hood, the colorless heterogeneous mixture was wrapped with 
aluminum foil and cooled to –40 °C using an acetonitrile/dry ice bath for 15 min.  
Trimethylsilyl iodide, TMSI (4.40 mL, 31.2 mmol) was added dropwise over a period of 40 
min.  After the addition was complete, the reaction mixture was warmed to 0 °C by 
replacing the acetonitrile/dry ice bath with an ice bath and the reaction mixture was stirred 
for 1 h.  After 1 h, the mixture was allowed to warm to room temperature by removing the 
ice bath and the solution was stirred for 16 h.  The crude product was filtered over a bed 
of Celite, and the Celite was then washed with CH2Cl2 (3 x 20 mL) and concentrated in 
vacuum.  The crude product was then redissolved in CH2Cl2 (15 mL) and washed with 
saturated Na2S2O3 (2 x 10 mL).  The organic layer was concentrated in vacuum to yield a 
dark brown oil.  The product was further purified via column chromatography on silica gel 
(hexanes:Et2O = 20:1) and then vacuum distilled (67–69 °C/50 mTorr) to yield a brown oil 
(1.30 g, 30% yield, Z/E ~ 10/1).  The 1H NMR spectrum matched the previously published 
literature data for Z-1,3-diiodobut-2-ene.  1H NMR (500 MHz, CDCl3): (Z)-1,3-
diiodobut-2-ene δ 5.7 (q, 1H), 3.9 (d, 2H), δ 2.5 (d, 3H).  (E)-1,3-diiodobut-2-ene δ 6.0 (q, 
1H), 4.4 (d, 2H), δ 1.7 (d, 3H). 
To obtain higher yield, the reaction of propargyl alcohol and TMSI was conducted 
based on a modified procedure of Gras et al[8]. that does not require a zinc chloride 
catalyst, as shown in Scheme 4-2B.  But-2-yn-1-ol (0.54 mL, 7.13 mmol) was diluted in 
dry Et2O (10 mL).  In a dark fume hood, the homogeneous mixture was wrapped with 
aluminum foil and cooled to --40 °C with an acetonitrile/dry ice bath for 15 min.  TMSI (2.23 
mL, 15.6 mmol) was added dropwise and with rapid stirring over a period of 30 min.  
Following addition of TMSI, the reaction mixture was allowed to warm to room 
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temperature, stirred for 1 h, and quenched with a saturated Na2S2O3 solution (10 mL).  A 
Z/E mixture of the 1,3-diiodobut-2-ene product was extracted with Et2O (3 x 15 mL).  The 
combined organic phases were washed with a brine solution (15 mL), dried over Na2SO4 
and concentrated under vacuum.  The product was purified via column chromatography 
on silica gel (hexanes:Et2O = 20:1) to yield a brown oil (1.85 g, 84% yield, Z/E ~ 5/1).  
Further purification was conducted to obtain a high-quality NMR spectrum via column 
chromatography on silica gel eluted with hexanes to yield a yellow oil (Z/E ~ 14:1).  For 
(Z)-1,3-diiodobut-2-ene 1H NMR (500 MHz, CDCl3):  δ 5.7 (q, 1H), 3.9 (d, 2H), δ 2.5 (d, 
3H) which is consistent with previous published literature data.  13C{1H} NMR (500 MHz, 
CDCl3) δ 132.1, 106.9, 33.7, 9.4.  For (E)-1,3-diiodobut-2-ene 1H NMR (500 MHz, CDCl3):  
δ 6.0 (q, 1H), 4.4 (d, 2H), 1.7 (d, 3H).  13C{1H} NMR (500 MHz, CDCl3) δ 134.6, 105.5, 
22.7, 18.6. HRMS (EI): m/z calculated for (Z/E)-1,3-diiodobut-2-ene 307.8559, observed 
307.8560.   
 
4.3.2. Synthesis of (E)-1,3-diiodo-2-methylprop-1-ene 
S1. Diethyl methylmalonate 
 
 
Anhydrous ethanol (70 mL, 298 K) was added to a dry two-neck round bottom flask 
equipped with a reflux condenser and purged with N2.  Under the N2 purge, small pieces 
of metallic sodium (3.48 g, 150 mmol) were added very carefully to the stirred solution with 
effervescence observed.  After all the sodium had reacted, diethyl malonate (23.0 mL, 150 
EtO
O
OEt
O
EtO
O
OEt
O
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mmol) was added dropwise to the colorless solution.  The room temperature reaction 
mixture was treated with iodomethane (9.80 mL, 157 mmol) by dropwise addition over 5 
min and the pale-yellow mixture was heated to reflux at 80 oC.  After 10 h, the mixture was 
allowed to cool to room temperature and the reaction mixture was concentrated under 
reduced pressure and diluted with Et2O and water.  The aqueous layer was extracted with 
Et2O (3 x 20 mL).  The combined organic layers were dried over Na2SO4 and concentrated 
under reduced pressure to afford a colorless oil (25.4 g, 97%).  1H NMR (500 MHz, CDCl3) 
δ 4.28-4.10 (m, 4H), 3.42 (q, J = 7.3 Hz, 1H), 1.42 (d, J = 7.3 Hz, 3H), 1.27 (t, J = 7.1 Hz, 
6H). 13C{1H} NMR (125 MHz, CDCl3) δ 170.0, 61.2, 46.1, 13.9, 13.4.  The spectroscopic 
data were identical to a previous report[9].  The crude product was used in the next step 
without further purification. 
        
S2. Diethyl 2-(diiodomethyl)-2-methylmalonate  
 
 
Under an N2 atmosphere, a dry two-neck 250 mL round-bottom flask was loaded with NaH 
(60% dispersion in oil, 1.65 g, 69.0 mmol) and dry Et2O (50 mL) at room temperature (23 
oC).  Diethyl methylmalonate (10.0 g, 57.4 mmol) was added dropwise by syringe with 
vigorous stirring and the resulting thick mixture was refluxed at 40 oC for 3 h.  After being 
cooled to room temperature, the yellow solid CHI3 (22.6 g, 57.4 mmol) was added in one 
portion and the yellow mixture was refluxed under N2 for another 24 h.  The reaction vessel 
was cooled to 0 oC and opened to air. 10% Aqueous HCl solution (50 mL) was added 
EtO OEt
O O
EtO OEt
O O
CHI2
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dropwise over 20 min and the orange homogeneous solution stirred for 30 min at 0 oC.  
The organic layer was separated and the residual organic material from the aqueous layer 
was extracted with Et2O (3 x 20 mL).  The combined organic layers were dried over 
Na2SO4, decanted, and concentrated under reduced pressure.  The yellow residue was 
redissolved in petroleum ether (30 mL) and the precipitated CHI3 was removed by filtration.  
The filtrate was concentrated under reduced pressure to afford the title compound (20.2 
g, 80%) as a dark orange oil.  The product was used directly for the next step without any 
further purification. 
        
S3. (E)-3-Iodo-2-methylprop-2-enoic acid 
 
 
A solution of crude diethyl diiodomethylmethylmalonate (20.2 g, 45.9 mmol), KOH (5.14 
g, 91.8 mmol) and EtOH/H2O (3:1, 80 mL) was added to a round-bottom flask (250 mL) 
and refluxed under air at 85 oC for 24 h.  After cooling to RT, the light-orange mixture was 
concentrated under vacuum.  The residue was then redissolved in 10% aqueous K2CO3 
(60 mL) and the mixture was washed with CH2Cl2 (3 x 20 mL), acidified with 12 M HCl (80 
mL), and extracted with CH2Cl2 (10 x 20 mL).  The organic layer was dried over Na2SO4 
and concentrated in vacuum.  The remaining thick oil was purified by column 
chromatography on silica gel (hexanes: EtOAc = 10:1, 0.5% AcOH, Rf = 0.25) to provide 
the carboxylic acid (5.33 g, 55%) as a white solid.  1H NMR (300 MHz, CDCl3) δ 9.51-10.7 
EtO OEt
O O
CHI2
I OH
O
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(br s, 1H), 8.03 (s, 1H), 2.06 (s, 3H).  13C{1H} NMR (125 MHz, CDCl3) δ 169.3, 139.2, 
102.2, 19.9.  The spectroscopic data were identical to those previously reported[10].  
 
S4. (E)-3-Iodo-2-methylprop-2-en-1-ol 
 
 
A solution of carboxylic acid (1.36 g, 6.42 mmol) in THF (25 mL) was added to a 100 mL 
Schlenk flask under N2 atmosphere.  The colorless solution was cooled to 0 oC for 15 min.  
LiAlH4 (270 mg, 7.10 mmol) was added as a solid into the reaction mixture in three portions 
over a 30 min period to form a gray heterogeneous mixture.  The reaction mixture was 
allowed to warm to RT and stirred for 16 h.  The reaction mixture was then cooled to 0 oC, 
opened to air and quenched by dropwise addition of saturated aqueous Na2SO4 (2 mL) 
over 5 min.  The reaction mixture was diluted with Et2O (10 mL) and 2M aqueous H2SO4 
(10 mL).  The mixture was next extracted with CH2Cl2 (3 x 15 mL).  The combined organic 
layers were concentrated under reduced pressure and the remaining oil dissolved in 
CH2Cl2 (10 mL) and washed with 10% aqueous K2CO3 (10 mL).  The aqueous layer was 
extracted with CH2Cl2 (3 x 10 mL).  The combined organic layers were dried over Na2SO4 
and concentrated under reduced pressure.  The crude oil product was purified by column 
chromatography on silica gel (hexanes: EtOAc = 4:1, Rf = 0.2) to afford the alcohol (0.66 
g, 52%) as a pale-yellow oil.  1H NMR (500 Mz, CDCl3) δ 6.28 (s, 1H), 4.09 (d, J = 5.1 Hz, 
2H), 3.52 (t, J = 5.5 Hz, 1H), 1.77 (s, 3H).  13C{1H} NMR (125 MHz, CDCl3) δ 147.2, 76.8, 
66.5, 21.4.  The spectroscopic data were identical to those previous reported [13]. 
I OH
O
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S5. (E)-3-Iodo-2-methylallyl methanesulfonate 
 
 
 
Et3N (0.59 mL, 6.66 mmol) and methanesulfonyl chloride (0.39 mL, 4.50 mmol) followed 
by DMAP (40.7 mg, 0.333 mmol) was added to a solution of the alcohol (0.660 g, 3.33 
mmol) in dry CH2Cl2 (10 mL) at 0 oC under an N2 atmosphere.  After the addition was 
complete, the pale yellow mixture was warmed to room temperature and stirred for 8 h.  
The reaction mixture was filtered through a short pad of silica, the silica was washed with 
CH2Cl2 (2 x 5 mL) and the solvent was removed under reduced pressure to give the 
mesylated compound (0.754 g, 82%) as a yellow oil.  The crude oil was used in the next 
step without further purification. 
        
S6. (E)-1,3-Diiodo-2-methylprop-1-ene 4.2 
 
 
 
Acetone (10 mL) and NaI (0.614 g, 4.10 mmol) were added to a solution of mesylated 
compound (0.754 g, 2.73 mmol) at room temperature in a dark fume hood under air.  The 
I OH I OMs
I OMs I I
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yellow reaction mixture was wrapped with aluminum foil (to exclude light) and stirred for 6 
h.  The reaction mixture was then filtered through a short pad of silica and then the silica 
was washed with CH2Cl2 (2 x 10 mL).  The filtrate was washed with saturated aqueous 
Na2S2O3 solution (2 x10 mL).  The combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure.  The crude product was purified via column 
chromatography on silica gel (hexanes: EtOAc = 4:1, Rf = 0.8) to afford a yellow oil (0.714 
g, 85%).  1H NMR (500 MHz, CDCl3) δ 6.48 (d, J = 0.9Hz, 1H), 4.11 (d, J = 0.8 Hz, 2H), 
1.96 (d, J = 1.1 Hz, 3H).  13C{1H} NMR (125 MHz, CDCl3) δ 143.3, 82.0, 48.6, 21.8.  HRMS 
(EI): m/z calculated for C4H6I2 307.8580, found: 307.8559. Spectroscopic data for this 
compound was not previously reported [11]. 
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APPENDIX A: Chapter 1 1H and 13C{1H} NMR Spectra 
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Figure A-1. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3aa in CDCl3 
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Figure A-2. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ba in CDCl3 
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Figure A-3. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ca in CDCl3 
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Figure A-4. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3da in CDCl3 
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Figure A-5. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ea in CDCl3 
154 
 
 
 
Figure A-6. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3fa in CDCl3 
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Figure A-7. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ga in CDCl3 
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Figure A-8. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ha in CDCl3 
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Figure A-9. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ia in CDCl3 
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Figure A-10. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ab in CDCl3 
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Figure A-11. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ac in CDCl3 
160 
 
   
 
Figure A-12. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ad in CDCl3 
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Figure A-13. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ae in CDCl3 
162 
 
 
 
Figure A-14. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3af in CDCl3 
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Figure A-15. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ag in CDCl3 
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Figure A-16. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3ah in CDCl3 
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Figure A-17. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-4ba in CDCl3 
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Figure A-18. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-4fa in CDCl3 
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Figure A-19. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-4ia in CDCl3 
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Figure A-20. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-4aa in CDCl3 
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Figure A-21. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-4ab in CDCl3 
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Figure A-22. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-4ac in CDCl3 
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Figure A-23. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-4ja in CDCl3 
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Figure A-24. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-4jb in CDCl3 
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Figure A-25. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-4jd in CDCl3 
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Figure A-26. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-5jb in CDCl3 
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Figure A-27. 500 MHz 1H NMR and 13C{1H} NMR spectra of 1-3aj in CDCl3 
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Figure A-28. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3a in CDCl3 
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Figure A-29. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3b in CDCl3 
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Figure A-30. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3c in CDCl3 
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Figure A-31. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3d in CDCl3 
SS
181 
 
 
Figure A-32. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3e in CDCl3 
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Figure A-33. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3f in CDCl3 
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Figure A-34. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3g in CDCl3 
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Figure A-35. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3h in CDCl3 
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Figure A-36. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3i in CDCl3 
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Figure A-37. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3j in CDCl3 
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Figure A-38. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3k in CDCl3 
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Figure A-39. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3l in CDCl3 
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Figure A-40. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3m in CDCl3 
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Figure A-41. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3n in CDCl3 
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Figure A-42. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3o in CDCl3 
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Figure A-43. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3p in CDCl3 
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Figure A-44. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3q in CDCl3 
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Figure A-45. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3r in CDCl3 
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Figure A-46. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3s in CDCl3 
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Figure A-47. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3t in CDCl3 
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Figure A-48. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3u in CDCl3 
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Figure A-49. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3v in CDCl3 
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Figure A-50. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3w in CDCl3 
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Figure A-51. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3x in CDCl3 
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Figure A-52. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3y in CDCl3 
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Figure A-53. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-3z in CDCl3 
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Figure A-54. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-4z in CDCl3 
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Figure A-55. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-6z in CDCl3 
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Figure A-56. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-4b in CDCl3 
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Figure A-57. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-4k in CDCl3 
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Figure A-58. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-4s in CDCl3 
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Figure A-59. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-5e in CDCl3 
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Figure A-60. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-5t in CDCl3 
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Figure A-61. 500 MHz 1H NMR and 13C{1H} NMR spectra of 2-5u in CDCl3 
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Figure A-62. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3aa in CDCl3 
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Figure A-63. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ab in CDCl3 
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Figure A-64. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ac in CDCl3 
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Figure A-65. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ad in CDCl3 
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Figure A-66. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ae in CDCl3 
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Figure A-67. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3af in CDCl3 
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Figure A-68. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ag in CDCl3 
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Figure A-69. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ah in CDCl3 
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Figure A-70. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ba in CDCl3 
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Figure A-71. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ca in CDCl3 
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Figure A-72. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3da in CDCl3 
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Figure A-73. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ea in CDCl3 
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Figure A-74. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3fa in CDCl3 
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Figure A-75. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ga in CDCl3 
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Figure A-76. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ha in CDCl3 
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Figure A-77. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ia in CDCl3 
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Figure A-78. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ja in CDCl3 
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Figure A-79. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3a’a in CDCl3 
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Figure A-80. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ba’ in CDCl3 
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Figure A-81. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3ca’ in CDCl3 
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Figure A-82. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-3da’ in CDCl3 
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Figure A-83. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-4 in CDCl3 
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Figure A-84. 500 MHz 1H NMR and 13C{1H} NMR spectra of 3-5 in CDCl3 
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APPENDIX D: Chapter 4 1H and 13C{1H} NMR Spectra 
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Figure A-86. 500 MHz 1H NMR and 13C{1H} NMR spectra of 4-1 in CDCl3 
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Figure A-87. 500 MHz 1H NMR and 13C{1H} NMR spectra of 4-2 in CDCl3 
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APPENDIX E: Data from Computational Studies of The Reaction of 2-Aryl-1,3-
dithianes and [1.1.1]Propellane by Dr. Yexenia Nieves-Quinones 
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Details of Computational Studies for Determination of the Mechanism 
 
Optimizations of intermediates and transition states were performed using Gaussian 094 with 
unrestricted-spin DFT using UB3LYP functional and basis set 6-31+G(d,p) all atoms in the gas 
phase. For all species, vibrational frequencies were also computed at the specified level of theory 
to obtain thermal Gibbs free energy corrections (at 298 K) and to characterize the stationary points 
as transition states or minima. Single point energy calculations were performed on the optimized 
geometries in 1,4-dioxane solvent using SMD solvation model, UM06-2X functional, and basis set 
6-311+G(d,p) for all atoms. Calculated single-point energies were converted to the enthalpies and 
Gibbs free energies using corrections from gas-phase frequency calculations (Figure B-1) 
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Figure B-1. Energy profiles for propellylations of 2-phenyl-1,3-dithiane via a two-electron pathway 
(1a) and a single-electron transfer pathway (1b). The blue lines represent free energies for 
equatorial phenyl dithiane and the black lines represent free energies for axial phenyl dithiane. The 
enthalpy free energies are shown in the bracket.  
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Coordinates and thermochemical data for computed intermediates and transition 
states 
 
Additional structures used to obtain energy diagram: 
HMDS: 
Zero-point correction = 0.238201 (Hartree/Particle) 
Thermal correction to Energy = 0.255089 
Thermal correction to Enthalpy = 0.256033 
Thermal correction to Gibbs Free Energy = 0.194586 
Sum of electronic and zero-point Energies = -873.756472 
Sum of electronic and thermal Energies = -873.739584 
Sum of electronic and thermal Enthalpies = -873.738640 
Sum of electronic and thermal Free Energies = -873.800087 
Electronic Energy = -873.85624 
 
 N,0,-1.2323859679,1.2988156658,0.0204419464 
 Si,0,-2.7290875499,2.2083613086,-0.1005312258 
 Si,0,0.457989711,1.7524276894,0.1600035399 
 C,0,-4.1340849593,1.048946248,0.4077985081 
 H,0,-4.0190103717,0.7134881125,1.4447141435 
 H,0,-5.105849522,1.5493711126,0.3228785432 
 H,0,-4.1694471329,0.1586338683,-0.2321692535 
 C,0,-3.0429130345,2.8180265892,-1.8657498059 
242 
 
 H,0,-2.2375449063,3.4786511015,-2.2063570705 
 H,0,-3.0988767579,1.9773992879,-2.5672007669 
 H,0,-3.9844341243,3.3769640424,-1.9348194422 
 C,0,-2.6699263658,3.7091375389,1.0493896948 
 H,0,-3.5999775526,4.2859293002,0.9787352489 
 H,0,-2.5404097885,3.4047058349,2.0938248182 
 H,0,-1.848010845,4.3880674883,0.7943101487 
 C,0,1.4826379051,0.238570424,-0.3251729353 
 H,0,1.2889278123,-0.0603177031,-1.3616516274 
 H,0,2.5552063449,0.4451839452,-0.231544937 
 H,0,1.2585164528,-0.6194056704,0.3205433171 
 C,0,0.8480335115,3.2010826615,-0.9932119629 
 H,0,0.650176774,2.9403324323,-2.0387858762 
 H,0,0.2534455928,4.089892237,-0.7516961641 
 
H,0,1.9038805894,3.4859696146,-0.9102514134 
 C,0,0.9071394939,2.2600470606,1.9281691581 
 H,0,0.3146266917,3.1205714077,2.2591032643 
 H,0,0.7197546704,1.4401657191,2.6313606061 
 H,0,1.966272627,2.5351114127,2.0065804543 
 H,0,-1.3730271425,0.2933509908,-0.0080004404 
 
243 
 
HMDS anion: 
Zero-point correction = 0.223703 (Hartree/Particle) 
Thermal correction to Energy = 0.239640 
Thermal correction to Enthalpy = 0.240584 
Thermal correction to Gibbs Free Energy = 0.181632 
Sum of electronic and zero-point Energies = -873.183874 
Sum of electronic and thermal Energies = -873.167937 
Sum of electronic and thermal Enthalpies = -873.166993 
Sum of electronic and thermal Free Energies = -873.225945 
Electronic Energy = -873.30258 
 
 N,0,-1.1018057442,2.2110318653,0.0312502658 
 Si,0,-2.7307189275,2.440278977,0.0276373344 
 Si,0,0.5270328126,1.9822098259,0.0348447817 
 C,0,-3.7605618893,0.8126353747,0.0413696727 
 H,0,-3.5168218526,0.2158271584,0.9302753599 
 H,0,-4.8448872357,0.9983189325,0.041834544 
 H,0,-3.5198296791,0.2013957798,-0.8384405568 
 C,0,-3.3914960168,3.4081495678,-1.5009209341 
 H,0,-2.9229555642,4.3997924606,-1.554170359 
 H,0,-3.1378545777,2.8771178928,-2.42797313 
 H,0,-4.4824306145,3.5471884301,-1.4745666767 
244 
 
 C,0,-3.3960109834,3.4329008757,1.5384341591 
 H,0,-4.4874246105,3.5676397358,1.5075501529 
 H,0,-3.1427177005,2.9181378625,2.474688423 
 H,0,-2.9308013807,4.426887698,1.5760637484 
 C,0,1.0685029728,0.1339192655,0.0243096005 
 H,0,0.6726628338,-0.3747174185,-0.8647185004 
 H,0,2.1620470792,0.0140822555,0.0277127156 
 H,0,0.6660988923,-0.3854524794,0.904068709 
 C,0,1.4387839025,2.7532465311,-1.4766846712 
 H,0,1.0518158134,2.3293013423,-2.412753646 
 H,0,1.2650073832,3.8368997482,-1.5127971481 
 H,0,2.5252142771,2.582796996,-1.4480885204 
 C,0,1.4303016145,2.7299290599,1.5630921194 
 H,0,1.2595201456,3.8134281053,1.6144911554 
 H,0,1.0364950044,2.2930477215,2.4903425409 
 H,0,2.5163181441,2.556187916,1.5383577798 
 
[1.1.1]Propellane: 
Zero-point correction = 0.093328 (Hartree/Particle) 
Thermal correction to Energy = 0.097296 
Thermal correction to Enthalpy = 0.098240 
Thermal correction to Gibbs Free Energy = 0.067025 
245 
 
Sum of electronic and zero-point Energies = -193.932924 
Sum of electronic and thermal Energies = -193.928955 
Sum of electronic and thermal Enthalpies = -193.928011 
Sum of electronic and thermal Free Energies = -193.959226 
Electronic Energy = -193.99164 
 
 C,0,-2.1890700233,0.6438238068,0.0660478312 
 C,0,-0.6126570466,0.6409105141,0.0613197964 
 C,0,-1.3988608163,1.941663818,0.0639210161 
 H,0,-1.3950263052,2.5267846269,0.9801034851 
 H,0,-1.4004903075,2.5267025948,-0.852232313 
 C,0,-1.3990372186,-0.0073129847,1.1890856078 
 C,0,-1.4058814457,-0.0077597491,-1.0617336416 
 H,0,-1.3951600955,0.4935991801,2.1538862283 
 H,0,-1.4008783555,-1.0932173493,1.238043557 
 H,0,-1.4080401929,-1.0937346873,-1.1099938921 
 H,0,-1.407785343,0.4925404696,-2.0268446252 
 
Substrate 2-2a with Phenyl Axial: 
Zero-point correction = 0.196198 (Hartree/Particle) 
Thermal correction to Energy = 0.207083 
Thermal correction to Enthalpy = 0.208027 
246 
 
Thermal correction to Gibbs Free Energy = 0.158157 
Sum of electronic and zero-point Energies = -1184.502284 
Sum of electronic and thermal Energies = -1184.491398 
Sum of electronic and thermal Enthalpies = -1184.490454 
Sum of electronic and thermal Free Energies = -1184.540324 
Electronic Energy = -1184.5952 
 
 C,0,-1.0858080535,-1.2041000797,-0.2037550667 
 C,0,-0.6590119106,0.2664253491,-0.2473220252 
 C,0,-1.0836282804,1.068373898,0.9868077837 
 C,0,-3.3796077257,-0.542901253,1.3024589097 
 H,0,0.4381954547,0.2991104235,-0.3117165829 
 H,0,-0.6673370118,-1.706216771,0.676023836 
 H,0,-0.7242789134,-1.7349989698,-1.0893506837 
 H,0,-0.6650986481,0.6302761223,1.9001279103 
 H,0,-0.7206026438,2.0981463937,0.9188562126 
 H,0,-4.4723440691,-0.5043047942,1.2308001929 
 H,0,-1.0556836796,0.7405937124,-1.1516616601 
 S,0,-2.9024140104,1.2388518288,1.186594285 
 S,0,-2.9050055042,-1.4626664477,-0.2287430232 
 C,0,-3.0014093924,-1.234606731,2.6221327464 
 C,0,-2.8715156585,-2.631193074,2.6933123379 
247 
 
 C,0,-2.8692021259,-0.4981358304,3.8106282374 
 C,0,-2.6099889799,-3.2682480318,3.9090219284 
 H,0,-2.9745688674,-3.2217616479,1.7895211879 
 C,0,-2.6076770214,-1.1352338786,5.0263137952 
 H,0,-2.9704303577,0.5812822,3.7815854946 
 C,0,-2.4743564562,-2.5240562783,5.0827184897 
 H,0,-2.5128051287,-4.3501149731,3.9342378365 
 H,0,-2.5086717224,-0.5401192799,5.929947017 
 H,0,-2.2687932636,-3.0191233472,6.0274238505 
 
Substrate 2-2a with Phenyl Equatorial: 
Zero-point correction = 0.196066 (Hartree/Particle) 
Thermal correction to Energy = 0.207088 
Thermal correction to Enthalpy = 0.208032 
Thermal correction to Gibbs Free Energy = 0.158227 
Sum of electronic and zero-point Energies = -1184.507363 
Sum of electronic and thermal Energies = -1184.496341 
Sum of electronic and thermal Enthalpies = -1184.495397 
Sum of electronic and thermal Free Energies = -1184.545202 
Electronic Energy = -1184.5984 
 
 C,0,-2.3401650487,-0.1770872562,-0.1841724646 
248 
 
 C,0,-2.401696706,2.186167036,1.3378251714 
 C,0,-3.9325171877,2.1559342283,1.3471548436 
 C,0,-4.5190684723,0.7416268528,1.3369114994 
 H,0,-2.0113881777,-0.6595587878,0.7413969637 
 H,0,-2.0003717731,1.6372468407,2.1991280918 
 H,0,-2.0368930037,3.2151264335,1.4096412066 
 H,0,-4.2750670024,2.6574506547,2.2638832695 
 H,0,-4.3211070056,2.7260602511,0.4962714491 
 H,0,-4.1549039631,0.1673883638,2.1982197614 
 H,0,-5.6102437176,0.7772787137,1.4080627275 
 S,0,-4.1879770326,-0.2140860425,-0.1980358995 
 S,0,-1.6317262151,1.5299249967,-0.1969560183 
 C,0,-1.810275354,-0.9530435514,-1.3669572331 
 C,0,-1.0291520438,-2.0980882816,-1.1593022692 
 C,0,-2.086050258,-0.5480660981,-2.6822125357 
 C,0,-0.5317163482,-2.8265497622,-2.2422946203 
 H,0,-0.8093784844,-2.420822954,-0.1449092703 
 C,0,-1.5889751043,-1.2759998517,-3.7645853006 
 H,0,-2.6902938481,0.3376799459,-2.8532672655 
 C,0,-0.8106060224,-2.4169969821,-3.5484284527 
 H,0,0.0721482213,-3.7117572055,-2.0645470755 
 H,0,-1.8100314117,-0.9513961541,-4.7772717315 
249 
 
 H,0,-0.4245647306,-2.98232932,-4.3917098872 
Transition States and Intermediates: 
3-phenyl-1,3-dithiane (INT1): 
Zero-point correction = 0.275813 (Hartree/Particle) 
Thermal correction to Energy = 0.291377 
Thermal correction to Enthalpy = 0.292322 
Thermal correction to Gibbs Free Energy = 0.232874 
Sum of electronic and zero-point Energies = -1377.844752 
Sum of electronic and thermal Energies = -1377.829187 
Sum of electronic and thermal Enthalpies = -1377.828243 
Sum of electronic and thermal Free Energies = -1377.887691 
Electronic Energy = -1184.0452 
 
 C,0,-2.163900649,2.5286644299,1.0834856163 
 C,0,-3.6889375104,2.6410317285,0.9794993092 
 C,0,-4.4144774328,1.2979592984,1.1170820641 
 H,0,-1.8759867865,2.105155365,2.0536567682 
 H,0,-1.7058379513,3.521603628,1.0069137714 
 H,0,-4.0414599739,3.307794805,1.7827580146 
 H,0,-3.9568871373,3.1048023549,0.02268116 
 H,0,-4.1909059102,0.8390901554,2.0881218024 
 H,0,-5.4991190111,1.4472294148,1.0635035211 
250 
 
 S,0,-4.0369782228,0.095581815,-0.2195446871 
 S,0,-1.385826265,1.5452310963,-0.258876948 
 C,0,-1.7209455056,-1.0194096191,-1.2911559251 
 C,0,-2.2053838896,-0.0984331317,-0.0069431965 
 C,0,-1.9244696345,-0.687541364,-2.7779746378 
 C,0,-2.1671038612,-2.4569200813,-1.5724443165 
 C,0,-0.2765977293,-1.4229705598,-1.600507629 
 C,0,-1.1579573549,-2.0889561116,-2.7707606572 
 H,0,0.4110426117,-0.624192024,-1.9073581596 
 H,0,0.2069057438,-2.1155857036,-0.9005985931 
 H,0,-1.8287168817,-3.2289360522,-0.8704142244 
 H,0,-3.2173604823,-2.6086546985,-1.8534958563 
 H,0,-1.3711602695,0.1744974976,-3.1709912425 
 H,0,-2.9575615424,-0.6931741467,-3.1473707091 
 C,0,-1.821651883,-0.7650120278,1.2940289407 
 C,0,-2.6556004714,-1.732262467,1.8989863301 
 C,0,-0.5439617572,-0.5774822613,1.8678874719 
 C,0,-2.2496448246,-2.4423538172,3.0293081928 
 H,0,-3.6328516319,-1.9224477707,1.4693168146 
 C,0,-0.139526149,-1.2884000986,2.9982418509 
 H,0,0.1334705292,0.1371599303,1.4138080021 
 C,0,-0.9896955523,-2.2242948446,3.5980811293 
251 
 
 H,0,-2.9245109281,-3.1759787429,3.465342384 
 H,0,0.8518787279,-1.1107747069,3.4097529907 
 H,0,-0.6748115235,-2.7763375797,4.4800257779 
 
Transition State with phenyl equatorial (TSEquat.): 
Zero-point correction = 0.275017 (Hartree/Particle) 
Thermal correction to Energy = 0.290512 
Thermal correction to Enthalpy = 0.291456 
Thermal correction to Gibbs Free Energy = 0.231670 
Sum of electronic and zero-point Energies = -1377.837883 
Sum of electronic and thermal Energies = -1377.822389 
Sum of electronic and thermal Enthalpies = -1377.821444 
Sum of electronic and thermal Free Energies = -1377.881230 
Electronic Energy = -1378.0174 
 
 C,0,-0.9532033004,-1.2170794029,-0.2579209326 
 C,0,-0.9437633949,1.2039858131,1.2206312801 
 C,0,-2.4746659265,1.2446082104,1.2410416254 
 C,0,-3.1144059255,-0.146571463,1.2585644968 
 H,0,-0.5605116492,0.6587835474,2.0879311874 
 H,0,-0.5353153667,2.2199391649,1.2544058299 
 H,0,-2.7968366904,1.7823573711,2.147194675 
252 
 
 H,0,-2.837694306,1.8092254983,0.3727111901 
 H,0,-2.7908199811,-0.7026750477,2.1414289245 
 H,0,-4.2060701451,-0.0616713793,1.2945823295 
 C,0,-0.4630044964,-2.0150731718,-1.4068418192 
 C,0,0.8452722461,-1.8398098179,-1.9265000776 
 C,0,-1.213739513,-3.0902119773,-1.9470292595 
 C,0,1.3567758419,-2.6714903429,-2.9211462003 
H,0,1.469171242,-1.0435228071,-1.5353345443 
 C,0,-0.6972150878,-3.9184971966,-2.9421591098 
 H,0,-2.2134516417,-3.2824496227,-1.5726970221 
 C,0,0.5929855228,-3.7204232809,-3.4473455819 
 H,0,2.3662815613,-2.4965401725,-3.2880673579 
 H,0,-1.31298219,-4.7294459428,-3.3263239419 
 H,0,0.9922918727,-4.3651506056,-4.226087677 
 S,0,-0.2401692823,0.4819189524,-0.3103921054 
 S,0,-2.7972485088,-1.1528758844,-0.2437383878 
 C,0,-0.2857607096,-2.203728099,1.2858644772 
 C,0,1.1655373834,-2.1336448932,1.7169379002 
 C,0,-0.7573807936,-2.1461313824,2.7371350064 
 C,0,-0.2807070096,-3.7194802551,1.3204654375 
 H,0,-1.2443299296,-4.2225386331,1.4467920001 
 H,0,0.3635510884,-4.2364993559,0.6047904414 
253 
 
 C,0,0.4180575982,-3.1868256494,2.6475976349 
 H,0,-0.5556279986,-1.2291241657,3.302731683 
 H,0,-1.7493315764,-2.5542114575,2.9594497615 
 H,0,1.9149365164,-2.5381676559,1.0310333043 
 H,0,1.5041256199,-1.2098596248,2.1969600217 
 
Transition State with phenyl axial (TSAxial): 
Zero-point correction = 0.274489 (Hartree/Particle) 
Thermal correction to Energy = 0.289116 
Thermal correction to Enthalpy = 0.290061 
Thermal correction to Gibbs Free Energy = 0.232823 
Sum of electronic and zero-point Energies = -1377.844635 
Sum of electronic and thermal Energies = -1377.830008 
Sum of electronic and thermal Enthalpies = -1377.829064 
Sum of electronic and thermal Free Energies = -1377.886302 
Electronic Energy = -1378.0237 
 
 C,0,-0.3843956917,2.7499139374,-1.2856451879 
 C,0,-0.8826045276,3.4227128609,-0.0000029844 
 C,0,-0.3843799062,2.7499198469,1.2856361131 
 H,0,0.7120137772,2.7612754407,-1.3231510365 
 H,0,-0.7540753345,3.2931791605,-2.1637083781 
254 
 
 H,0,-0.5343411121,4.4682151915,-0.0000076837 
 H,0,-1.9794868159,3.4410794863,0.0000036743 
 H,0,0.712029968,2.7612832153,1.3231298189 
 H,0,-0.7540506658,3.2931876543,2.163701468 
 S,0,-0.9700979607,1.0177933922,1.4990900033 
 S,0,-0.9701156033,1.0177870838,-1.4990884667 
 C,0,-1.1314099651,-1.4631130436,-0.0000039271 
 C,0,-0.2888741288,0.2330801444,-0.0000003182 
 C,0,-2.6353021364,-1.679106237,0.0001316404 
 C,0,-0.9341054868,-2.4975984796,1.0894433454 
 C,0,-0.9343201228,-2.4974784228,-1.0896050364 
 C,0,-1.9316554266,-3.1011220781,-0.0000165566 
 H,0,-1.364272812,-2.2820628958,-2.0731793085 
 H,0,0.0501160748,-2.9686846876,-1.1637131683 
 H,0,0.0503449586,-2.9688132135,1.1633056711 
 H,0,-1.3638642576,-2.2822918803,2.0731264376 
 H,0,-3.1790939344,-1.3988165231,-0.9070427623 
 H,0,-3.178917444,-1.3989226093,0.9074446863 
 C,0,1.179290549,0.0189189156,-0.0000101073 
 C,0,1.9071236382,-0.1676142187,1.2043399955 
 C,0,1.9071047161,-0.1676283505,-1.2043694366 
 C,0,3.264397944,-0.4854661931,1.2013504241 
255 
 
 H,0,1.3869918108,-0.0557379106,2.149322665 
 C,0,3.2643791821,-0.4854803892,-1.2013972693 
 H,0,1.3869584726,-0.0557627293,-2.1493454391 
 C,0,3.9669163275,-0.6431689834,-0.0000279595 
 H,0,3.7787379089,-0.6138611746,2.1521225433 
 H,0,3.7787042467,-0.613886989,-2.1521758579 
 H,0,5.0258219077,-0.8888350507,-0.0000347116 
 
Anionic intermediate with equatorial phenyl (INT2): 
Zero-point correction = 0.276219 (Hartree/Particle) 
Thermal correction to Energy = 0.291782 
Thermal correction to Enthalpy = 0.292726 
Thermal correction to Gibbs Free Energy = 0.232881 
Sum of electronic and zero-point Energies = -1377.839464 
Sum of electronic and thermal Energies = -1377.823901 
Sum of electronic and thermal Enthalpies = -1377.822957 
Sum of electronic and thermal Free Energies = -1377.882803 
Electronic Energy = -1378.0261 
 
 C,0,-0.8259529392,-1.3800112507,-0.0282517272 
 C,0,-1.055862921,1.1657089698,1.3317758714 
 C,0,-2.5807998332,1.1448130386,1.2133279983 
256 
 
 C,0,-3.1615291271,-0.2690647416,1.2735911557 
 H,0,-0.7384217568,0.7081425448,2.2719341522 
 H,0,-0.685990811,2.1968311305,1.3175091114 
 H,0,-2.9991830256,1.7270882825,2.0496307094 
 H,0,-2.8888538658,1.6329313678,0.2803294323 
 H,0,-2.8842484058,-0.7597712473,2.2101427438 
 H,0,-4.2553669977,-0.2356153953,1.2224409943 
 C,0,-0.3230531511,-2.086451001,-1.2757731463 
 C,0,0.9267285595,-1.7737845487,-1.8476239814 
 C,0,-1.0224419106,-3.1829920286,-1.8204803555 
 C,0,1.4342263603,-2.4967204073,-2.928285732 
 H,0,1.5175370088,-0.9627169251,-1.4364938201 
 C,0,-0.5151394361,-3.9056178185,-2.9012260452 
 H,0,-1.9700306539,-3.4815592811,-1.3861124941 
 C,0,0.7156475169,-3.5659894039,-3.4710378036 
 H,0,2.4012924208,-2.2221604768,-3.3433709893 
 H,0,-1.0862167646,-4.7434145525,-3.2947046561 
 H,0,1.1104841079,-4.128375875,-4.3134325483 
 S,0,-0.1683855125,0.3734989745,-0.0659534713 
 S,0,-2.6955412173,-1.3386491206,-0.1421660148 
 C,0,-0.2880001967,-2.2154559516,1.2740017864 
 C,0,1.1853442381,-2.5700708397,1.5276228693 
257 
 
 C,0,-0.4155205668,-1.900120166,2.7805080215 
 C,0,-0.662648666,-3.6696932687,1.5966448342 
 H,0,-1.6937299456,-3.8533272884,1.9266435951 
 H,0,-0.3361069018,-4.4366521457,0.8830171459 
 C,0,0.3943597341,-3.2685481273,2.7393213375 
 H,0,0.1372486792,-1.0283982541,3.1580797179 
 H,0,-1.4205425054,-1.9481148244,3.2238079655 
 H,0,1.6635045195,-3.2464882913,0.8080297148 
 H,0,1.8548280066,-1.7415113773,1.7935814582 
 
Anionic intermediate with axial phenyl (INT2): 
Zero-point correction = 0.275813 (Hartree/Particle) 
Thermal correction to Energy = 0.291377 
Thermal correction to Enthalpy = 0.292322 
Thermal correction to Gibbs Free Energy = 0.232874 
Sum of electronic and zero-point Energies = -1377.844752 
Sum of electronic and thermal Energies = -1377.829187 
Sum of electronic and thermal Enthalpies = -1377.828243 
Sum of electronic and thermal Free Energies = -1377.887691 
Electronic Energy = -1378.0311 
 
C,0,-2.163900649,2.5286644299,1.0834856163 
258 
 
 C,0,-3.6889375104,2.6410317285,0.9794993092 
 C,0,-4.4144774328,1.2979592984,1.1170820641 
 H,0,-1.8759867865,2.105155365,2.0536567682 
 H,0,-1.7058379513,3.521603628,1.0069137714 
 H,0,-4.0414599739,3.307794805,1.7827580146 
 H,0,-3.9568871373,3.1048023549,0.02268116 
 H,0,-4.1909059102,0.8390901554,2.0881218024 
 H,0,-5.4991190111,1.4472294148,1.0635035211 
 S,0,-4.0369782228,0.095581815,-0.2195446871 
 S,0,-1.385826265,1.5452310963,-0.258876948 
 C,0,-1.7209455056,-1.0194096191,-1.2911559251 
 C,0,-2.2053838896,-0.0984331317,-0.0069431965 
 C,0,-1.9244696345,-0.687541364,-2.7779746378 
 C,0,-2.1671038612,-2.4569200813,-1.5724443165 
 C,0,-0.2765977293,-1.4229705598,-1.600507629 
 C,0,-1.1579573549,-2.0889561116,-2.7707606572 
 H,0,0.4110426117,-0.624192024,-1.9073581596 
 H,0,0.2069057438,-2.1155857036,-0.9005985931 
 H,0,-1.8287168817,-3.2289360522,-0.8704142244 
 H,0,-3.2173604823,-2.6086546985,-1.8534958563 
 H,0,-1.3711602695,0.1744974976,-3.1709912425 
 H,0,-2.9575615424,-0.6931741467,-3.1473707091 
259 
 
 C,0,-1.821651883,-0.7650120278,1.2940289407 
 C,0,-2.6556004714,-1.732262467,1.8989863301 
 C,0,-0.5439617572,-0.5774822613,1.8678874719 
C,0,-2.2496448246,-2.4423538172,3.0293081928 
 H,0,-3.6328516319,-1.9224477707,1.4693168146 
 C,0,-0.139526149,-1.2884000986,2.9982418509 
 H,0,0.1334705292,0.1371599303,1.4138080021 
 C,0,-0.9896955523,-2.2242948446,3.5980811293 
 H,0,-2.9245109281,-3.1759787429,3.465342384 
 H,0,0.8518787279,-1.1107747069,3.4097529907 
 H,0,-0.6748115235,-2.7763375797,4.4800257779 
 
Product with phenyl equatorial: 
Zero-point correction = 0.293140 (Hartree/Particle) 
Thermal correction to Energy = 0.308364 
Thermal correction to Enthalpy = 0.309309 
Thermal correction to Gibbs Free Energy = 0.249943 
Sum of electronic and zero-point Energies = -1378.474050 
Sum of electronic and thermal Energies = -1378.458826 
Sum of electronic and thermal Enthalpies = -1378.457882 
Sum of electronic and thermal Free Energies = -1378.517248 
Electronic Energy = -1378.6317 
260 
 
 
 C,0,-0.7968617787,-1.4110547183,0.0392685136 
 C,0,-1.0608373717,1.196600778,1.3293177528 
 C,0,-2.5760085839,1.1824043646,1.1358857776 
 C,0,-3.1721363991,-0.2185327034,1.2591867056 
 H,0,-0.7920399777,0.8038881334,2.3139462064 
 H,0,-0.6754215805,2.2193872333,1.2696139299 
 H,0,-3.0271913886,1.8188472752,1.9106630017 
 H,0,-2.8324621919,1.6124675598,0.1615468234 
 H,0,-2.9549370498,-0.6486720078,2.2412098251 
 H,0,-4.2609332216,-0.1843305692,1.151378613 
 C,0,-0.2951287271,-2.123966274,-1.2310370766 
 C,0,0.9190291395,-1.7697552909,-1.8404421699 
 C,0,-1.0042763524,-3.2131537366,-1.7650243689 
 C,0,1.396887427,-2.4651633663,-2.9540177422 
 H,0,1.5077368442,-0.9478555498,-1.4481916924 
 C,0,-0.527928816,-3.9082000725,-2.8786579139 
 H,0,-1.937586433,-3.5280512516,-1.3109249259 
 C,0,0.6750201189,-3.5366239043,-3.4820021045 
 H,0,2.3369645661,-2.1628900212,-3.4067351839 
 H,0,-1.1029875331,-4.7414377459,-3.2725529526 
 H,0,1.0446978536,-4.0749381863,-4.3499036846 
261 
 
 S,0,-0.109907786,0.3288393361,0.0200420343 
 S,0,-2.6661182453,-1.3813903868,-0.0682472235 
 C,0,-0.2985042941,-2.2028055267,1.2590065449 
 C,0,1.1961807462,-2.5523107085,1.5700982256 
 C,0,-0.4570439697,-1.9240496581,2.7945085019 
 C,0,-0.6278324722,-3.6978947274,1.5886337744 
 H,0,-1.6553980483,-3.9072469543,1.9009830038 
 H,0,-0.2596414126,-4.4437066199,0.8782352021 
 C,0,0.3645645792,-3.2350917582,2.6903555917 
 H,0,0.0709540048,-1.052149687,3.1929411657 
 H,0,-1.4644412568,-2.0146378134,3.2129797589 
 H,0,1.6969777709,-3.2138012351,0.857207061 
 H,0,1.8358804991,-1.7152427163,1.8654076057 
 H,0,0.7473878508,-3.8321028106,3.5204839197 
 
Product with phenyl axial: 
Zero-point correction = 0.292864 (Hartree/Particle) 
Thermal correction to Energy = 0.308109 
Thermal correction to Enthalpy = 0.309053 
Thermal correction to Gibbs Free Energy = 0.249647 
Sum of electronic and zero-point Energies = -1378.481030 
Sum of electronic and thermal Energies = -1378.465785 
262 
 
Sum of electronic and thermal Enthalpies = -1378.464841 
Sum of electronic and thermal Free Energies = -1378.524247 
Electronic Energy = -1378.6385 
 
C,0,-2.1582198087,2.5112330534,1.0790288947 
 C,0,-3.6815513247,2.6255663593,0.979664366 
 C,0,-4.4052185728,1.2830682765,1.1118620388 
 H,0,-1.8616291273,2.0745322867,2.0393975254 
 H,0,-1.6937200917,3.4995034679,1.0082975856 
 H,0,-4.0271637319,3.2794625322,1.7934000253 
 H,0,-3.9567079887,3.1037406433,0.0332540135 
 H,0,-4.1765324966,0.8096863212,2.0734217648 
 H,0,-5.4891672751,1.4250156633,1.063342078 
 S,0,-4.0483433899,0.0925433003,-0.2397700685 
 S,0,-1.3796901073,1.5518139724,-0.2792244683 
 C,0,-1.7528357472,-0.9620450758,-1.2421501266 
 C,0,-2.2037498432,-0.1053034618,-0.051286723 
 C,0,-1.9345044225,-0.6699543476,-2.7674956642 
 C,0,-2.1800825484,-2.4343050286,-1.5521887175 
 C,0,-0.2903224294,-1.4017247167,-1.5795250538 
 C,0,-1.1894983121,-2.0311888721,-2.6813536331 
 H,0,0.3958867112,-0.6100379013,-1.8961128209 
263 
 
 H,0,0.1842817639,-2.0910665383,-0.874698088 
 H,0,-1.8405812431,-3.1974628847,-0.8454011355 
 H,0,-3.2237822319,-2.587826355,-1.8437329809 
 H,0,-1.3726741701,0.1777857444,-3.1700888229 
 H,0,-2.9601182646,-0.6895280977,-3.147126906 
 C,0,-1.8038073764,-0.8010493296,1.2650999877 
 C,0,-2.65069519,-1.7438666384,1.8714512522 
 C,0,-0.5393810021,-0.5897262024,1.8399224562 
 C,0,-2.2537146721,-2.4399017541,3.0159674985 
 H,0,-3.6293863359,-1.9297647042,1.4430870546 
 C,0,-0.1414845822,-1.2852253094,2.9844115229 
 H,0,0.1353019276,0.1281744225,1.3868002092 
 C,0,-0.9974717967,-2.2127888292,3.5818430627 
 H,0,-2.9325635916,-3.1602023881,3.4642670279 
 H,0,0.8413178274,-1.0971695274,3.407940526 
 H,0,-0.6907832024,-2.7493610098,4.4751041385 
 H,0,-0.8614682937,-2.6535993811,-3.51621926
